{"meta":{"query_hash":"89014c6b0aca","filters":{"venue":"Regular and Young Investigator Award Abstracts"},"cohort_total":145,"direct_labels_cover":0,"predictions_cover":145,"exported":145,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/89014c6b0aca","api":"https://metacan.xera.ac/api/v1/cohort?venue=Regular+and+Young+Investigator+Award+Abstracts"},"results":[{"id":"W3100538981","doi":"10.1136/jitc-2020-sitc2020.0379","title":"379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CD8; Medicine; T-cell receptor; Internal medicine; Antigen; Cancer; T cell; Gastroenterology; Oncology; Immunology; Immune system","score_opus":0.05083607555745884,"score_gpt":0.29174663320772787,"score_spread":0.24091055765026903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100538981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877034,0.0016497744,0.000028218177,0.00748589,0.00013399094,0.0023831762,0.00021629038,0.00014620763,0.0002530504],"genre_scores_gemma":[0.9901129,0.00066925865,0.005553754,0.0009491079,0.0018634677,0.000045926816,0.000591942,0.00011506757,0.000098588986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963791,0.0005882738,0.0006779556,0.0009860826,0.0007941758,0.0005744064],"domain_scores_gemma":[0.9971172,0.00058232155,0.00034490082,0.00048388258,0.00020206957,0.0012696288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001627317,0.0005189734,0.000867628,0.000073188436,0.00048461626,0.00039574027,0.00022564101,0.00020883816,0.00015000334],"category_scores_gemma":[0.0012101245,0.0003587706,0.00009039772,0.0003097787,0.0010350824,0.0003364893,0.0001394323,0.0009105758,0.00001066612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.105397224,0.0007482465,0.03675377,0.00034661463,0.0008368751,0.00039514346,0.008434168,0.00013589933,0.8326491,0.000035106194,0.005593158,0.008674676],"study_design_scores_gemma":[0.31723574,0.015461815,0.109670185,0.0010727455,0.0010133969,0.00046271054,0.005204679,0.002866653,0.5051961,0.00036104108,0.03841686,0.0030380897],"about_ca_topic_score_codex":0.0005842632,"about_ca_topic_score_gemma":0.000038598224,"teacher_disagreement_score":0.32745305,"about_ca_system_score_codex":0.000052177103,"about_ca_system_score_gemma":0.00066705997,"threshold_uncertainty_score":0.99988645},"labels":[],"label_agreement":null},{"id":"W3101543312","doi":"10.1136/jitc-2020-sitc2020.0727","title":"727 Increased serum levels of EBI3 are associated with poor outcome in hepatocellular carcinoma patients and SRF388, a first-in-class IL-27 blocking antibody, inhibits the growth of murine liver tumors","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"TIGIT; Cancer research; Antibody; Cytokine; Hepatocellular carcinoma; Proinflammatory cytokine; Tumor microenvironment; Immune system; Biology; Medicine; Molecular biology; Immunology; T cell; Inflammation","score_opus":0.022493175923070513,"score_gpt":0.2240064407249474,"score_spread":0.2015132648018769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101543312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629503,0.0006061092,8.759733e-7,0.0021789493,0.000042089447,0.0006675317,0.00015698379,0.000020397247,0.000032037082],"genre_scores_gemma":[0.99907756,0.00005413226,0.0000428385,0.0007052981,0.000026353986,0.0000074976674,0.000029384684,0.00003607431,0.00002087118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980083,0.000105310326,0.0007361396,0.00037727298,0.00044559705,0.00032735764],"domain_scores_gemma":[0.99876684,0.00010392648,0.0004898884,0.00018916595,0.00015749456,0.000292661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044900278,0.0002957058,0.0007089576,0.00015348916,0.0000619027,0.000020773026,0.00011687446,0.00015235404,0.000008611059],"category_scores_gemma":[0.00053659506,0.00021490465,0.0000880442,0.0004963267,0.000389228,0.00012539599,0.000069573674,0.00029087428,4.4078882e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005361879,0.00015187252,0.9765156,0.0006507864,0.00011677099,0.00018406229,0.001219132,0.0000048633865,0.020513847,0.000009457616,0.00003624752,0.00006118421],"study_design_scores_gemma":[0.0053931456,0.0004242416,0.92970914,0.0012444862,0.000106276726,0.000027994905,0.00024819453,0.0006548507,0.06192373,0.000015019199,0.00003358583,0.0002193599],"about_ca_topic_score_codex":0.0018474652,"about_ca_topic_score_gemma":0.00045156924,"teacher_disagreement_score":0.046806473,"about_ca_system_score_codex":0.000098051576,"about_ca_system_score_gemma":0.00019904009,"threshold_uncertainty_score":0.87635577},"labels":[],"label_agreement":null},{"id":"W3102487262","doi":"10.1136/jitc-2020-sitc2020.0597","title":"597 In situ vaccination with oncolytic vesicular stomatitis virus improves anti-tumor immune response and outcome in bladder cancer","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Oncolytic virus; Vesicular stomatitis virus; Immune system; Medicine; Vaccination; Cancer; Vesicular Stomatitis; Bladder cancer; Virus; Virology; Immunology; Internal medicine","score_opus":0.01603602895359507,"score_gpt":0.27865911129045634,"score_spread":0.26262308233686127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102487262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942969,0.002935524,0.000009679398,0.0022140983,0.000038114085,0.00043664526,0.000018451814,0.000017560735,0.000033010783],"genre_scores_gemma":[0.9983176,0.0004076096,0.0002280732,0.0008052639,0.00006790568,0.000057957113,0.000025478077,0.00004261334,0.00004747533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832076,0.0001921696,0.0003808111,0.0005086336,0.000243298,0.00035434758],"domain_scores_gemma":[0.9992041,0.000025940988,0.000119892306,0.00025116745,0.000069545385,0.00032937777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053946767,0.0002452848,0.00031408793,0.000113641014,0.000065100976,0.00007194877,0.00014227717,0.00014332315,0.0000069276725],"category_scores_gemma":[0.0003355972,0.00022554022,0.00003593885,0.0002675826,0.00015281668,0.000028646777,0.00008250607,0.00022978571,0.0000029225785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014873361,0.00004414558,0.027764581,0.00008847344,0.000048898182,0.00012339398,0.0002933432,0.0002383327,0.9689092,0.0000057962834,0.000065849956,0.0009306478],"study_design_scores_gemma":[0.0014216487,0.0008863176,0.46960762,0.00004589647,0.000014916984,0.000026092535,0.000102692895,0.00020089222,0.5270298,0.000021693317,0.00040901024,0.00023343967],"about_ca_topic_score_codex":0.00028135025,"about_ca_topic_score_gemma":0.001206046,"teacher_disagreement_score":0.44187942,"about_ca_system_score_codex":0.0000550337,"about_ca_system_score_gemma":0.00039109713,"threshold_uncertainty_score":0.9197264},"labels":[],"label_agreement":null},{"id":"W3103244011","doi":"10.1136/jitc-2020-sitc2020.0351","title":"351 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Oncology; Immunotherapy; Head and neck squamous-cell carcinoma; Chemotherapy; Internal medicine; Head and neck cancer; Head and neck; Radiation therapy; Surgery; Cancer","score_opus":0.04785480680630224,"score_gpt":0.2749732537829019,"score_spread":0.22711844697659964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103244011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650548,0.02307801,0.000033119682,0.008710152,0.00017637732,0.0025837068,0.000094045456,0.00013760194,0.00013215822],"genre_scores_gemma":[0.9835534,0.005736013,0.002357332,0.0074879387,0.00024487122,0.00017648509,0.00008322606,0.0001688876,0.00019186408],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99700844,0.000112516835,0.00071547227,0.0010408906,0.00046447944,0.0006581715],"domain_scores_gemma":[0.998082,0.00023221054,0.0004285347,0.00042341516,0.0000914569,0.0007424142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040814708,0.0007644002,0.0010332785,0.0001602929,0.00035936054,0.00025567983,0.00015009876,0.00027563405,0.000026602045],"category_scores_gemma":[0.00008447516,0.0006462506,0.0001752442,0.0002236778,0.00068954786,0.00026652563,0.000033196524,0.0004218906,0.0000016597029],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15464878,0.0014390302,0.12687863,0.0053668944,0.0015793189,0.00021869189,0.036529865,0.000022145081,0.3291618,0.00046752716,0.009133747,0.33455357],"study_design_scores_gemma":[0.13827372,0.026969176,0.5641825,0.0010319623,0.0003397747,0.00066279044,0.0017778515,0.0031386751,0.18517195,0.0008580867,0.0750327,0.0025608107],"about_ca_topic_score_codex":0.00013502852,"about_ca_topic_score_gemma":0.000017337221,"teacher_disagreement_score":0.43730387,"about_ca_system_score_codex":0.000081053506,"about_ca_system_score_gemma":0.00034438042,"threshold_uncertainty_score":0.99959886},"labels":[],"label_agreement":null},{"id":"W3103606205","doi":"10.1136/jitc-2020-sitc2020.0307","title":"307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Pritzker School of Medicine; American Society of Hematology","keywords":"Vemurafenib; Internal medicine; Medicine; Atezolizumab; Hazard ratio; Oncology; Progression-free survival; Melanoma; Pembrolizumab; Immunotherapy; Cancer research; Cancer; Overall survival; Metastatic melanoma; Confidence interval","score_opus":0.00991258563327047,"score_gpt":0.21943228970482428,"score_spread":0.20951970407155382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103606205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979126,0.00036019264,0.0000033636177,0.00041951126,0.00005130564,0.0011741841,0.00003619383,0.000014441783,0.000028198137],"genre_scores_gemma":[0.99933594,0.000013851328,0.00014397566,0.00019528411,0.000089656554,0.00005668606,0.00011798094,0.000025871122,0.000020759433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852204,0.00015859463,0.00032217745,0.00049017166,0.00024949524,0.00025754224],"domain_scores_gemma":[0.9993579,0.000024864341,0.00014146495,0.0001974537,0.000053177777,0.00022516206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032047954,0.00026300692,0.0003215451,0.000050068902,0.00009292835,0.0000882907,0.00012150406,0.00011432534,9.033142e-7],"category_scores_gemma":[0.00016935907,0.00018568683,0.000023065633,0.00010359764,0.000156756,0.000028865503,0.00007049189,0.00019484796,6.943601e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012657648,0.00044688283,0.83115125,0.00035053355,0.00016386088,0.00046394783,0.006628434,0.00026023446,0.15779656,0.0000936368,0.00012324257,0.0012556468],"study_design_scores_gemma":[0.010765829,0.0026445668,0.94720066,0.000056568755,0.00007808321,0.000034046552,0.001953762,0.000116896816,0.035946965,0.00008115986,0.0006322903,0.00048918085],"about_ca_topic_score_codex":0.00019146754,"about_ca_topic_score_gemma":0.0001731319,"teacher_disagreement_score":0.1218496,"about_ca_system_score_codex":0.000014731836,"about_ca_system_score_gemma":0.00018280798,"threshold_uncertainty_score":0.75720894},"labels":[],"label_agreement":null},{"id":"W3103926827","doi":"10.1136/jitc-2020-sitc2020.0155","title":"155 iPSC-derived NK cells mediate robust anti-tumor activity against glioblastoma","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Cancer research; Immunotherapy; Adoptive cell transfer; NK-92; Cytotoxicity; Perforin; Biology; Immunology; Interleukin 21; Immune system; CD8; T cell; In vitro","score_opus":0.03077527250515736,"score_gpt":0.25573247412130745,"score_spread":0.2249572016161501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103926827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904399,0.00032668028,0.00003463042,0.005609647,0.000330044,0.0007528602,0.00003716172,0.00026618943,0.002202919],"genre_scores_gemma":[0.9949847,0.00048410866,0.0004733313,0.0025227757,0.00073677476,0.000024276093,0.000027444114,0.000114587405,0.0006320299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99684066,0.00015028559,0.0004771126,0.0008232445,0.00091901596,0.00078965793],"domain_scores_gemma":[0.99656725,0.000105171515,0.00020327432,0.0005435189,0.00016828549,0.002412495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047895883,0.00047065062,0.0007854898,0.000156024,0.00020384754,0.00014689949,0.00024160216,0.00024546485,0.00024391076],"category_scores_gemma":[0.00056214555,0.0004368229,0.00022418927,0.00044659275,0.00061829755,0.00028856902,0.00015553743,0.0008181664,0.00015842257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003834572,0.0001271896,0.0025944328,0.0004542587,0.00014207952,0.0012931027,0.0005437895,0.00022632687,0.9877215,0.000012983098,0.00406427,0.0024366206],"study_design_scores_gemma":[0.0026852973,0.00058949227,0.031133218,0.00023606732,0.00012556122,0.00024762747,0.00020747747,0.0029173822,0.9470398,0.000036886933,0.014239373,0.00054186117],"about_ca_topic_score_codex":0.00006286561,"about_ca_topic_score_gemma":0.000020609641,"teacher_disagreement_score":0.04068173,"about_ca_system_score_codex":0.00011696312,"about_ca_system_score_gemma":0.00061004,"threshold_uncertainty_score":0.9998084},"labels":[],"label_agreement":null},{"id":"W3104499934","doi":"10.1136/jitc-2020-sitc2020.0498","title":"498 Downregulation of CD5 in CD8+ T tumour-infiltrating lymphocytes associates with increased level of activation and exhaustion","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"CD5; CD8; T cell; Molecular biology; T-cell receptor; CD28; Biology; Cytotoxic T cell; Cancer research; Flow cytometry; Chemistry; Immunology; Antigen; Immune system; In vitro; Biochemistry","score_opus":0.04433985947392986,"score_gpt":0.2528445104636845,"score_spread":0.20850465098975463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104499934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998241,0.00027333613,0.000060943115,0.0010197955,0.000012609362,0.00025640184,0.000019690575,0.000019030216,0.000097192235],"genre_scores_gemma":[0.9983969,0.00006168819,0.0012326471,0.00018063601,0.000043332257,0.0000056827193,0.000051430558,0.000014670273,0.000013068972],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989964,0.000039765164,0.00039075656,0.00020096064,0.00024342291,0.00012871948],"domain_scores_gemma":[0.99929273,0.00006431941,0.00031367055,0.00008502967,0.00008973805,0.00015450858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000282181,0.00013887632,0.0003145728,0.00008760088,0.000038020473,0.000015956199,0.000030262558,0.00010612028,0.000005194827],"category_scores_gemma":[0.000296178,0.00011810594,0.00003511037,0.00023198267,0.00019492955,0.00018952221,0.0000112006,0.00008948093,2.0053311e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075443235,0.000035836318,0.17585179,0.00034110085,0.0000663261,0.000003957398,0.0008620227,0.000062216466,0.8209138,0.000047780875,0.00005579758,0.0010049685],"study_design_scores_gemma":[0.0018363324,0.00017999139,0.59258413,0.00044085542,0.000042940686,0.0000162083,0.00028829442,0.0004933266,0.40397638,0.00004076552,0.00002171649,0.00007903606],"about_ca_topic_score_codex":0.00081824383,"about_ca_topic_score_gemma":0.00004356601,"teacher_disagreement_score":0.41693738,"about_ca_system_score_codex":0.00006576618,"about_ca_system_score_gemma":0.0002463338,"threshold_uncertainty_score":0.48162204},"labels":[],"label_agreement":null},{"id":"W3104819140","doi":"10.1136/jitc-2020-sitc2020.0428","title":"428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tolerability; Vismodegib; Internal medicine; Clinical endpoint; Interim analysis; Basal cell carcinoma; Progression-free survival; Oncology; Surgery; Gastroenterology; Randomized controlled trial; Chemotherapy; Adverse effect; Basal cell","score_opus":0.02856484540316573,"score_gpt":0.270789013981223,"score_spread":0.2422241685780573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104819140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978448,0.00014749133,0.00010150575,0.0005085811,0.00006380789,0.00081438356,0.00046765173,0.000013276338,0.000038493934],"genre_scores_gemma":[0.9978396,0.000006512205,0.0010828807,0.0005362239,0.00006730432,0.00007272125,0.00031643407,0.000040020015,0.000038296774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793136,0.00007707924,0.0006454673,0.00070643186,0.00028490854,0.0003547381],"domain_scores_gemma":[0.99862415,0.000046016536,0.00033334477,0.00032539494,0.00021557741,0.00045554637],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025897988,0.000340135,0.00066053495,0.00020777494,0.000071078495,0.00003675068,0.00017496945,0.00011225422,0.0000013002361],"category_scores_gemma":[0.0007331726,0.00026614897,0.00013459624,0.0005152943,0.00017310423,0.000012090187,0.00009176711,0.00012188165,0.0000011856806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03979018,0.0039335843,0.2824783,0.0027658523,0.0036468562,0.00021991966,0.012972513,0.010648336,0.62825304,0.00002269762,0.013021066,0.0022476348],"study_design_scores_gemma":[0.011029483,0.00786678,0.13577117,0.0003307151,0.0007527742,0.0000010422197,0.0007115796,0.0008667976,0.8401536,0.0000066967023,0.0018446437,0.00066472957],"about_ca_topic_score_codex":0.000029567173,"about_ca_topic_score_gemma":0.00008719794,"teacher_disagreement_score":0.21190053,"about_ca_system_score_codex":0.000032292824,"about_ca_system_score_gemma":0.00017353281,"threshold_uncertainty_score":0.9999791},"labels":[],"label_agreement":null},{"id":"W3105595935","doi":"10.1136/jitc-2020-sitc2020.0054","title":"54 Patient stratification using clinical proteomics – validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Caprion (Canada)","funders":"","keywords":"Biomarker; Biomarker discovery; Quantitative proteomics; Multiplex; Selected reaction monitoring; Proteomics; Repeatability; Reproducibility; Computational biology; Chemistry; Biology; Mass spectrometry; Bioinformatics; Tandem mass spectrometry; Chromatography; Biochemistry","score_opus":0.0894014995236722,"score_gpt":0.3655048005106565,"score_spread":0.27610330098698427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105595935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572605,0.000105469626,0.0015869611,0.0014015238,0.000050263432,0.0007738494,0.000075982214,0.00015293552,0.00012698167],"genre_scores_gemma":[0.8605065,0.0000676941,0.13856077,0.00056848396,0.00012430825,0.00007451189,0.000036530953,0.000049528633,0.000011663603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974548,0.00008960546,0.0011914921,0.0007678292,0.00019897801,0.00029727598],"domain_scores_gemma":[0.9983327,0.00010630623,0.0003794053,0.00039021226,0.00007416319,0.0007172454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005835477,0.00027343328,0.00042164754,0.00004866655,0.00011883948,0.00011209064,0.00017285283,0.00037654702,0.0000117408],"category_scores_gemma":[0.0008046896,0.0002777033,0.00008347032,0.00019973678,0.0002980736,0.00014155463,0.00010411423,0.00043145937,0.000006669316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021107611,0.00025797662,0.17358984,0.00021891818,0.000115925075,0.000022420414,0.0007689993,0.00029493173,0.8147523,0.000789188,0.000449119,0.008529343],"study_design_scores_gemma":[0.0019749245,0.0003282671,0.03276715,0.00050925446,0.0001254143,0.000043892716,0.0007039111,0.020224355,0.9190235,0.0026325209,0.020399472,0.0012673364],"about_ca_topic_score_codex":0.00023828063,"about_ca_topic_score_gemma":0.000040690575,"teacher_disagreement_score":0.1408227,"about_ca_system_score_codex":0.000044581553,"about_ca_system_score_gemma":0.00013340489,"threshold_uncertainty_score":0.9999675},"labels":[],"label_agreement":null},{"id":"W3105826467","doi":"10.1136/jitc-2020-sitc2020.0075","title":"75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Generalizability theory; Blockade; CTLA-4; Cancer; Cancer therapy; Medicine; Oncology; Internal medicine; Immunology; Immune system; Mathematics; T cell; Receptor; Statistics","score_opus":0.02573454979681641,"score_gpt":0.2777691241262219,"score_spread":0.2520345743294055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105826467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985819,0.0038948723,0.0000072317557,0.009625307,0.00010161364,0.00045678936,0.00004618939,0.000018347422,0.000030695424],"genre_scores_gemma":[0.99700516,0.0009549151,0.0005616233,0.0013447852,0.000060494167,0.000015219768,0.0000057821508,0.00002073901,0.00003128562],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99854994,0.00012088731,0.00050887774,0.00034254225,0.00026436584,0.00021337571],"domain_scores_gemma":[0.9990795,0.000040254377,0.00014612656,0.00021463321,0.0000763081,0.00044315212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005740383,0.00018439634,0.00043863372,0.00012017149,0.000031257117,0.000012568913,0.00007758241,0.00013064242,0.000028571698],"category_scores_gemma":[0.00022457103,0.00015974161,0.000090161884,0.00032971427,0.0004009737,0.00006409256,0.000033838107,0.00011027398,4.2252438e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009455079,0.000072165436,0.07719027,0.00019637014,0.00016504111,0.000023951876,0.0013799904,0.000038015736,0.9075911,0.000003882917,0.0006655342,0.003218595],"study_design_scores_gemma":[0.0027424642,0.0005779046,0.60280365,0.0001516138,0.00003925309,0.000023096136,0.00013044634,0.00008593677,0.39133698,0.000031477317,0.0019414086,0.00013573669],"about_ca_topic_score_codex":0.001561173,"about_ca_topic_score_gemma":0.00003095337,"teacher_disagreement_score":0.5256134,"about_ca_system_score_codex":0.000046128655,"about_ca_system_score_gemma":0.00028782964,"threshold_uncertainty_score":0.6514074},"labels":[],"label_agreement":null},{"id":"W3113081454","doi":"10.1136/jitc-2020-sitc2020.0265","title":"265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Interim analysis; Interim; Avelumab; Cohort; Urothelial carcinoma; Oncology; Medicine; Internal medicine; Political science; Bladder cancer; Immunotherapy; Cancer; Clinical trial","score_opus":0.01670594694064256,"score_gpt":0.26632339166413244,"score_spread":0.24961744472348987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113081454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774086,0.00015546032,0.000012834041,0.00037765916,0.000094105846,0.0012613869,0.00025005103,0.000046869347,0.000060742794],"genre_scores_gemma":[0.9987627,0.000025747775,0.0003264971,0.0003689391,0.000082948565,0.00003122158,0.0003383622,0.000042275096,0.000021264581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710554,0.00010897045,0.0010332627,0.0007649749,0.0006354692,0.00035181176],"domain_scores_gemma":[0.9983116,0.000050036382,0.00045373867,0.0005149146,0.00015714052,0.00051256357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031366144,0.00036035303,0.0009902021,0.00024603674,0.00007656832,0.00003887249,0.00015362156,0.00012594654,0.000018705276],"category_scores_gemma":[0.00025004917,0.00029225726,0.00015380049,0.00075040804,0.00023738606,0.00019398498,0.000060866354,0.0002802466,0.0000023003468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03773657,0.0035056677,0.9098084,0.00012377505,0.0018940622,0.00024748567,0.00988936,0.0002405701,0.03396284,0.0000010905238,0.00018258131,0.00240762],"study_design_scores_gemma":[0.044526692,0.005237709,0.93079704,0.0003007904,0.00090256624,0.0000042700467,0.0014385632,0.0003957526,0.015979094,0.0000053291155,0.00009615445,0.00031603387],"about_ca_topic_score_codex":0.0024393261,"about_ca_topic_score_gemma":0.0003500867,"teacher_disagreement_score":0.020988664,"about_ca_system_score_codex":0.000106568594,"about_ca_system_score_gemma":0.00030853637,"threshold_uncertainty_score":0.999953},"labels":[],"label_agreement":null},{"id":"W3113360743","doi":"10.1136/jitc-2020-sitc2020.0020","title":"20 Quantification of sBCMA in human plasma using a high-throughput mass spectrometry workflow for exploratory, CAP/CLIA or regulated studies","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Caprion (Canada)","funders":"","keywords":"Chemistry; Chromatography; Mass spectrometry; Peptide; Selected reaction monitoring; Tandem mass spectrometry; Biochemistry","score_opus":0.1380512454315843,"score_gpt":0.3556764921383321,"score_spread":0.21762524670674777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113360743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995715,0.0009142217,0.00019090324,0.0018889754,0.000115482595,0.001032038,0.00006079688,0.000060620765,0.000021935408],"genre_scores_gemma":[0.9826815,0.00011893574,0.01656069,0.000096844065,0.00015804198,0.000055118293,0.00013352,0.000050284605,0.00014503796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978837,0.00008455177,0.00060968794,0.0005483413,0.00042484616,0.0004488707],"domain_scores_gemma":[0.99850357,0.000117909585,0.00025390557,0.0003200735,0.00020788821,0.0005966774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035208245,0.00029143685,0.0007244137,0.0002270476,0.00014308227,0.000038752132,0.000105094434,0.0001685299,0.000012084347],"category_scores_gemma":[0.0010928045,0.00023873625,0.000099879355,0.0005210178,0.00035004155,0.00021451095,0.000037327405,0.00021342517,0.000004509431],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001552856,0.00027983604,0.048465937,0.0017945616,0.00082225417,0.00038764617,0.0017035155,0.00035326276,0.9420641,0.00042209,0.0015410866,0.0006128204],"study_design_scores_gemma":[0.012110361,0.0018383004,0.15393046,0.0015444532,0.00046741127,0.00008560426,0.0025047234,0.0081566665,0.8167805,0.0014722954,0.00050628814,0.00060295],"about_ca_topic_score_codex":0.0001342007,"about_ca_topic_score_gemma":0.00008885083,"teacher_disagreement_score":0.12528364,"about_ca_system_score_codex":0.00016484632,"about_ca_system_score_gemma":0.00032305325,"threshold_uncertainty_score":0.97353816},"labels":[],"label_agreement":null},{"id":"W3211713559","doi":"10.1136/jitc-2021-sitc2021.459","title":"459 Phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1–positive metastatic NSCLC","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Pembrolizumab; TIGIT; Medicine; Internal medicine; Oncology; Lung cancer; Antibody; Phases of clinical research; Chemotherapy; Immunotherapy; Cancer; Immunology","score_opus":0.013459531560581944,"score_gpt":0.2621275120378249,"score_spread":0.24866798047724298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211713559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773914,0.0007375735,0.000011226836,0.00030047394,0.000049612998,0.0009396833,0.00004770703,0.000024744822,0.00014986178],"genre_scores_gemma":[0.99896324,0.00011441889,0.00050125574,0.00018133667,0.000022627404,0.000027796717,0.00007849979,0.000043393517,0.00006741625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813557,0.00008051176,0.00048761256,0.00049617706,0.00049161015,0.00030852208],"domain_scores_gemma":[0.99879694,0.00004372636,0.00023938733,0.00034432826,0.00024478912,0.0003308015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001984266,0.00032305872,0.00070474745,0.00016846108,0.00009687251,0.000048588547,0.0000593693,0.000072242474,0.000011237984],"category_scores_gemma":[0.0000829746,0.0002361718,0.000046677535,0.00038950954,0.00038536725,0.00020102157,0.000035216948,0.00021452982,6.3404576e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011735657,0.0034651894,0.9752382,0.0004199701,0.00097836,0.00039903514,0.0028761963,0.000034442535,0.0026682345,0.0000100277775,0.000044884786,0.0021298057],"study_design_scores_gemma":[0.04754683,0.00494136,0.9320618,0.0009848981,0.0005746031,0.00027047153,0.0011561686,0.000059002305,0.011897276,0.000015398542,0.00017720352,0.00031501142],"about_ca_topic_score_codex":0.0004712099,"about_ca_topic_score_gemma":0.00059261476,"teacher_disagreement_score":0.04317642,"about_ca_system_score_codex":0.0000665637,"about_ca_system_score_gemma":0.00034897562,"threshold_uncertainty_score":0.9630807},"labels":[],"label_agreement":null},{"id":"W3212221590","doi":"10.1136/jitc-2021-sitc2021.587","title":"587 Inducing mismatch repair deficiency in combination with anti-CTLA4 therapy is highly effective against non-immunogenic neuroblastoma tumors","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Neuroblastoma; Cancer research; Immunotherapy; Medicine; Melanoma; DNA mismatch repair; Tumor-infiltrating lymphocytes; Flow cytometry; Nivolumab; Antibody; MLH1; Cancer; Oncology; Immunology; Internal medicine; Biology; Cell culture; Colorectal cancer","score_opus":0.010589970114445417,"score_gpt":0.24355012770787968,"score_spread":0.23296015759343425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212221590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656576,0.00067807175,0.0000046368846,0.0009757123,0.000104826344,0.0009162705,0.000009772615,0.00012194712,0.0006230142],"genre_scores_gemma":[0.99814445,0.00026956305,0.00036770757,0.0007653304,0.000037480717,0.00006625911,0.000045705998,0.00006362334,0.0002398929],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99747247,0.00016354138,0.00041896,0.00074593246,0.00061712344,0.0005819778],"domain_scores_gemma":[0.99847865,0.000102757316,0.00014888737,0.0004982215,0.00021516418,0.000556321],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002944476,0.00036712585,0.00052059797,0.0002601176,0.00019307615,0.00009063726,0.00009815579,0.00014244259,0.000007962748],"category_scores_gemma":[0.00022701292,0.00030552896,0.00013478707,0.0007006042,0.00025685751,0.00026865385,0.00006146318,0.0004949017,0.0000216957],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007302845,0.00213075,0.26798734,0.00062144554,0.00041958803,0.011319583,0.0022942475,0.00012890782,0.7080312,0.00007639528,0.0008228155,0.005437452],"study_design_scores_gemma":[0.004508867,0.0010289218,0.6644456,0.0005422885,0.000039235798,0.0006882008,0.00014913129,0.00020338545,0.327934,0.000074224845,0.00016289848,0.00022324546],"about_ca_topic_score_codex":0.00015849817,"about_ca_topic_score_gemma":0.00004228727,"teacher_disagreement_score":0.39645827,"about_ca_system_score_codex":0.00014961523,"about_ca_system_score_gemma":0.00066601654,"threshold_uncertainty_score":0.9999397},"labels":[],"label_agreement":null},{"id":"W3212274217","doi":"10.1136/jitc-2021-sitc2021.374","title":"374 A phase IB trial of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Sanofi","keywords":"Pembrolizumab; Aflibercept; Medicine; Oncology; Internal medicine; Cancer; Bevacizumab; Immunotherapy; Chemotherapy","score_opus":0.010628406773812712,"score_gpt":0.26602352087909115,"score_spread":0.25539511410527843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212274217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975437,0.0005818963,0.000004401092,0.00036303294,0.00023581428,0.00066892017,0.00003090154,0.00003263995,0.0005386813],"genre_scores_gemma":[0.99853164,0.00010472244,0.00046767978,0.00032378657,0.00007825277,0.000026883665,0.00010790542,0.00003739672,0.0003217266],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981542,0.000059154965,0.000605423,0.00039742608,0.00045270406,0.00033108788],"domain_scores_gemma":[0.9988559,0.000030595493,0.00023824528,0.0003729157,0.00015558256,0.0003468001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020052938,0.00025008785,0.0006296302,0.00012770275,0.000055507375,0.000026378963,0.000073772244,0.00013228606,0.00004086946],"category_scores_gemma":[0.00018318032,0.00020877893,0.00011658176,0.00032480253,0.0003141531,0.00016418699,0.000028533017,0.00021907197,0.0000022834058],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6637543,0.0073625525,0.07087082,0.0019692993,0.0014037755,0.0015918297,0.0064983927,0.00027835026,0.19186299,0.00021384074,0.0024917824,0.05170208],"study_design_scores_gemma":[0.47360414,0.0054068337,0.41526788,0.0015912408,0.0002519339,0.00017051645,0.00052471913,0.00007502394,0.098217286,0.00013087774,0.00414113,0.0006184206],"about_ca_topic_score_codex":0.000092250775,"about_ca_topic_score_gemma":0.00005431468,"teacher_disagreement_score":0.34439707,"about_ca_system_score_codex":0.00013511366,"about_ca_system_score_gemma":0.0009582291,"threshold_uncertainty_score":0.8513758},"labels":[],"label_agreement":null},{"id":"W3212494582","doi":"10.1136/jitc-2021-sitc2021.036","title":"36 Digital Whole Slide Image (WSI) scoring is equivalent to microscope glass slide scoring for evaluation of programmed death-ligand 1 (PD-L1) expression across multiple tumor indications","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Concordance; Medicine; Digital pathology; Digital image analysis; Nuclear medicine; Cutoff; Pathology; Internal medicine; Computer science; Computer vision; Physics","score_opus":0.03299134903457568,"score_gpt":0.3410151725997529,"score_spread":0.3080238235651772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212494582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99256843,0.00070339517,0.0025165812,0.0023742456,0.0003459677,0.0011911945,0.00010717046,0.00007413629,0.000118866395],"genre_scores_gemma":[0.97592753,0.000024947205,0.022608135,0.00047907792,0.00024261909,0.00017164729,0.00021857471,0.00006761003,0.00025983117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99712586,0.000063083295,0.0007141026,0.00067805726,0.0008284437,0.000590456],"domain_scores_gemma":[0.9975559,0.00015924542,0.0003206849,0.00048680027,0.0005786111,0.00089871744],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012911756,0.00029939107,0.0005146266,0.0001248384,0.0003146648,0.00030874021,0.00015928263,0.000118639844,0.00000637419],"category_scores_gemma":[0.0061947373,0.0002837925,0.0001703227,0.00026871377,0.00022501108,0.000377041,0.0001738133,0.00034357145,0.000008152474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011334155,0.00019815713,0.057610814,0.00061125896,0.0000925415,0.00004358108,0.001721474,0.00018207729,0.9300602,0.000021362108,0.00084738404,0.0084978],"study_design_scores_gemma":[0.0038324688,0.00016179626,0.12150577,0.0020644176,0.00027158821,0.00020011126,0.0007989265,0.005511531,0.8585632,0.00034074878,0.00639993,0.00034953657],"about_ca_topic_score_codex":0.00006544569,"about_ca_topic_score_gemma":0.0000092232,"teacher_disagreement_score":0.07149703,"about_ca_system_score_codex":0.0001573977,"about_ca_system_score_gemma":0.0006409855,"threshold_uncertainty_score":0.99996144},"labels":[],"label_agreement":null},{"id":"W3212495819","doi":"10.1136/jitc-2021-sitc2021.302","title":"302 Characterization of TIGIT and PVR expression in colorectal liver metastases","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Institut Du Cancer de Montréal; Bristol-Myers Squibb","keywords":"TIGIT; Immune system; Cancer research; Immune checkpoint; Immunotherapy; Medicine; Metastasis; Cancer; Immunology; Internal medicine","score_opus":0.014115980077505693,"score_gpt":0.2360600032502943,"score_spread":0.2219440231727886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212495819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722177,0.0019970012,0.000007326503,0.00033998373,0.00009277491,0.00015420938,0.000028299572,0.000015344742,0.00014329361],"genre_scores_gemma":[0.9979127,0.0011482139,0.0004082854,0.00020206504,0.000040823572,0.000006979673,0.00010322076,0.000012796157,0.00016490222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991745,0.00004608419,0.00027102273,0.0002157811,0.00016058517,0.00013204885],"domain_scores_gemma":[0.999542,0.000024556257,0.00010198049,0.00011391096,0.00005821092,0.00015931453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016766253,0.0001171879,0.000255025,0.00007368369,0.0000348873,0.000023757124,0.00002447578,0.00009251262,0.00003152664],"category_scores_gemma":[0.000111830115,0.000103075385,0.000043655717,0.00014225655,0.0001781339,0.0001373592,0.000026702726,0.000090132424,9.321939e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023862996,0.00006545229,0.03303371,0.00018855502,0.000038641145,0.00010446032,0.00033601015,4.6622148e-7,0.96362984,0.000024703328,0.000103129896,0.0022364012],"study_design_scores_gemma":[0.00075651694,0.000060598526,0.45743793,0.00026785245,0.000030258732,0.0001371741,0.00006131159,0.000021131085,0.53959525,0.000021420028,0.0015437283,0.00006682939],"about_ca_topic_score_codex":0.000054532593,"about_ca_topic_score_gemma":0.000022026534,"teacher_disagreement_score":0.42440423,"about_ca_system_score_codex":0.000024199664,"about_ca_system_score_gemma":0.00016610498,"threshold_uncertainty_score":0.4203292},"labels":[],"label_agreement":null},{"id":"W3212553475","doi":"10.1136/jitc-2021-sitc2021.466","title":"466 Use of a 27-gene immuno-oncology (IO) assay to associate response to single-agent immune checkpoint inhibitor (ICI) therapy in advanced-stage NSCLC patients from a large Canadian cohort","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Oncology; Medicine; Internal medicine; Lung cancer; Cancer; Targeted therapy; Biomarker; Breast cancer; Immunotherapy; Immunohistochemistry; Biology","score_opus":0.02346754772782018,"score_gpt":0.2608376512464363,"score_spread":0.23737010351861615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212553475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920183,0.0018881302,0.0000076204556,0.0032181707,0.0008448641,0.0012470508,0.0006360851,0.000037297552,0.000102480175],"genre_scores_gemma":[0.9932568,0.00033546606,0.0015251549,0.0034255402,0.000082115555,0.0000744579,0.0003112829,0.00007276627,0.00091642264],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99650484,0.00043580605,0.0010850097,0.0006869292,0.00052481063,0.0007625885],"domain_scores_gemma":[0.99735063,0.00020471014,0.0003144469,0.0006658893,0.00036475924,0.0010995374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014865178,0.00039862565,0.00088989007,0.0003790064,0.00012210988,0.00007288613,0.00015418943,0.0003567428,0.000080109916],"category_scores_gemma":[0.0017547604,0.00039468278,0.00022682546,0.0006351198,0.00015477662,0.00018755127,0.00009242788,0.00031664496,0.0000133077065],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006072059,0.000558321,0.1199599,0.000033465218,0.00038252937,0.00037143368,0.0026664014,0.000031213836,0.865175,0.000003278976,0.00078558375,0.0039608213],"study_design_scores_gemma":[0.004434815,0.00080018,0.5732615,0.0004299225,0.00004619399,0.000014663596,0.000326556,0.0000074469076,0.3513645,0.000010027853,0.06900817,0.00029606014],"about_ca_topic_score_codex":0.04383892,"about_ca_topic_score_gemma":0.039051667,"teacher_disagreement_score":0.5138105,"about_ca_system_score_codex":0.0015079587,"about_ca_system_score_gemma":0.002149456,"threshold_uncertainty_score":0.9998505},"labels":[],"label_agreement":null},{"id":"W3212850110","doi":"10.1136/jitc-2021-sitc2021.597","title":"597 The role of CCL20 in mediating regulatory T cell infiltration and resistance to radiotherapy in head and neck squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"CCL20; Radioresistance; Cancer research; Chemokine; Head and neck squamous-cell carcinoma; Cetuximab; Tumor microenvironment; Head and neck cancer; Medicine; Radiation therapy; Immune system; Immunology; Chemokine receptor; Antibody; Internal medicine; Tumor cells; Monoclonal antibody","score_opus":0.008062825554022547,"score_gpt":0.22243572269095008,"score_spread":0.21437289713692753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212850110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835102,0.014572102,0.0000028164948,0.0009705202,0.000049787857,0.00026437768,0.00000492437,0.00001046561,0.0006148032],"genre_scores_gemma":[0.9976792,0.00021040507,0.0015551723,0.00027805523,0.00010273885,0.000009278384,0.000011817543,0.000023221108,0.00013012346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998707,0.00007049611,0.00043226196,0.00032574727,0.0002378912,0.00022662243],"domain_scores_gemma":[0.9992109,0.000106275904,0.00012028571,0.00021935474,0.000068685076,0.00027450387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041889466,0.00017035515,0.00035402714,0.00010006718,0.0000582003,0.000033302298,0.000045153938,0.00012635469,0.0000044094727],"category_scores_gemma":[0.00022152245,0.00014566536,0.000031627602,0.0002770989,0.00012831728,0.000088791785,0.00002935899,0.00022514297,2.3843464e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000624395,0.00005666156,0.4086646,0.00031653012,0.0000046708374,0.00003872174,0.0032888278,0.000048471033,0.5869124,0.000092952614,0.00009195933,0.00042178784],"study_design_scores_gemma":[0.0014760916,0.00007384966,0.45257175,0.00018987578,0.000019580655,0.00003941058,0.0008817349,0.0002334319,0.54304695,0.0002842665,0.0010444879,0.0001385671],"about_ca_topic_score_codex":0.00023160758,"about_ca_topic_score_gemma":0.00040383145,"teacher_disagreement_score":0.043907147,"about_ca_system_score_codex":0.000058416303,"about_ca_system_score_gemma":0.0002521885,"threshold_uncertainty_score":0.59400606},"labels":[],"label_agreement":null},{"id":"W3212914573","doi":"10.1136/jitc-2021-sitc2021.509","title":"509 A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; CD8; Immunotherapy; Refractory (planetary science); Cytotoxic T cell; Cancer; Internal medicine; Oncology; Cancer immunotherapy; Dosing; Immune system; Cancer research; Immunology; Chemistry; Biology; In vitro","score_opus":0.018619486975963523,"score_gpt":0.28676740589623634,"score_spread":0.2681479189202728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212914573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997993,0.0007708432,2.9064128e-7,0.00031846168,0.00013542698,0.00061876705,0.000018593786,0.000019204144,0.0001253991],"genre_scores_gemma":[0.9990206,0.00012693196,0.000070141825,0.00021220758,0.00004087336,0.000043438937,0.0000345659,0.000031168118,0.00042009182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835545,0.00006480832,0.0005357814,0.00039133945,0.00038384716,0.00026878098],"domain_scores_gemma":[0.9990619,0.00003477028,0.00019343625,0.00035966432,0.00011803661,0.00023219868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023668923,0.00021468278,0.00048251232,0.0001612407,0.0000618055,0.000020227937,0.00006929004,0.00011936637,0.000078261364],"category_scores_gemma":[0.00010876457,0.0001623107,0.0000475906,0.00039083618,0.0001696157,0.00013623174,0.000025551997,0.00024822645,7.1118546e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005320512,0.004547309,0.9707889,0.00035591694,0.00025542922,0.00053959544,0.0031532396,0.000022735825,0.01245791,0.0000053213857,0.0006067403,0.0019463875],"study_design_scores_gemma":[0.029228857,0.0024941072,0.95691144,0.000938269,0.000105254236,0.000016826743,0.00090167904,0.000008541108,0.0069770077,0.000012122705,0.0021831193,0.0002227725],"about_ca_topic_score_codex":0.0019285082,"about_ca_topic_score_gemma":0.006107031,"teacher_disagreement_score":0.023908345,"about_ca_system_score_codex":0.00016442852,"about_ca_system_score_gemma":0.00051335676,"threshold_uncertainty_score":0.66188383},"labels":[],"label_agreement":null},{"id":"W3214232282","doi":"10.1136/jitc-2021-sitc2021.353","title":"353 Identification of potential response predictors to maveropepimut-S (DPX-Survivac), a novel T cell activating immunotherapy, in patients with advanced recurrent ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Immunotherapy; CD8; Immune system; T cell; Antigen; Ovarian cancer; Oncology; Immunohistochemistry; Cancer research; Cancer; Cyclophosphamide; Internal medicine; Chemotherapy; Immunology","score_opus":0.00683929153160976,"score_gpt":0.22010438966044987,"score_spread":0.21326509812884012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214232282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956045,0.0024486443,0.00016291728,0.00032286427,0.000761165,0.00050457765,0.00013201634,0.00003765391,0.000025675867],"genre_scores_gemma":[0.99837214,0.00021742529,0.0003912189,0.00012000577,0.000016353804,0.000053699096,0.00011218843,0.000048332764,0.00066864426],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976762,0.00043180137,0.00077467586,0.0005224865,0.00016092882,0.00043390915],"domain_scores_gemma":[0.99861693,0.0001202558,0.00042754613,0.00048549887,0.00026428193,0.0000854934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006466656,0.00031540744,0.00045858466,0.00022146363,0.00018269668,0.00004790386,0.00021767037,0.00024085578,0.000054045257],"category_scores_gemma":[0.00035969084,0.00028986132,0.00008526142,0.00040221974,0.00023095969,0.00027521182,0.000077775345,0.00033913294,0.0000093679355],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007805084,0.000436645,0.019241335,0.00005250432,0.00017964293,0.0000071255604,0.0014468217,0.00031389788,0.9663523,0.0000262431,0.00005191809,0.0040865266],"study_design_scores_gemma":[0.0031433941,0.00027534194,0.5042745,0.00020015983,0.000020887186,0.000012044984,0.00019643444,0.0000031216641,0.48964164,0.0000072407734,0.0020120014,0.00021322566],"about_ca_topic_score_codex":0.00018515573,"about_ca_topic_score_gemma":0.000024069976,"teacher_disagreement_score":0.48503315,"about_ca_system_score_codex":0.00011233021,"about_ca_system_score_gemma":0.00048972666,"threshold_uncertainty_score":0.99995536},"labels":[],"label_agreement":null},{"id":"W3214459545","doi":"10.1136/jitc-2021-sitc2021.538","title":"538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melanoma; Refractory (planetary science); Internal medicine; Gastroenterology; Nuclear medicine; Urology; Surgery; Oncology; Cancer research; Biology","score_opus":0.013254783814050257,"score_gpt":0.2431491939966965,"score_spread":0.22989441018264622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214459545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972556,0.0004885159,0.0000048918832,0.00037735145,0.00012905576,0.0005275789,0.00007075647,0.000054587203,0.0010916621],"genre_scores_gemma":[0.99630505,0.00007239325,0.0012591787,0.00016513743,0.000028799997,0.000016212669,0.0009800671,0.00004162025,0.001131519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814224,0.00018492396,0.00046248268,0.00045516767,0.0003978414,0.00035731896],"domain_scores_gemma":[0.9984321,0.00005159528,0.00024464843,0.00039141806,0.0003223708,0.00055787776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000198927,0.00030516402,0.00074206584,0.00009309692,0.000103090584,0.000023741533,0.00006638923,0.00015630727,0.00007643823],"category_scores_gemma":[0.00020800556,0.0002340443,0.0001054412,0.00027601226,0.00032405395,0.000142239,0.00003913901,0.00020210272,0.0000137600255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004655142,0.0007915306,0.9928583,0.00020196846,0.0013035164,0.0008367474,0.0002835318,0.000008279514,0.0019367327,0.000092959264,0.0005404758,0.0006804458],"study_design_scores_gemma":[0.0069254283,0.0009462544,0.9527004,0.00026826575,0.0013314262,0.00014792616,0.00011943112,0.000020694635,0.03549156,0.00011777723,0.001694003,0.0002368616],"about_ca_topic_score_codex":0.00010320955,"about_ca_topic_score_gemma":0.00010951184,"teacher_disagreement_score":0.040157925,"about_ca_system_score_codex":0.00007555753,"about_ca_system_score_gemma":0.00047917184,"threshold_uncertainty_score":0.95440495},"labels":[],"label_agreement":null},{"id":"W4308375764","doi":"10.1136/jitc-2022-sitc2022.0059","title":"59 DetermaIO (IO score) is associated with efficacy of ICI monotherapy in advanced NSCLC patients: a retrospective BC Cancer study","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Internal medicine; Medicine; Cohort; Oncology; Retrospective cohort study; Chemotherapy; Cancer; Combination therapy; PD-L1; Immunotherapy","score_opus":0.013312479880391408,"score_gpt":0.25634213303346753,"score_spread":0.24302965315307612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308375764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703926,0.0008200326,0.0000010133772,0.00032405937,0.00018112431,0.0013635962,0.00007665447,0.000042922027,0.00015135598],"genre_scores_gemma":[0.99865514,0.0001193554,0.00004662074,0.0006789641,0.000030164067,0.00016593585,0.000033648532,0.00005012689,0.00022003324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978923,0.00011861127,0.00052537705,0.00048435168,0.0006442779,0.0003350373],"domain_scores_gemma":[0.9988994,0.000048215024,0.000376072,0.00033205334,0.0001404819,0.00020376797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003756883,0.00027660624,0.00058645685,0.00018894445,0.00015536505,0.000021907917,0.00012461132,0.00007742841,0.000082781604],"category_scores_gemma":[0.0001138139,0.00023858051,0.00010095933,0.00056752446,0.00022956102,0.00013181899,0.000043958284,0.00035315682,5.4625394e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004621529,0.0013332106,0.9755773,0.00003832305,0.0005268051,0.00006507057,0.0056006624,0.0000797685,0.00917009,0.000004583622,0.00029620007,0.0026864528],"study_design_scores_gemma":[0.017308602,0.00252748,0.9713516,0.00034310707,0.0001264156,0.000011073052,0.0008234283,0.000030425725,0.0067435694,0.000030684998,0.00043166394,0.00027194287],"about_ca_topic_score_codex":0.001820858,"about_ca_topic_score_gemma":0.00056193426,"teacher_disagreement_score":0.012687072,"about_ca_system_score_codex":0.00057740515,"about_ca_system_score_gemma":0.00041582828,"threshold_uncertainty_score":0.9729031},"labels":[],"label_agreement":null},{"id":"W4308377062","doi":"10.1136/jitc-2022-sitc2022.0009","title":"9 A pan-cancer multi-omic immune single-cell atlas for cancer immunotherapy: focus on CD4+ T cells","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute; Society for Immunotherapy of Cancer; Parker Institute for Cancer Immunotherapy; AstraZeneca; Bristol-Myers Squibb","keywords":"Immunotherapy; Cancer immunotherapy; T cell; Immune system; Computational biology; CD8; Metadata; Cancer; Transcriptome; Biology; Computer science; Immunology; Gene expression; World Wide Web; Gene; Genetics","score_opus":0.020840147660867253,"score_gpt":0.24210162126527568,"score_spread":0.22126147360440843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308377062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879331,0.008521736,0.00024384388,0.0009274563,0.0012317443,0.0006544267,0.0003115521,0.00005932971,0.00011683765],"genre_scores_gemma":[0.99412775,0.0010297786,0.00087039167,0.0010053287,0.0003443783,0.0003887435,0.00011608499,0.00014397956,0.0019735664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980779,0.00008542034,0.00043061472,0.00065948395,0.00024269144,0.0005038584],"domain_scores_gemma":[0.99901485,0.000027985609,0.00022187013,0.00041759128,0.00007393239,0.00024375497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000265099,0.00037566602,0.0003503664,0.00007195762,0.0003670658,0.00007796328,0.0002995826,0.00019625125,0.00002617524],"category_scores_gemma":[0.00002999654,0.0003801217,0.00024321662,0.000100996425,0.00018813032,0.000011001938,0.00008403969,0.0002672148,0.0000029456776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003614644,0.00033547304,0.0009968034,0.00007347959,0.0001255648,0.0000059499876,0.00021762204,0.0011566883,0.99126047,0.000026001688,0.002500016,0.0029404706],"study_design_scores_gemma":[0.002421634,0.0006084136,0.0016876967,0.000038624727,0.00006254535,0.000011580396,0.00008750922,0.0002467374,0.88517153,0.00011202251,0.10906261,0.0004890704],"about_ca_topic_score_codex":0.0007283613,"about_ca_topic_score_gemma":0.0001540146,"teacher_disagreement_score":0.1065626,"about_ca_system_score_codex":0.00010059464,"about_ca_system_score_gemma":0.00029999748,"threshold_uncertainty_score":0.99986506},"labels":[],"label_agreement":null},{"id":"W4308378248","doi":"10.1136/jitc-2022-sitc2022.0234","title":"234 Bead-bound antibody-activation of T cells provides sub-optimal metabolic programming and tumour control compared to dendritic cell-activated T cells","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"CD28; T cell; Biology; Cell biology; Cytotoxic T cell; Antigen; Dendritic cell; Cancer research; CD8; Molecular biology; Immunology; Biochemistry; Immune system; In vitro","score_opus":0.018158421451222675,"score_gpt":0.27313632410871636,"score_spread":0.2549779026574937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308378248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627477,0.0006951114,0.00009076237,0.0005745799,0.00017586809,0.0019483638,0.000059573696,0.00008767935,0.00009326842],"genre_scores_gemma":[0.9973775,0.00006129488,0.0014665802,0.00026069267,0.000117597665,0.00012816302,0.00008177032,0.000079675876,0.0004266835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970448,0.00022777493,0.0006259181,0.0006146565,0.0008590001,0.0006278578],"domain_scores_gemma":[0.9981192,0.00015731157,0.00026021068,0.00036616795,0.000225542,0.0008716009],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007713637,0.00035850948,0.00079138705,0.00035059953,0.0003300773,0.0001359187,0.00016137793,0.00011147059,0.00007740449],"category_scores_gemma":[0.00013288403,0.00036324415,0.00012536775,0.00049744436,0.0003836689,0.00021643075,0.00012906286,0.0005204362,0.00000444819],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005789933,0.00028888482,0.0034525988,0.0004305233,0.00016004936,0.00007590632,0.0009903848,0.0006645532,0.99223983,0.000039578787,0.00028432082,0.00079436804],"study_design_scores_gemma":[0.0027692127,0.000579516,0.0206452,0.0001202821,0.00018677227,0.00012937924,0.00087046606,0.0006537552,0.9663994,0.000039901486,0.007273507,0.0003326552],"about_ca_topic_score_codex":0.0004545261,"about_ca_topic_score_gemma":0.0000082322595,"teacher_disagreement_score":0.025840484,"about_ca_system_score_codex":0.00012761833,"about_ca_system_score_gemma":0.00047622147,"threshold_uncertainty_score":0.9998819},"labels":[],"label_agreement":null},{"id":"W4308378595","doi":"10.1136/jitc-2022-sitc2022.0052","title":"52 Digital pathology training effectiveness for the evaluation of PD-L1 expression in multiple tumor indications","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Digital pathology; Concordance; Medicine; Digital image analysis; Test (biology); Medical physics; Artificial intelligence; Computer science; Pathology; Computer vision; Internal medicine","score_opus":0.04122079206106776,"score_gpt":0.3111353124665198,"score_spread":0.26991452040545205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308378595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996677,0.0005454302,0.00067377905,0.0009607605,0.00020143583,0.00080176606,0.000024386389,0.0000192719,0.00009620954],"genre_scores_gemma":[0.9986697,0.000009114213,0.00067974126,0.00017315324,0.000060564158,0.0002982336,0.00007408601,0.0000195187,0.000015893705],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986905,0.00018838688,0.00029406667,0.00023501823,0.00040978627,0.00018223781],"domain_scores_gemma":[0.9988901,0.0005387266,0.0001687382,0.00018645987,0.00007402511,0.000141953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025630083,0.00010479307,0.00023683916,0.000117474665,0.00023270062,0.000021317419,0.00009321195,0.000039655723,0.000009777903],"category_scores_gemma":[0.0039693913,0.00008114587,0.00006439478,0.0001463731,0.00023381345,0.00008292159,0.000055922752,0.00032583706,3.7476937e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064008427,0.0006165301,0.411416,0.00073682604,0.00018454234,0.00010307297,0.011119444,0.025733238,0.4573691,0.00085820485,0.00080659916,0.09041639],"study_design_scores_gemma":[0.003708653,0.00020654086,0.9216999,0.00026555112,0.00017212266,0.00034056517,0.001620122,0.05809037,0.009514578,0.00239805,0.0018352346,0.00014835883],"about_ca_topic_score_codex":0.000024782117,"about_ca_topic_score_gemma":0.000002924384,"teacher_disagreement_score":0.5102839,"about_ca_system_score_codex":0.00007670996,"about_ca_system_score_gemma":0.0003287919,"threshold_uncertainty_score":0.4752019},"labels":[],"label_agreement":null},{"id":"W4308381384","doi":"10.1136/jitc-2022-sitc2022.1350","title":"1350 AI/ML-driven discovery of Collagen Triple Helix Repeat-Containing 1, CTHRC1, a novel proteoglycan for disruption of stromal barriers and enhancement of immunotherapy responses in desmoplastic tumors","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Centre for Phenogenomics","funders":"","keywords":"Stromal cell; Cancer-Associated Fibroblasts; Cancer research; Tumor microenvironment; Breast cancer; Cancer immunotherapy; Pancreatic cancer; Medicine; Immunotherapy; Cancer; Immune system; Immunology; Internal medicine; Tumor cells","score_opus":0.010093382535066147,"score_gpt":0.2456134219118275,"score_spread":0.23552003937676136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308381384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969195,0.001073871,0.0006923954,0.00009101562,0.00009626662,0.0006165924,0.000499555,0.000002458492,0.000008356187],"genre_scores_gemma":[0.99822193,0.0002012104,0.0011771604,0.00005808819,0.000029449478,0.00013641192,0.00009224064,0.000022194348,0.000061337334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987949,0.00005272869,0.0005077408,0.00029724286,0.0001565228,0.0001908383],"domain_scores_gemma":[0.9992138,0.00005617348,0.00034512693,0.00020797212,0.000068569396,0.00010836172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039125618,0.00015207569,0.00031735701,0.000091911235,0.00008222882,0.000016251188,0.000100871206,0.00006791561,0.0000023636312],"category_scores_gemma":[0.00043628647,0.00016360612,0.00007469494,0.00008838569,0.00023870931,0.000013369146,0.00009390851,0.000060811388,1.571227e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017748943,0.000075167336,0.02887211,0.00015284492,0.000072180665,0.000002770213,0.00050789834,0.0008270445,0.9673685,0.00018922602,0.00003523541,0.0001221315],"study_design_scores_gemma":[0.0031056895,0.0025032796,0.05173633,0.00016224167,0.000048977094,0.000026765305,0.0012181784,0.00031149614,0.93978184,0.00018321737,0.0006808836,0.00024106646],"about_ca_topic_score_codex":0.00023827955,"about_ca_topic_score_gemma":0.00010669294,"teacher_disagreement_score":0.027586622,"about_ca_system_score_codex":0.00004471621,"about_ca_system_score_gemma":0.00055257184,"threshold_uncertainty_score":0.6671664},"labels":[],"label_agreement":null},{"id":"W4308383460","doi":"10.1136/jitc-2022-sitc2022.1185","title":"1185 Optimization of purine-based TLR7 agonists as payloads for immune-stimulating antibody conjugates (ISACs)","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nuvation (Canada); Zymeworks (Canada)","funders":"","keywords":"Immune system; TLR7; Purine; Pharmacology; Antibody; Peripheral blood mononuclear cell; Splenocyte; In vitro; Chemistry; Cytokine; Cancer research; Immunology; Biology; Biochemistry; Toll-like receptor; Innate immune system","score_opus":0.020887112292559094,"score_gpt":0.3131224107280727,"score_spread":0.2922352984355136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308383460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203795,0.0007683769,0.0017076961,0.0034327628,0.00010580941,0.0007867293,0.00010055627,0.00009215443,0.0009679866],"genre_scores_gemma":[0.99249744,0.000021540678,0.0060461857,0.00032509104,0.00009306076,0.00010147303,0.0004840119,0.00003417568,0.00039698847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985966,0.00003168696,0.0004905261,0.00032362345,0.00029429072,0.00026325465],"domain_scores_gemma":[0.9988897,0.00012707958,0.00021609919,0.00028186062,0.00011697651,0.00036830243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033796878,0.00018868224,0.0003437816,0.000057345478,0.00031444622,0.00003091891,0.000108427135,0.000082517014,0.000079795],"category_scores_gemma":[0.00038762327,0.00019186134,0.00012723809,0.00019073677,0.0002532743,0.00006779864,0.000045183264,0.00022459244,0.0000019753593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021686389,0.00024132633,0.0038848035,0.0006687391,0.00009265345,0.000020965916,0.0001346716,0.08482493,0.9084727,0.00086793996,0.0003967021,0.00017767484],"study_design_scores_gemma":[0.0034406523,0.00040623717,0.0052362788,0.00015344148,0.0003486089,0.00018324652,0.00017501731,0.096214786,0.88136244,0.00097354705,0.011143971,0.00036179242],"about_ca_topic_score_codex":0.000021694672,"about_ca_topic_score_gemma":1.2340954e-7,"teacher_disagreement_score":0.027110314,"about_ca_system_score_codex":0.000054855594,"about_ca_system_score_gemma":0.0002791597,"threshold_uncertainty_score":0.78238785},"labels":[],"label_agreement":null},{"id":"W4308385775","doi":"10.1136/jitc-2022-sitc2022.0750","title":"750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Gastroenterology; Oncology; Cancer; Immunotherapy","score_opus":0.010732607277661305,"score_gpt":0.2477301152551453,"score_spread":0.23699750797748398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308385775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972238,0.0013878839,0.0000023795005,0.00014606742,0.00008508072,0.0010599021,0.000024704372,0.000008676064,0.00006149092],"genre_scores_gemma":[0.9991959,0.00013531934,0.00015624343,0.00008100616,0.000029128803,0.00027229977,0.00004922753,0.000038764407,0.00004216333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998261,0.00008602057,0.0004914268,0.00054803974,0.0002875862,0.00032593872],"domain_scores_gemma":[0.99918157,0.000039762934,0.0002367565,0.0002861742,0.000067193934,0.0001885228],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029082515,0.00026230392,0.0003918128,0.00017995201,0.00009411591,0.00004198711,0.0001169683,0.000087066896,0.0000034668535],"category_scores_gemma":[0.00015529217,0.0002548622,0.00003205127,0.00027494124,0.000176027,0.000019073985,0.00014050418,0.0001827946,3.911236e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009307068,0.014243004,0.37002045,0.0010401063,0.00023548432,0.0017737177,0.012270779,0.0068631624,0.58255947,0.00013222882,0.0003131748,0.0012413493],"study_design_scores_gemma":[0.06886103,0.037690017,0.23180301,0.0011156381,0.0002238988,0.0008292262,0.0169227,0.0004416007,0.6366526,0.0007180544,0.0028312881,0.0019109211],"about_ca_topic_score_codex":0.00037568022,"about_ca_topic_score_gemma":0.0038424532,"teacher_disagreement_score":0.13821743,"about_ca_system_score_codex":0.00009814185,"about_ca_system_score_gemma":0.0003648583,"threshold_uncertainty_score":0.99999034},"labels":[],"label_agreement":null},{"id":"W4308395446","doi":"10.1136/jitc-2022-sitc2022.1196","title":"1196 Streamlining T cell engager development with a diverse panel of fully human CD3-binding antibodies, bispecific engineering technology, and an integrated discovery engine","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"CD3; Bispecific antibody; Antibody; Flow cytometry; T cell; Chemistry; Molecular biology; Cancer research; Biology; Computational biology; Monoclonal antibody; Antigen; Immunology; Immune system","score_opus":0.030233380629322352,"score_gpt":0.2584438281147855,"score_spread":0.22821044748546315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308395446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983956,0.0007063523,0.000029060606,0.00022289627,0.000069369846,0.00028409713,0.00006526017,0.000084244944,0.00014307973],"genre_scores_gemma":[0.9939035,0.00007998653,0.0045762104,0.000029146719,0.000055290384,0.000024144445,0.00020759641,0.00004130998,0.0010827994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819475,0.00004990327,0.00040006664,0.00044985302,0.00048141836,0.00042398463],"domain_scores_gemma":[0.9990725,0.00005316409,0.00014086881,0.0002387902,0.00008521603,0.0004094798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004620379,0.0002982103,0.0004539363,0.0005587087,0.00047372305,0.000058916932,0.00013976957,0.0001000164,0.000024161936],"category_scores_gemma":[0.00007309098,0.00024381359,0.0000446527,0.00044510377,0.00036649636,0.00021040512,0.00023323696,0.00072876253,0.0000012628329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039183776,0.0004409839,0.28379077,0.0010479769,0.0003831367,0.0010646704,0.0032489696,0.00071414775,0.7037076,0.0010982024,0.0002350944,0.0038766407],"study_design_scores_gemma":[0.0052353907,0.0032794075,0.3985199,0.0014490293,0.0003764162,0.0018523957,0.018440792,0.001831008,0.5308577,0.00012264904,0.03641687,0.0016184346],"about_ca_topic_score_codex":0.0001691569,"about_ca_topic_score_gemma":0.000023064205,"teacher_disagreement_score":0.17284988,"about_ca_system_score_codex":0.0000861323,"about_ca_system_score_gemma":0.00031643186,"threshold_uncertainty_score":0.99424297},"labels":[],"label_agreement":null},{"id":"W4308396193","doi":"10.1136/jitc-2022-sitc2022.0936","title":"936 Assessing educational needs for immune-related adverse events curriculum in clinical practice","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; MEDLINE; Curriculum; Family medicine; Oncology; Psychology","score_opus":0.021263464959580085,"score_gpt":0.338515185282241,"score_spread":0.3172517203226609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308396193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984947,0.0019372393,0.000008746914,0.010069613,0.0014460628,0.0006617407,0.000017401346,0.00003634758,0.0008758138],"genre_scores_gemma":[0.99460083,0.00012696294,0.002263823,0.0015004463,0.00018885867,0.00012299475,0.00016002484,0.000034244094,0.0010018355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781936,0.00022470632,0.0009296336,0.00033123215,0.00038953655,0.00030555532],"domain_scores_gemma":[0.998679,0.0002924789,0.00038351974,0.00025399047,0.00010689569,0.0002841333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023782558,0.00018582129,0.00034175944,0.00019988224,0.00031418333,0.000023472347,0.00010944626,0.00013068331,0.00007828642],"category_scores_gemma":[0.001543987,0.0001843326,0.0002216407,0.00041864024,0.00017199705,0.00033207418,0.00005976789,0.0005692403,0.0000045091006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036246,0.0052918307,0.90147287,0.0007535683,0.0017244755,0.00025516786,0.0042719985,0.00049463136,0.035239894,0.0032791705,0.024041265,0.019550538],"study_design_scores_gemma":[0.0064272247,0.00043509295,0.8922101,0.00026686865,0.00026350867,0.00085726695,0.004479511,0.0004901031,0.0005240092,0.0009355277,0.09274167,0.00036910834],"about_ca_topic_score_codex":0.0002608446,"about_ca_topic_score_gemma":0.000006196256,"teacher_disagreement_score":0.0687004,"about_ca_system_score_codex":0.00023658537,"about_ca_system_score_gemma":0.0011230578,"threshold_uncertainty_score":0.7516865},"labels":[],"label_agreement":null},{"id":"W4308396215","doi":"10.1136/jitc-2022-sitc2022.0464","title":"464 Anti-CTLA-4 therapy depletes Tregs and expands ICOS<sup>+</sup> T-cells in neuroblastoma tumors with induced DNA mismatch repair deficiency","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer research; Cytotoxic T cell; CTLA-4; Effector; T cell; Immunology; Biology; Neuroblastoma; Immune system; Cell culture; Genetics","score_opus":0.01719596409556085,"score_gpt":0.2377407066382172,"score_spread":0.22054474254265635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308396215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969701,0.0006246983,6.7106333e-7,0.0008615152,0.000058659094,0.0008896724,0.000030507043,0.00018385352,0.0003803322],"genre_scores_gemma":[0.99843085,0.00021444331,0.000244763,0.00053881557,0.000048878213,0.00012740637,0.000029367877,0.000087418404,0.00027806096],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99676764,0.00021839215,0.00050517335,0.0008871048,0.0008413158,0.00078035257],"domain_scores_gemma":[0.9981917,0.0001134331,0.00015758009,0.0005188553,0.00006743136,0.0009509676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040844554,0.00046012647,0.00061280956,0.0004007431,0.00038280172,0.000075441145,0.00016328027,0.000099743855,0.000024982137],"category_scores_gemma":[0.0001257397,0.00037652443,0.00011207983,0.0006122758,0.00035360435,0.00022547586,0.00013952091,0.00063389476,0.0000070363144],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017232138,0.0021427101,0.2957966,0.00050521735,0.00029900603,0.009737557,0.003428922,0.00068298366,0.6812341,0.00010378534,0.0018354123,0.0025104808],"study_design_scores_gemma":[0.01387243,0.008078475,0.6147654,0.00042789042,0.00014169693,0.0046941186,0.0019614033,0.0017698155,0.35126317,0.00025019003,0.001801105,0.0009743127],"about_ca_topic_score_codex":0.00030110133,"about_ca_topic_score_gemma":0.000025442923,"teacher_disagreement_score":0.32997096,"about_ca_system_score_codex":0.00010526744,"about_ca_system_score_gemma":0.0004996705,"threshold_uncertainty_score":0.9998687},"labels":[],"label_agreement":null},{"id":"W4308398250","doi":"10.1136/jitc-2022-sitc2022.0999","title":"999 Investigating the immunomodulatory role of innate lymphoid cells in epithelial ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Innate lymphoid cell; Population; Biology; Immunology; Flow cytometry; Ovarian cancer; Cancer; Innate immune system; Tumor microenvironment; Cancer research; Immune system; Medicine; Genetics","score_opus":0.008682836945489242,"score_gpt":0.18897282713329414,"score_spread":0.1802899901878049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308398250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359167,0.0027815076,0.0000015870074,0.00020549391,0.0009716665,0.0003486631,0.00083890394,0.00005240185,0.0012081331],"genre_scores_gemma":[0.9988502,0.000045851637,0.00009536951,0.0003795483,0.00006612651,0.000055420503,0.00010455974,0.000041485793,0.0003614075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975203,0.0005369171,0.0007262597,0.0004755127,0.00015498954,0.0005859921],"domain_scores_gemma":[0.9987883,0.00012078057,0.00037641788,0.0005302995,0.00006899315,0.00011522592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011090272,0.00032499482,0.00046556338,0.00019224396,0.0006357459,0.00003109854,0.00046935186,0.00021975487,0.00004780004],"category_scores_gemma":[0.00023715508,0.0002822367,0.00012080244,0.0003576572,0.0008707953,0.00015905502,0.0003309847,0.0007046644,0.000029553295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052890216,0.00008466118,0.026818093,0.00005535958,0.00008068762,0.000021145248,0.0050354195,0.00027255347,0.96455854,0.0018644875,0.00051900645,0.0006371561],"study_design_scores_gemma":[0.0019109214,0.00022506929,0.15598589,0.000063322295,0.00006553535,0.00040527235,0.0031710283,0.00008240855,0.7879297,0.003541685,0.046151876,0.00046726092],"about_ca_topic_score_codex":0.0020547197,"about_ca_topic_score_gemma":0.00007396582,"teacher_disagreement_score":0.17662881,"about_ca_system_score_codex":0.00011914719,"about_ca_system_score_gemma":0.0007048209,"threshold_uncertainty_score":0.999963},"labels":[],"label_agreement":null},{"id":"W4308398717","doi":"10.1136/jitc-2022-sitc2022.0261","title":"261 Evidence for durable anti-tumor responses by TAC-T cells in preclinical models of solid tumors","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cancer research; Flow cytometry; T cell; Antigen; Bone marrow; Immune system; Cytotoxic T cell; Biology; Molecular biology; Immunology; In vitro","score_opus":0.09622014376030799,"score_gpt":0.36606365320160206,"score_spread":0.2698435094412941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308398717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450535,0.0020255444,0.000031283147,0.001634986,0.000171851,0.0012215115,0.00021625977,0.000041256448,0.00015197146],"genre_scores_gemma":[0.993507,0.00029962038,0.00069276115,0.00043136015,0.00007636629,0.00018419439,0.00002924933,0.000058127684,0.0047213174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969893,0.00027060232,0.00084487954,0.0005830054,0.0007638278,0.0005483567],"domain_scores_gemma":[0.9977683,0.00078196987,0.00024533444,0.0005161467,0.00013366668,0.0005545891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024644248,0.00023840647,0.00071470306,0.00022651574,0.00015903005,0.00003086294,0.00024812797,0.00009985931,0.00014733305],"category_scores_gemma":[0.0015024527,0.00023547374,0.00017323847,0.0003326839,0.00042844104,0.00023167177,0.000150282,0.0005358509,0.0000027965186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020356379,0.00031922275,0.00874896,0.0005342829,0.00006853916,0.00016327706,0.0004896127,0.0016218323,0.97494787,0.00008341233,0.010670227,0.00031710605],"study_design_scores_gemma":[0.004345729,0.0020327915,0.023390304,0.00089942035,0.00013027653,0.00043354073,0.00068315584,0.009260139,0.9429799,0.0024911752,0.012814539,0.00053907215],"about_ca_topic_score_codex":0.0003036767,"about_ca_topic_score_gemma":0.000014775494,"teacher_disagreement_score":0.031968035,"about_ca_system_score_codex":0.00015447053,"about_ca_system_score_gemma":0.0010205022,"threshold_uncertainty_score":0.960234},"labels":[],"label_agreement":null},{"id":"W4308398799","doi":"10.1136/jitc-2022-sitc2022.1130","title":"1130 Investigating macrophage modulation in a murine model of soft tissue sarcoma","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Macrophage; Molecular biology; Immune system; Chemokine; Biology; Immunology; Biochemistry","score_opus":0.01672973063910705,"score_gpt":0.2365844651266673,"score_spread":0.21985473448756027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308398799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950162,0.003205889,0.000077576675,0.00033326668,0.0005147559,0.00030962154,0.00005606704,0.000056065073,0.00043056815],"genre_scores_gemma":[0.9969723,0.00002940774,0.0011627635,0.00023360735,0.000021798147,0.00005708929,0.00010907425,0.000039186503,0.0013747453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821424,0.00021369872,0.0006323746,0.0004088026,0.00012628327,0.0004045937],"domain_scores_gemma":[0.9991368,0.000068543995,0.00030259238,0.00036308827,0.000048892307,0.00008007302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006314937,0.00023753283,0.00038884737,0.00019798402,0.00024847168,0.000015061929,0.0002492194,0.00017612922,0.00010721243],"category_scores_gemma":[0.00023779452,0.0002641323,0.00005882474,0.00024290194,0.00048823567,0.00015340262,0.000274783,0.0005837897,0.000013550445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003948741,0.00008456595,0.008911187,0.000116321906,0.0000455385,0.000016571807,0.0014025373,0.04822008,0.93770283,0.0006929251,0.0007657814,0.0020021687],"study_design_scores_gemma":[0.003148216,0.00028240558,0.057784386,0.00016900599,0.00006951779,0.00031657866,0.0006025475,0.016733075,0.90487653,0.008889951,0.006401866,0.0007259351],"about_ca_topic_score_codex":0.0004890639,"about_ca_topic_score_gemma":0.00003411628,"teacher_disagreement_score":0.048873197,"about_ca_system_score_codex":0.00012874215,"about_ca_system_score_gemma":0.00026092344,"threshold_uncertainty_score":0.9999811},"labels":[],"label_agreement":null},{"id":"W4308399396","doi":"10.1136/jitc-2022-sitc2022.0558","title":"558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Renal cell carcinoma; Fludarabine; Medicine; Clear cell renal cell carcinoma; Internal medicine; Refractory (planetary science); Chimeric antigen receptor; Oncology; Gastroenterology; Cyclophosphamide; Cancer research; Immunotherapy; Chemotherapy; Cancer; Biology","score_opus":0.01358275220468149,"score_gpt":0.24546656095012168,"score_spread":0.23188380874544018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308399396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948153,0.000734407,0.0000027932338,0.0003903091,0.000374313,0.0026352357,0.0006467216,0.00008284593,0.00031807405],"genre_scores_gemma":[0.9971241,0.000079668964,0.0004504296,0.00031321382,0.00018189909,0.00011280946,0.00065600895,0.00013513184,0.000946755],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9953815,0.0004752024,0.00083850307,0.0010716323,0.001405224,0.0008279389],"domain_scores_gemma":[0.99740267,0.00020051353,0.00031999714,0.0011141299,0.00016686933,0.000795816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009349402,0.0005333969,0.0007176059,0.00022444648,0.00040782272,0.00008895021,0.00045375215,0.00013417855,0.00027000578],"category_scores_gemma":[0.00013852355,0.00041970066,0.00013919923,0.0007407345,0.00028229528,0.00016005739,0.00024692903,0.0010975831,0.000026644493],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010933471,0.004245551,0.1321316,0.00009595619,0.0002380181,0.00046155354,0.006407877,0.0020618755,0.8343323,0.0000015246502,0.007815538,0.0012747386],"study_design_scores_gemma":[0.047919005,0.008442093,0.6575248,0.000094399504,0.00027924794,0.000021849472,0.0041784407,0.0002824638,0.25921926,0.000014803797,0.021096703,0.0009269435],"about_ca_topic_score_codex":0.0013405511,"about_ca_topic_score_gemma":0.00008317419,"teacher_disagreement_score":0.57511306,"about_ca_system_score_codex":0.0003071182,"about_ca_system_score_gemma":0.0005493125,"threshold_uncertainty_score":0.9998255},"labels":[],"label_agreement":null},{"id":"W4308400024","doi":"10.1136/jitc-2022-sitc2022.1156","title":"1156 STING activation in sarcoma: assessing translational therapeutic strategies","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Sting; Stimulator of interferon genes; Medicine; Cancer research; Immunotherapy; Soft tissue sarcoma; Combination therapy; Sarcoma; Immune system; Flow cytometry; Pharmacology; Immunology; Internal medicine; Pathology; Innate immune system","score_opus":0.022096676126277227,"score_gpt":0.2623944532731848,"score_spread":0.24029777714690756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308400024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949942,0.0018521687,0.00011913911,0.00094377174,0.0003818945,0.00016219815,0.000008448491,0.000060923576,0.0014772423],"genre_scores_gemma":[0.9990225,0.000011663027,0.00009617296,0.00025352286,0.000021290458,0.000027865693,0.00008936331,0.000019464043,0.0004581498],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986219,0.00037200918,0.00034779203,0.00026746758,0.00008535701,0.00030549604],"domain_scores_gemma":[0.9995263,0.00014337704,0.0001255819,0.00013893514,0.000028892333,0.000036862173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005156076,0.00017317265,0.0002110037,0.00017973997,0.00043614613,0.000090277485,0.00012947028,0.000110015804,0.00015331103],"category_scores_gemma":[0.00008100283,0.00017450583,0.000055777877,0.00015643527,0.00020591303,0.00040703875,0.00005031376,0.00050180283,0.000010650507],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014485036,0.000105357365,0.0057840804,0.000031857842,0.00007258488,0.000010244784,0.0016740446,0.0003816427,0.9822552,0.004665076,0.00023357794,0.0046414547],"study_design_scores_gemma":[0.002621123,0.0002835749,0.6836681,0.00014221601,0.000050497558,0.00042883615,0.010441151,0.00015085502,0.27242607,0.0061138365,0.023046883,0.0006268513],"about_ca_topic_score_codex":0.00017898095,"about_ca_topic_score_gemma":0.000017623508,"teacher_disagreement_score":0.70982915,"about_ca_system_score_codex":0.000066547575,"about_ca_system_score_gemma":0.0003479277,"threshold_uncertainty_score":0.7116141},"labels":[],"label_agreement":null},{"id":"W4308400766","doi":"10.1136/jitc-2022-sitc2022.0913","title":"913 Translational analysis of advanced metastatic bladder cancer patients treated with IO combination maveropepimut-S, cyclophosphamide, and pembrolizumab","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ELISPOT; Immune system; Medicine; Immunotherapy; Immunology; Antigen; T cell; Cancer research; Pembrolizumab","score_opus":0.009540570406654516,"score_gpt":0.23996536801863053,"score_spread":0.230424797611976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308400766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967455,0.0019500616,0.0000066957928,0.00045121112,0.00005844179,0.00041858503,0.00019884472,0.00002477571,0.00014588106],"genre_scores_gemma":[0.9984182,0.00030062775,0.00023531189,0.00024852314,0.000008342851,0.00006423456,0.0003908206,0.00002288673,0.00031102126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858224,0.000062886356,0.00037741705,0.0003074876,0.00048799985,0.00018198047],"domain_scores_gemma":[0.9992506,0.000037614653,0.00023314962,0.00015688023,0.00012888783,0.00019287404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016922293,0.0001885286,0.00043302038,0.00025353028,0.00016517816,0.000018457997,0.000049936625,0.00003792536,0.000119523414],"category_scores_gemma":[0.000022575106,0.0001588474,0.00009524687,0.0006756874,0.0002384255,0.0001284738,0.000017403872,0.00013180434,2.1302189e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048108827,0.000652913,0.957495,0.00027383605,0.0069384947,0.00004232787,0.0015747856,0.00274777,0.01682841,0.00017531747,0.00045558834,0.008004683],"study_design_scores_gemma":[0.0064135515,0.0005951576,0.98402333,0.00005839419,0.002329521,0.000022619155,0.00016725565,0.0006817311,0.0044558584,0.00006158724,0.0009945997,0.00019638521],"about_ca_topic_score_codex":0.0005189214,"about_ca_topic_score_gemma":0.00008926364,"teacher_disagreement_score":0.02652835,"about_ca_system_score_codex":0.000083345934,"about_ca_system_score_gemma":0.00020249093,"threshold_uncertainty_score":0.64776087},"labels":[],"label_agreement":null},{"id":"W4308400784","doi":"10.1136/jitc-2022-sitc2022.1028","title":"1028 IL-12 and IL-27 upregulate CD39 expression on CD8<sup>+</sup> T-cells and differentially affect CD39<sup>+</sup>CD8<sup>+</sup> T-cell effector function","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cytotoxic T cell; CD8; CD28; Biology; T cell; Molecular biology; IL-2 receptor; Tumor-infiltrating lymphocytes; Flow cytometry; Interleukin 21; Cancer research; Immune system; Cell biology; Chemistry; Immunology; In vitro; Biochemistry","score_opus":0.013384548176180563,"score_gpt":0.23369773829873697,"score_spread":0.2203131901225564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308400784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939314,0.00095233857,0.00003037664,0.00078227767,0.00036845246,0.0024438957,0.00044942737,0.00034495755,0.00069684087],"genre_scores_gemma":[0.9929787,0.0004284444,0.0003354123,0.00063355896,0.00047705125,0.00026908098,0.00043071737,0.0002566187,0.0041904165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9925383,0.0009159364,0.00096024247,0.0020655778,0.00193989,0.0015801094],"domain_scores_gemma":[0.9950315,0.00052961055,0.00038040068,0.001215199,0.00015446694,0.0026888235],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00091381086,0.001284852,0.0013776969,0.00068221666,0.0011844325,0.0004018551,0.00034496054,0.00046680612,0.00023971911],"category_scores_gemma":[0.0003567061,0.0011200351,0.0003983155,0.00046956574,0.0007419256,0.0005239389,0.0006102758,0.0014825719,0.00011669505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007811361,0.0031801993,0.03367142,0.003613657,0.0014971273,0.0027970814,0.0035058137,0.011871594,0.8934772,0.00014400492,0.030838767,0.007591754],"study_design_scores_gemma":[0.042994667,0.020829163,0.13099268,0.003205625,0.0032007722,0.0025931054,0.0020848894,0.034561288,0.7084825,0.0011993684,0.045627277,0.0042286725],"about_ca_topic_score_codex":0.00017959201,"about_ca_topic_score_gemma":0.000009411534,"teacher_disagreement_score":0.18499473,"about_ca_system_score_codex":0.00032758628,"about_ca_system_score_gemma":0.0004302986,"threshold_uncertainty_score":0.99999034},"labels":[],"label_agreement":null},{"id":"W4308407496","doi":"10.1136/jitc-2022-sitc2022.1071","title":"1071 Autologous tumor cell immunotherapeutic platform induces stress-correlated immunogenic cell death leading to immune activation within the draining lymph nodes","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Flow cytometry; Immunophenotyping; Cancer research; Immune system; Programmed cell death; Medicine; Apoptosis; Chemistry; Immunology","score_opus":0.022170415442404542,"score_gpt":0.2453659956535131,"score_spread":0.22319558021110858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308407496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942791,0.002687022,0.0000066606967,0.0010550562,0.0004064508,0.0007497887,0.00002500203,0.0001385684,0.0006523687],"genre_scores_gemma":[0.99793243,0.000039495335,0.00038272043,0.00087652024,0.00006519205,0.00020779067,0.00010295939,0.000078182646,0.00031468752],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768835,0.00009844352,0.0006393011,0.0005172386,0.0005427355,0.0005139411],"domain_scores_gemma":[0.9984945,0.00015768837,0.00040523207,0.00053807435,0.0000757304,0.0003287973],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005636417,0.00040844714,0.00050146953,0.00022899355,0.0009768774,0.0001512488,0.00024732895,0.000118166805,0.000041270938],"category_scores_gemma":[0.00011080785,0.0003141223,0.00016810853,0.0004143828,0.00014563712,0.00020546297,0.00016586912,0.0005132941,0.00002985614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025296916,0.000512775,0.028948242,0.00012770866,0.00036592994,0.00030177628,0.0060726283,0.00434913,0.95771295,0.00024037284,0.00008007584,0.0010354512],"study_design_scores_gemma":[0.0029972675,0.00047612708,0.22296116,0.0003137261,0.00044047783,0.00062736415,0.004608857,0.0006864218,0.7655758,0.00030189825,0.00051524356,0.00049564056],"about_ca_topic_score_codex":0.00066696893,"about_ca_topic_score_gemma":0.0000051127354,"teacher_disagreement_score":0.19401291,"about_ca_system_score_codex":0.00038719314,"about_ca_system_score_gemma":0.00043318255,"threshold_uncertainty_score":0.9999311},"labels":[],"label_agreement":null},{"id":"W4388042304","doi":"10.1136/jitc-2023-sitc2023.1257","title":"1257 Augmenting post-market surveillance of serious drug-induced adverse events with artificial intelligence (AI)-aggregated case reports: proof-of-concept for PD-1/PD-L1 inhibitors for NSCLC","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Adverse Event Reporting System; Adverse effect; Medicine; Internal medicine","score_opus":0.06243865175087545,"score_gpt":0.37209425398336576,"score_spread":0.30965560223249033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944942,0.00015083436,0.00015066282,0.00095428346,0.0014667569,0.001972285,0.0005638103,0.00014015599,0.000107039596],"genre_scores_gemma":[0.9981943,0.00003169395,0.00035056178,0.0002947884,0.00025576746,0.0002436417,0.00021354012,0.000061799095,0.00035392027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971586,0.00017881389,0.0010896745,0.00062442356,0.00027202285,0.0006764786],"domain_scores_gemma":[0.9972434,0.00050922594,0.0009247466,0.00030693927,0.0005124306,0.0005032411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015105894,0.0003998339,0.0005966345,0.00024038949,0.00041890595,0.00001703747,0.00014764894,0.0002901439,0.000023419976],"category_scores_gemma":[0.0007688866,0.00037935728,0.00022162989,0.0005411243,0.00042114942,0.00035862974,0.00006656213,0.0004517331,0.000002641842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006527644,0.0018258023,0.03540868,0.0042617833,0.003051681,0.0060159024,0.009203478,0.031829752,0.8417797,0.0005337605,0.016087161,0.043474663],"study_design_scores_gemma":[0.00130375,0.00030566388,0.0016013992,0.00029427922,0.00037954302,0.0012208739,0.0018761144,0.005826808,0.978279,0.00085182564,0.007477964,0.00058276573],"about_ca_topic_score_codex":0.00012147685,"about_ca_topic_score_gemma":0.0001200666,"teacher_disagreement_score":0.13649932,"about_ca_system_score_codex":0.00007173842,"about_ca_system_score_gemma":0.0005428387,"threshold_uncertainty_score":0.99986583},"labels":[],"label_agreement":null},{"id":"W4388042466","doi":"10.1136/jitc-2023-sitc2023.1118","title":"1118 The iodinated fluorescein derivative PV-10 enhances the antiviral activity of CD8+ T-Cells by inducing STING dimerization: implications for enhanced vaccine applications","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Bible College","funders":"Alberta Children's Hospital Foundation; Children's Hospital Foundation","keywords":"Cytotoxic T cell; Sting; Adjuvant; CD8; Cytotoxicity; Chemistry; Medicine; Immunology; Immune system; Biology; Molecular biology; Cancer research; Biochemistry","score_opus":0.016271690769014174,"score_gpt":0.2621915126719617,"score_spread":0.24591982190294756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290615,0.0006047423,0.0019283494,0.0029982843,0.00020768734,0.00090182194,0.00016975922,0.00009591035,0.00018729568],"genre_scores_gemma":[0.9974745,0.00013945204,0.00006581221,0.00010013255,0.000035746827,0.0003086259,0.00020416897,0.000023051538,0.0016485157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987033,0.00020937122,0.00038246482,0.00032407095,0.00004917273,0.00033161868],"domain_scores_gemma":[0.9984697,0.00061755534,0.00033524708,0.00037746454,0.00016230946,0.000037692953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004927461,0.00020821387,0.00027417723,0.00007853498,0.0007403963,0.00004563993,0.00029820946,0.00016342037,0.000015411622],"category_scores_gemma":[0.0004219811,0.00013934555,0.000087203625,0.00039744875,0.00048084257,0.00014518684,0.00008755652,0.00023537813,0.000030502411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082622566,0.000041486175,0.000122058,0.00003566822,0.0001296147,9.622999e-8,0.0006064259,0.000016325259,0.9909426,0.0005325329,0.0053297654,0.002160799],"study_design_scores_gemma":[0.00042874968,0.00009841978,0.017993795,0.000053975484,0.000057928428,0.0000064560086,0.00043860413,0.00003120144,0.9707637,0.00031480403,0.009657676,0.00015469371],"about_ca_topic_score_codex":0.00006500585,"about_ca_topic_score_gemma":0.000012002746,"teacher_disagreement_score":0.020178908,"about_ca_system_score_codex":0.000022898004,"about_ca_system_score_gemma":0.00013392261,"threshold_uncertainty_score":0.56946045},"labels":[],"label_agreement":null},{"id":"W4388042528","doi":"10.1136/jitc-2023-sitc2023.0689","title":"689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; CD38; Pharmacodynamics; Internal medicine; Multiple myeloma; CD8; Oncology; Refractory (planetary science); Antibody; Monoclonal antibody; Pharmacology; Immunology; Gastroenterology; Bortezomib; Immune system; Pharmacokinetics; Stem cell; Biology; CD34","score_opus":0.014267462257194538,"score_gpt":0.255296573393422,"score_spread":0.24102911113622744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683243,0.00026662578,7.5347697e-7,0.000617281,0.00008523347,0.0010354432,0.00004801195,0.00010770859,0.0010065079],"genre_scores_gemma":[0.9974151,0.0002245841,0.00018358165,0.00012240419,0.000054761134,0.000048919872,0.0002337323,0.00008066261,0.0016362536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730474,0.000121445555,0.0005211228,0.00070279546,0.0007097589,0.0006401205],"domain_scores_gemma":[0.9985483,0.00015731035,0.00014187221,0.000418294,0.00010697565,0.000627241],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069652434,0.0003509132,0.00053343223,0.0005808095,0.000099019184,0.00006509749,0.000111990295,0.00019505827,0.000015545504],"category_scores_gemma":[0.0003450854,0.00027536714,0.000040232015,0.0008645481,0.0004628356,0.0002946041,0.00006913094,0.00073464937,0.000015156915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010526639,0.0004956867,0.93682307,0.00040292417,0.00016626748,0.0014179156,0.0017336559,0.00018858671,0.040016733,0.00001546938,0.0011487536,0.0070642945],"study_design_scores_gemma":[0.024627326,0.0009638788,0.9647894,0.0005794489,0.000044567398,0.000070810645,0.00020458679,0.00090341805,0.004388939,0.000034161098,0.003049015,0.00034444607],"about_ca_topic_score_codex":0.00042026106,"about_ca_topic_score_gemma":0.0006004384,"teacher_disagreement_score":0.035627794,"about_ca_system_score_codex":0.0001990949,"about_ca_system_score_gemma":0.00037495833,"threshold_uncertainty_score":0.99996984},"labels":[],"label_agreement":null},{"id":"W4388042546","doi":"10.1136/jitc-2023-sitc2023.0601","title":"601 Identification of non-squamous NSCLC molecular subtypes and association with outcomes in the phase 3 IMpower150 study of 1L atezolizumab ± bevacizumab + carboplatin-paclitaxel in metastatic NSCLC","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Carboplatin; Atezolizumab; Bevacizumab; Medicine; Internal medicine; Paclitaxel; Oncology; Population; Chemotherapy; Cancer research; Cancer; Immunotherapy; Cisplatin; Nivolumab","score_opus":0.010029377704778903,"score_gpt":0.27238898583694954,"score_spread":0.26235960813217063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986771,0.000395965,0.000017377894,0.00017927361,0.000060941406,0.0005642587,0.000063477106,0.0000053294875,0.000036306556],"genre_scores_gemma":[0.9996036,0.0001204087,0.000058692392,0.000040656705,0.000014025935,0.000043412805,0.000076548764,0.00001974739,0.000022888029],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99857074,0.00010262153,0.0005236838,0.00031191137,0.00028095586,0.00021005809],"domain_scores_gemma":[0.9990841,0.00010140824,0.00033949965,0.00030944703,0.0000856616,0.0000798819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074969605,0.00017208036,0.0003150965,0.0001365895,0.00004055709,0.00003700569,0.0001256835,0.00009270688,4.2655182e-7],"category_scores_gemma":[0.00059097726,0.00013996784,0.000041655872,0.00026252193,0.00009152024,0.000013149708,0.000050681952,0.000106650376,5.179706e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030555928,0.0008174787,0.39971477,0.00019057233,0.00023262053,0.00007994342,0.004396448,0.001489306,0.5917275,0.000101007754,0.00014515567,0.00079966715],"study_design_scores_gemma":[0.0064882883,0.0011542661,0.8415901,0.000057360427,0.00017465226,0.000016217742,0.0039033098,0.00044191556,0.14549157,0.0003496579,0.000049073456,0.00028356066],"about_ca_topic_score_codex":0.00071334135,"about_ca_topic_score_gemma":0.0010146247,"teacher_disagreement_score":0.44623592,"about_ca_system_score_codex":0.000034972567,"about_ca_system_score_gemma":0.00014759795,"threshold_uncertainty_score":0.57077235},"labels":[],"label_agreement":null},{"id":"W4388042564","doi":"10.1136/jitc-2023-sitc2023.0695","title":"695 Efficacy and safety of trastuzumab deruxtecan (T-DXd) with durvalumab in patients with non-small cell lung cancer (HER2 altered NSCLC) who progressed on anti-PD1/PD-L1 therapy (HUDSON)","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Clinical endpoint; Oncology; Tremelimumab; Lung cancer; Trastuzumab; non-small cell lung cancer (NSCLC); Adverse effect; Cancer; Immunotherapy; Clinical trial; Nivolumab; Ipilimumab; Breast cancer","score_opus":0.010455952032273884,"score_gpt":0.2406354814381965,"score_spread":0.2301795294059226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959452,0.0012452885,0.0000044894646,0.00053244014,0.00012423232,0.0017902323,0.000052767547,0.00007650938,0.00022882981],"genre_scores_gemma":[0.99780107,0.0011603448,0.00025886545,0.00027665612,0.00007528964,0.00007573388,0.000076642515,0.00008804608,0.00018732877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766976,0.00007751281,0.00054566213,0.00063025893,0.0005376075,0.0005392319],"domain_scores_gemma":[0.99868715,0.00006792337,0.0003086149,0.00041504475,0.00012972385,0.0003915743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003597268,0.00044692418,0.00072018435,0.00025130232,0.00013465647,0.000055561643,0.00012805012,0.00018552695,0.000014858864],"category_scores_gemma":[0.000026882446,0.00032085576,0.00007515775,0.0005971455,0.00046950535,0.00013471162,0.000026351754,0.00031170325,0.0000013889588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018047603,0.0008760779,0.93970394,0.0009931795,0.00067180366,0.00009704966,0.0030196423,0.00017426923,0.015348398,0.00000893973,0.00060975185,0.020449348],"study_design_scores_gemma":[0.02229468,0.002102692,0.94707394,0.0022457484,0.00012907873,0.000013768648,0.0001628904,0.00011927232,0.024856202,0.0000065251998,0.0006016375,0.00039358696],"about_ca_topic_score_codex":0.00072103966,"about_ca_topic_score_gemma":0.00022256294,"teacher_disagreement_score":0.020055762,"about_ca_system_score_codex":0.00013337382,"about_ca_system_score_gemma":0.00056866306,"threshold_uncertainty_score":0.99992436},"labels":[],"label_agreement":null},{"id":"W4388042588","doi":"10.1136/jitc-2023-sitc2023.0347","title":"347 Functional characterization of GUCY2C-TAC T cells for the treatment of colorectal cancer using preclinical models","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"In vivo; Cancer research; Receptor; In vitro; Antigen; Cancer; Cancer cell; Colorectal cancer; Cytotoxic T cell; Chemistry; Cell biology; Biology; Medicine; Immunology; Internal medicine; Biochemistry","score_opus":0.11431374849587565,"score_gpt":0.34841567456806927,"score_spread":0.2341019260721936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755555,0.00027338174,0.00014818122,0.0005703707,0.00034531546,0.00089691195,0.00013911877,0.000027475771,0.00004371399],"genre_scores_gemma":[0.996488,0.0012821642,0.00025213088,0.000042796688,0.000261602,0.00009274558,0.00011434689,0.000032402415,0.0014338597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987776,0.000037177455,0.00039138432,0.00023150968,0.00034262927,0.00021964582],"domain_scores_gemma":[0.9990538,0.00021587864,0.00016434009,0.00018715262,0.0001847454,0.00019410576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003350622,0.00013772548,0.000334264,0.000090380265,0.000085522064,0.000014584451,0.000052974643,0.00012110595,0.000060752227],"category_scores_gemma":[0.00007003504,0.00009701987,0.00015280263,0.00020791369,0.00029330366,0.00007836289,0.00001707701,0.00007767092,0.0000016279678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005538503,0.00014070107,0.0044476422,0.00015868153,0.00024767127,0.0000033826775,0.00046909216,0.0022007918,0.9887898,0.000068927235,0.00014575792,0.0027736805],"study_design_scores_gemma":[0.0019557725,0.00063671515,0.120559424,0.00013361577,0.0002776565,0.000017532968,0.00008287376,0.06494081,0.80807465,0.0002953559,0.0029056333,0.0001199549],"about_ca_topic_score_codex":0.00017832548,"about_ca_topic_score_gemma":0.000016644652,"teacher_disagreement_score":0.18071516,"about_ca_system_score_codex":0.00008845518,"about_ca_system_score_gemma":0.00043702687,"threshold_uncertainty_score":0.39563555},"labels":[],"label_agreement":null},{"id":"W4388042728","doi":"10.1136/jitc-2023-sitc2023.0121","title":"121 Quantifying statistical and systematic uncertainties in predicting clinical outcomes using multiplex immunofluorescence","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Calibration; Multiplex; Poisson distribution; Statistical power; Computer science; Statistics; Statistical hypothesis testing; Microscope; Pattern recognition (psychology); Artificial intelligence; Optics; Mathematics; Physics; Bioinformatics; Biology","score_opus":0.06725253300185183,"score_gpt":0.32539977783584545,"score_spread":0.25814724483399365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980983,0.0007658496,0.00028968154,0.00007534251,0.00038653496,0.00030315088,0.000023744753,0.000041827127,0.000015548585],"genre_scores_gemma":[0.99744105,0.00034182816,0.001889828,0.00009423766,0.00008578017,0.000011766543,0.000050022805,0.000031512678,0.000053944554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981201,0.00017368264,0.00070366694,0.00045589329,0.00018581701,0.00036082295],"domain_scores_gemma":[0.9991568,0.00015785449,0.00014291379,0.00024322899,0.000048376987,0.0002508477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096043857,0.00022903102,0.00043800622,0.00008980353,0.00014857964,0.00010055149,0.00012101298,0.00022566019,8.5902786e-7],"category_scores_gemma":[0.0016516595,0.0002045155,0.00007442946,0.00012400276,0.00036928212,0.000016515905,0.00009158056,0.00020736174,0.0000025628676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035113306,0.00003467321,0.8670838,0.0018780401,0.00007995342,0.000039551476,0.00027817674,0.00026106247,0.1300239,0.0000909631,0.000057423975,0.00013736814],"study_design_scores_gemma":[0.0013636405,0.00016439905,0.9600212,0.0018262448,0.00011362105,0.00008287772,0.001131855,0.023244452,0.011212084,0.00022202918,0.000079176265,0.0005384167],"about_ca_topic_score_codex":0.00044249257,"about_ca_topic_score_gemma":0.00016663181,"teacher_disagreement_score":0.11881181,"about_ca_system_score_codex":0.000017149912,"about_ca_system_score_gemma":0.00012192506,"threshold_uncertainty_score":0.83399},"labels":[],"label_agreement":null},{"id":"W4388047619","doi":"10.1136/jitc-2023-sitc2023.0778","title":"778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Cancer; Internal medicine; Oncology; Surgery; Immunotherapy; Cancer research","score_opus":0.04680987990646559,"score_gpt":0.31675635918176015,"score_spread":0.2699464792752946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942449,0.0008478409,0.0000026040664,0.00020125388,0.00011031,0.0030050995,0.000056665263,0.00017771471,0.0013536421],"genre_scores_gemma":[0.9922957,0.00078574126,0.00040367118,0.000114094306,0.0000929589,0.0003522287,0.00012030092,0.00015650204,0.005678794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99558187,0.00035608068,0.0010334923,0.0009229711,0.0010918201,0.0010137904],"domain_scores_gemma":[0.99716586,0.00043702757,0.00040301646,0.0008994964,0.00022404554,0.0008705383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083323766,0.0006795656,0.0014984278,0.00066468236,0.00020335677,0.00011970147,0.00025927887,0.00013084979,0.00021997825],"category_scores_gemma":[0.0002598752,0.0004904941,0.00015917714,0.0014799213,0.0003957777,0.00029572952,0.00007189978,0.00039783944,0.000027050135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.082627185,0.013038325,0.075858146,0.0017272828,0.0019930024,0.011136144,0.017941032,0.001208886,0.78167784,0.000048444646,0.0010939229,0.011649788],"study_design_scores_gemma":[0.21657489,0.055012718,0.067867205,0.001080115,0.0006370976,0.0010339958,0.011055015,0.005960967,0.63599324,0.00016773604,0.0032887387,0.0013283034],"about_ca_topic_score_codex":0.0022941015,"about_ca_topic_score_gemma":0.000772726,"teacher_disagreement_score":0.14568463,"about_ca_system_score_codex":0.00039610302,"about_ca_system_score_gemma":0.0016595207,"threshold_uncertainty_score":0.99975467},"labels":[],"label_agreement":null},{"id":"W4388047658","doi":"10.1136/jitc-2023-sitc2023.0654","title":"654 A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cytokine release syndrome; Chimeric antigen receptor; Adverse effect; Refractory (planetary science); Internal medicine; Pharmacokinetics; Immunotherapy; Leukapheresis; T cell; Chemotherapy; Oncology; Gastroenterology; Immunology; Immune system; Cancer; Stem cell","score_opus":0.044519737722509396,"score_gpt":0.3424634879703385,"score_spread":0.2979437502478291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578595,0.0003389056,0.0000013722903,0.0013888277,0.00024230461,0.0013181565,0.000028099197,0.00018417426,0.00071222545],"genre_scores_gemma":[0.9954566,0.00031045635,0.00044381764,0.00023091046,0.00026211434,0.0000393189,0.00007460593,0.00008337687,0.0030988492],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99653363,0.00023930632,0.0011570164,0.0006746845,0.00068977295,0.0007055704],"domain_scores_gemma":[0.99747515,0.00049549993,0.0003426666,0.000541065,0.000111191126,0.0010344186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018357565,0.00037431566,0.0010302254,0.00052944047,0.00021232334,0.000046331254,0.00016404911,0.00034434118,0.000101369915],"category_scores_gemma":[0.0046992605,0.00031997493,0.00012958916,0.00090768817,0.0010082473,0.00014803879,0.00016723976,0.0007873501,0.000011363046],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05092726,0.0015941149,0.0068234825,0.0013956184,0.00042536558,0.0024345778,0.008551176,0.00017691917,0.8870169,0.00028869833,0.0030048578,0.03736106],"study_design_scores_gemma":[0.41844836,0.026440293,0.30664232,0.0053464826,0.00059793814,0.0019085334,0.0033132124,0.007852544,0.19676499,0.0017818934,0.028702673,0.0022007492],"about_ca_topic_score_codex":0.00031671743,"about_ca_topic_score_gemma":0.00007595139,"teacher_disagreement_score":0.6902519,"about_ca_system_score_codex":0.0001430145,"about_ca_system_score_gemma":0.0011320155,"threshold_uncertainty_score":0.99992526},"labels":[],"label_agreement":null},{"id":"W4388047700","doi":"10.1136/jitc-2023-sitc2023.0609","title":"609 Phase 1/2a dose selection of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced solid malignancies","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Antibody; Pharmacokinetics; In vitro; Monoclonal antibody; Pharmacology; Receptor; Cancer research; Cell cycle; Medicine; Chemistry; Internal medicine; Immunology; Cancer; Biochemistry","score_opus":0.010168535610960905,"score_gpt":0.27046151261438733,"score_spread":0.2602929770034264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981677,0.00028556437,0.0000033905935,0.00050663616,0.00017423366,0.000627418,0.000028174618,0.00007280106,0.00013409997],"genre_scores_gemma":[0.99891853,0.0003692206,0.00018658928,0.0001473065,0.000037734782,0.000023918814,0.0001208833,0.00003678243,0.00015902803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822766,0.000037898124,0.0005402478,0.00038634965,0.0003840174,0.00042380719],"domain_scores_gemma":[0.9991868,0.0000440414,0.00021309289,0.00023100254,0.00011183632,0.00021323378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033721104,0.00025318467,0.0005097082,0.00038181563,0.00007217557,0.00002437755,0.00007563802,0.00014875997,0.000013401855],"category_scores_gemma":[0.00015145405,0.00021407293,0.00007443111,0.00092612486,0.00027129118,0.00023212528,0.000023999442,0.00019401369,0.0000048331044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034488996,0.0007530731,0.77933705,0.0006532394,0.00015189865,0.00013679168,0.0008728281,0.0003482468,0.2102766,0.000027817774,0.00062760344,0.0033659432],"study_design_scores_gemma":[0.012731005,0.0009513926,0.93152326,0.001061657,0.000047675625,0.00002120028,0.0001498223,0.00027123853,0.051353827,0.00003883393,0.0016013418,0.0002487519],"about_ca_topic_score_codex":0.00029537722,"about_ca_topic_score_gemma":0.00028301938,"teacher_disagreement_score":0.15892278,"about_ca_system_score_codex":0.000107502245,"about_ca_system_score_gemma":0.00027024306,"threshold_uncertainty_score":0.87296414},"labels":[],"label_agreement":null},{"id":"W4388047770","doi":"10.1136/jitc-2023-sitc2023.0607","title":"607 TTFields therapy with an immune checkpoint inhibitor in metastatic non-small cell lung cancer (mNSCLC) with progression on/after platinum-based therapy: histology subgroups in the pivotal LUNAR study","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Novocure","keywords":"Medicine; Docetaxel; Internal medicine; Oncology; Lung cancer; Cancer","score_opus":0.019905545277624854,"score_gpt":0.27974167768409136,"score_spread":0.2598361324064665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929608,0.0024574902,0.000004008845,0.0018007596,0.00014131104,0.0024872338,0.000010228622,0.000069194146,0.000068979156],"genre_scores_gemma":[0.9974833,0.0002793928,0.00024128171,0.0009373961,0.00008711503,0.00078651536,0.000041866133,0.00007183861,0.00007129267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750525,0.00025923483,0.0005726803,0.000610992,0.0005231903,0.00052867894],"domain_scores_gemma":[0.99885136,0.000100696976,0.00023131513,0.00054217,0.00006333719,0.00021109373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010209536,0.00044548075,0.00057973573,0.0003224633,0.0001249934,0.00007286219,0.00018475183,0.00015769363,0.000023042929],"category_scores_gemma":[0.000018213186,0.00025234564,0.000087265806,0.000695047,0.000329475,0.00013989322,0.000018053504,0.0005667839,0.000002051171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033077992,0.0036374673,0.83881855,0.00047733827,0.00043733,0.0030142718,0.02530628,0.00043925352,0.087724745,0.0000055971163,0.00021662696,0.0068445625],"study_design_scores_gemma":[0.01694918,0.006299171,0.94096315,0.0008737342,0.000090774745,0.00007411444,0.0028718626,0.0005737855,0.030546889,0.000012691602,0.00030723665,0.00043742053],"about_ca_topic_score_codex":0.0016494609,"about_ca_topic_score_gemma":0.0024088204,"teacher_disagreement_score":0.10214461,"about_ca_system_score_codex":0.00014455664,"about_ca_system_score_gemma":0.00068065786,"threshold_uncertainty_score":0.9999929},"labels":[],"label_agreement":null},{"id":"W4388047823","doi":"10.1136/jitc-2023-sitc2023.0985","title":"985 PSGL-1 is a novel inhibitor of tumor cell phagocytosis by macrophages","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Phagocytosis; Macrophage; Cell biology; Biology; Immune system; Molecular biology; Myeloid; Chemistry; Immunology; In vitro; Biochemistry","score_opus":0.013055454565177592,"score_gpt":0.22480916438329723,"score_spread":0.21175370981811964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933106,0.0041488362,0.000019222509,0.0007519402,0.00069693086,0.0002795679,0.0003214744,0.00015615598,0.00031529597],"genre_scores_gemma":[0.9944292,0.0002872021,0.00013053017,0.00032366614,0.00005951063,0.000025149366,0.00031024605,0.000048857906,0.004385691],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809414,0.000080653626,0.000654487,0.00050435244,0.00013350879,0.00053286983],"domain_scores_gemma":[0.99891675,0.00008120398,0.0003559142,0.0004012114,0.00009884666,0.0001460819],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039349365,0.0003411706,0.00052420836,0.00019764474,0.00022692526,0.00004338931,0.00022819042,0.00029459165,0.000072867],"category_scores_gemma":[0.00011039324,0.00028587558,0.00016980337,0.00038875284,0.0005300591,0.00024346348,0.00012860422,0.0002925797,0.00024228041],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003856382,0.00012368473,0.0027159187,0.0001552003,0.00010510048,0.000004634636,0.0004365976,0.000008323023,0.93766415,0.00006800072,0.058206923,0.00047287758],"study_design_scores_gemma":[0.0014913623,0.0001309905,0.033120237,0.000115889634,0.000084617124,0.000058099926,0.00018497297,0.000032068754,0.9246655,0.00014061763,0.03966008,0.00031555115],"about_ca_topic_score_codex":0.00020153887,"about_ca_topic_score_gemma":0.0000033611877,"teacher_disagreement_score":0.030404318,"about_ca_system_score_codex":0.000038764683,"about_ca_system_score_gemma":0.00015028167,"threshold_uncertainty_score":0.99995935},"labels":[],"label_agreement":null},{"id":"W4388047842","doi":"10.1136/jitc-2023-sitc2023.0544","title":"544 Coordinated blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector memory responses","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; EMD Serono","keywords":"Ovarian cancer; Cancer research; Immune system; Immunotherapy; Tumor microenvironment; Cytotoxic T cell; Cancer; Medicine; Immunology; Cytokine; Biology; Internal medicine","score_opus":0.03204473608297409,"score_gpt":0.30242633622972054,"score_spread":0.27038160014674645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99028504,0.0042798044,0.0000040281625,0.0038882087,0.0002454672,0.0008996901,0.00020302052,0.00012222213,0.000072507166],"genre_scores_gemma":[0.9979788,0.00079176447,0.00010317036,0.00013271946,0.00008401551,0.00007342497,0.00010081531,0.000055573804,0.00067970646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747896,0.00031338888,0.00076853146,0.0005828326,0.00037751417,0.00047874235],"domain_scores_gemma":[0.9985363,0.00037893435,0.00025289503,0.00028936105,0.00008216357,0.0004603388],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019863732,0.00031078744,0.00068779493,0.00018886961,0.000098556804,0.000049183065,0.00011278094,0.0003156693,0.0000152103985],"category_scores_gemma":[0.0008508081,0.0002798152,0.000100252444,0.0004943354,0.00056267483,0.00017113502,0.00006134126,0.00036701225,0.0000018586073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023647274,0.00021209255,0.035156693,0.00092156493,0.00033511498,0.00009563248,0.0012551823,0.000022659116,0.9479404,0.0000110158135,0.004627244,0.007057646],"study_design_scores_gemma":[0.0099341655,0.0010561951,0.31556407,0.002595241,0.0003209619,0.00016472692,0.000382172,0.006811852,0.6600025,0.00042895827,0.0019410083,0.0007981412],"about_ca_topic_score_codex":0.0018490434,"about_ca_topic_score_gemma":0.00010971792,"teacher_disagreement_score":0.28793794,"about_ca_system_score_codex":0.00007643345,"about_ca_system_score_gemma":0.0003948285,"threshold_uncertainty_score":0.9999654},"labels":[],"label_agreement":null},{"id":"W4388047897","doi":"10.1136/jitc-2023-sitc2023.0912","title":"912 A comparison of 37+ immune populations in whole blood by CyTOF® flow cytometry collected with 4 different preservation reagents","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada); Hospital for Sick Children","funders":"","keywords":"Immune system; Whole blood; Flow cytometry; Mass cytometry; Heparin; Antibody; Multiplex; Medicine; Immunology; Biology; Internal medicine; Bioinformatics; Biochemistry","score_opus":0.030803681376204067,"score_gpt":0.2641109275763721,"score_spread":0.23330724620016804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852955,0.0005506673,0.00013676766,0.00021565202,0.000108388755,0.00027347784,0.00009417037,0.000031144446,0.000060193626],"genre_scores_gemma":[0.9976203,0.000068772126,0.00047889166,0.000031894793,0.000038310798,0.000023105396,0.001214688,0.00003071401,0.0004933548],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986803,0.00006323157,0.00044658562,0.00032444432,0.00022903904,0.00025637946],"domain_scores_gemma":[0.9993165,0.000014052966,0.00015660723,0.00026958933,0.00007432486,0.00016889877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014709726,0.00019733475,0.00030241412,0.00011162193,0.00009529227,0.00003589146,0.00012940474,0.00019062433,0.0000022818642],"category_scores_gemma":[0.0001359151,0.00017883435,0.000055519988,0.00042425984,0.00012918381,0.00001625428,0.000043875214,0.00013242244,0.0000013699834],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075091804,0.00019137835,0.25301677,0.00006990427,0.000058844686,0.0000036038712,0.00017395965,0.0005854884,0.7441774,0.000009409281,0.0015419831,0.00009614739],"study_design_scores_gemma":[0.001298732,0.0002489834,0.49880219,0.00009748174,0.00005623795,0.0000061083683,0.000089508576,0.0016676778,0.49660164,0.000059612645,0.0008623385,0.00020950574],"about_ca_topic_score_codex":0.00025653167,"about_ca_topic_score_gemma":0.0004433457,"teacher_disagreement_score":0.24757579,"about_ca_system_score_codex":0.000015590818,"about_ca_system_score_gemma":0.00007934452,"threshold_uncertainty_score":0.72926533},"labels":[],"label_agreement":null},{"id":"W4388047947","doi":"10.1136/jitc-2023-sitc2023.0400","title":"400 Preclinical characterization and modelling of allogeneic Vγ9Vδ2 TAC T cells for the treatment of solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Antigen; T cell; Cytotoxic T cell; Cell therapy; Immunotherapy; Chimeric antigen receptor; Immunology; In vivo; Antigen-presenting cell; Biology; Medicine; In vitro; Immune system; Cell biology; Stem cell","score_opus":0.08392283671548659,"score_gpt":0.3301677903857863,"score_spread":0.24624495367029972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388047947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972336,0.00054636755,0.00034227132,0.0007297485,0.00011376966,0.00089827663,0.00008506943,0.000029208839,0.000021657657],"genre_scores_gemma":[0.993143,0.004061589,0.00038959002,0.000049115566,0.00015731141,0.000055073353,0.00009191437,0.00003487047,0.0020175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987348,0.000040392475,0.00045695604,0.00026269394,0.0002619859,0.00024321182],"domain_scores_gemma":[0.9989354,0.00026124282,0.00016277161,0.00027742147,0.000109443914,0.00025373686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004719723,0.00015217633,0.00041361913,0.00009032812,0.00007499827,0.000015128631,0.00006335995,0.000113922084,0.000017063692],"category_scores_gemma":[0.000089261506,0.000106159656,0.000117405856,0.00014456807,0.0003343562,0.000050301747,0.000021154163,0.00007991113,0.000002374693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031383714,0.00014646172,0.0052886433,0.00036077996,0.00022522984,0.000010537102,0.0010183421,0.0012690176,0.9840428,0.000051727555,0.0000976707,0.0071749073],"study_design_scores_gemma":[0.0021355192,0.0013389619,0.050347712,0.00021916973,0.0002703286,0.000034286524,0.00016557625,0.04926002,0.887566,0.00029021362,0.008204768,0.0001674548],"about_ca_topic_score_codex":0.000046735164,"about_ca_topic_score_gemma":0.0000033771241,"teacher_disagreement_score":0.09647686,"about_ca_system_score_codex":0.00002839981,"about_ca_system_score_gemma":0.0001779815,"threshold_uncertainty_score":0.4329065},"labels":[],"label_agreement":null},{"id":"W4388048003","doi":"10.1136/jitc-2023-sitc2023.0312","title":"312 IL7 increases targeted lipid nanoparticle-mediated mRNA protein expression in T cells<i> in vitro</i> and<i> in situ</i> by enhancing T cell translation","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Acuitas Therapeutics (Canada)","funders":"","keywords":"Molecular biology; Biology; T cell; mCherry; CD28; CD8; Cell biology; Antigen; Immune system; Green fluorescent protein; Immunology; Biochemistry","score_opus":0.014291793481288098,"score_gpt":0.24408714815614044,"score_spread":0.22979535467485235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662507,0.0011646225,0.0000020880696,0.0006598669,0.00006474976,0.0011690311,0.000027027761,0.000108558175,0.00017900669],"genre_scores_gemma":[0.9983421,0.00038107112,0.00030947765,0.00017309029,0.00006715395,0.00011808935,0.00018066393,0.000059021968,0.00036931082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99724984,0.00025977136,0.0006901305,0.00058587326,0.0005297125,0.0006846708],"domain_scores_gemma":[0.9987927,0.00018990925,0.000110493,0.00027207288,0.00004234787,0.00059247046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011687872,0.00030025837,0.00050928566,0.0004955703,0.00006585507,0.000058732006,0.000097523705,0.0002714994,0.000023907724],"category_scores_gemma":[0.00031254994,0.00029431365,0.000054072556,0.0009788824,0.00018781108,0.00028911352,0.000055429202,0.0005641336,0.000019145022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000609659,0.0002118607,0.008772786,0.0003407558,0.000007330978,0.00021168096,0.0010365066,0.00005484936,0.9875919,5.359149e-7,0.00031074914,0.00085136277],"study_design_scores_gemma":[0.0037786542,0.00011691838,0.02225545,0.00056297454,0.0000121032845,0.000014933218,0.00028308228,0.0010868533,0.97042656,0.00005757091,0.0011299946,0.0002749355],"about_ca_topic_score_codex":0.00085096,"about_ca_topic_score_gemma":0.00054510316,"teacher_disagreement_score":0.017165393,"about_ca_system_score_codex":0.00013432956,"about_ca_system_score_gemma":0.00025510677,"threshold_uncertainty_score":0.9999509},"labels":[],"label_agreement":null},{"id":"W4388048048","doi":"10.1136/jitc-2023-sitc2023.0582","title":"582 Analysis of the HR+/HER2- breast cancer tumor microenvironment following immune priming with pelareorep and atezolizumab using imaging mass cytometry – Results from the AWARE-1 trial","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Tumor microenvironment; Breast cancer; Immune system; Oncology; Internal medicine; Antibody; Triple-negative breast cancer; Cancer; Cancer research; Immunotherapy; Immunology; Nivolumab","score_opus":0.012596636400107528,"score_gpt":0.2596904684011493,"score_spread":0.24709383200104176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966893,0.0015802907,0.000030408335,0.00063014025,0.0001185302,0.0003642925,0.000561504,0.000011496614,0.000013996206],"genre_scores_gemma":[0.99913913,0.00028601938,0.00011910886,0.00007258348,0.0001096385,0.000021059544,0.00017011212,0.000029019036,0.000053324165],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99833554,0.00010462072,0.0003417491,0.0004960902,0.00036863802,0.00035336363],"domain_scores_gemma":[0.9990007,0.000040706764,0.00023003148,0.0005067268,0.000035140285,0.00018664871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003586474,0.00022512434,0.0003026889,0.000088944136,0.00029130292,0.00009053859,0.00019729347,0.00006288478,0.0000029668465],"category_scores_gemma":[0.0000917712,0.00014056366,0.00018954302,0.00045438757,0.0003439999,0.000017090862,0.00019181837,0.00013747155,5.1870677e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038324813,0.00006469692,0.2510486,0.000040502677,0.0036047185,0.000099630895,0.00050950417,0.0014766648,0.73777664,0.0000026421012,0.00018236683,0.001361553],"study_design_scores_gemma":[0.010767931,0.00011535394,0.83305174,0.00023232108,0.0016153973,0.000048012953,0.0006364499,0.0014151594,0.15142576,0.000032515367,0.000336132,0.00032322583],"about_ca_topic_score_codex":0.0056921905,"about_ca_topic_score_gemma":0.00045334068,"teacher_disagreement_score":0.58635086,"about_ca_system_score_codex":0.00007127908,"about_ca_system_score_gemma":0.00022533486,"threshold_uncertainty_score":0.8604927},"labels":[],"label_agreement":null},{"id":"W4388048115","doi":"10.1136/jitc-2023-sitc2023.0372","title":"372 TAC-T cells persist and remain functional during and after repeated tumor exposure <i>in vitro</i> and <i>in vivo</i>","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Cancer research; In vivo; T cell; Antigen; Flow cytometry; In vitro; Tumor antigen; Biology; Immune system; Immunotherapy; Molecular biology; Immunology; Biochemistry","score_opus":0.012901209380400826,"score_gpt":0.22928253968148246,"score_spread":0.21638133030108164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620086,0.0015278256,2.9212927e-7,0.00117271,0.00010472144,0.0004592792,0.00002935227,0.00006984586,0.00043509106],"genre_scores_gemma":[0.99443537,0.0006778711,0.00012759645,0.00037755046,0.00013399062,0.000044351556,0.000021163183,0.0000508055,0.004131298],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979308,0.00009151958,0.00039538127,0.00065925706,0.00040926092,0.0005137381],"domain_scores_gemma":[0.99887127,0.00009333177,0.00006661135,0.00026457245,0.00004937273,0.00065484055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007349375,0.0002785781,0.00043622233,0.00034221073,0.0001131558,0.00010290046,0.000044586606,0.00016346357,0.00006362976],"category_scores_gemma":[0.00015525919,0.0002669999,0.00005147758,0.0003734999,0.00045036164,0.00017286505,0.00010265827,0.00043082196,0.00000586198],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092900946,0.000037356353,0.104512945,0.00044183346,0.000038404494,0.0013027423,0.0005208347,0.000009879146,0.89150333,0.0000049231708,0.0004931794,0.00020558394],"study_design_scores_gemma":[0.0034881744,0.00012844166,0.70659953,0.00038332207,0.000046968747,0.000811597,0.00054026267,0.00021115002,0.2850822,0.00010593318,0.0022861331,0.0003162824],"about_ca_topic_score_codex":0.00013865113,"about_ca_topic_score_gemma":0.00010313855,"teacher_disagreement_score":0.6064211,"about_ca_system_score_codex":0.0000766298,"about_ca_system_score_gemma":0.00012577968,"threshold_uncertainty_score":0.99997824},"labels":[],"label_agreement":null},{"id":"W4388048122","doi":"10.1136/jitc-2023-sitc2023.0738","title":"738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Immunotherapy; Leukapheresis; Chimeric antigen receptor; Cancer research; Radioimmunotherapy; Stem cell; Immunology; Immune system; Antibody; Biology; CD34","score_opus":0.037706947430035526,"score_gpt":0.3355257030615537,"score_spread":0.29781875563151816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598956,0.00033429352,0.0000104983,0.0007246959,0.000070891474,0.0024889433,0.000025444378,0.00011330508,0.00024234857],"genre_scores_gemma":[0.99766225,0.00018984548,0.0006498887,0.0001937881,0.000047555455,0.00008007931,0.000026536063,0.000080855694,0.0010692173],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99642986,0.00037539087,0.00087889045,0.00067346334,0.0008954315,0.0007469478],"domain_scores_gemma":[0.997381,0.0008275042,0.00030798966,0.00059963163,0.00015864045,0.000725251],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020417718,0.0004108984,0.0009763315,0.0003828414,0.00021266883,0.00008318114,0.00023085916,0.00010439381,0.000047903966],"category_scores_gemma":[0.0016146795,0.00026264606,0.000069078604,0.0014853235,0.0010909087,0.00017805975,0.00015395154,0.00068248995,0.0000063160805],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01192709,0.0020120016,0.058444187,0.0021608623,0.0011339707,0.00578228,0.01707678,0.0054345066,0.87712514,0.00010433596,0.00083540473,0.017963428],"study_design_scores_gemma":[0.061639514,0.014453293,0.57570887,0.003584063,0.000822011,0.0016906352,0.017840892,0.009871161,0.31121078,0.0005685849,0.001254307,0.0013558749],"about_ca_topic_score_codex":0.0004576085,"about_ca_topic_score_gemma":0.000503426,"teacher_disagreement_score":0.5659144,"about_ca_system_score_codex":0.000098881166,"about_ca_system_score_gemma":0.0011130122,"threshold_uncertainty_score":0.9999826},"labels":[],"label_agreement":null},{"id":"W4388048242","doi":"10.1136/jitc-2023-sitc2023.0589","title":"589 RUBY trial post hoc analysis of number needed to treat and incremental costs per outcome of dostarlimab + carboplatin-paclitaxel (CP) vs placebo + CP for primary advanced/recurrent endometrial cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Placebo; Medicine; Internal medicine; Number needed to treat; Population; Post-hoc analysis; Carboplatin; Clinical endpoint; Endometrial cancer; Oncology; Randomized controlled trial; Cancer; Confidence interval; Chemotherapy; Relative risk; Cisplatin","score_opus":0.017014224711491638,"score_gpt":0.2957273220226049,"score_spread":0.27871309731111327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946545,0.001046285,0.000015830496,0.00031627828,0.0004698877,0.001011689,0.0023559986,0.000012822392,0.00011676103],"genre_scores_gemma":[0.9965752,0.0008860539,0.0007823726,0.0002862838,0.00025066786,0.0001344501,0.0009232049,0.000038946808,0.00012283635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998141,0.00004630011,0.0006746949,0.0005135465,0.00027273383,0.00035171083],"domain_scores_gemma":[0.9986215,0.00017210902,0.00030624736,0.0003147294,0.00019127142,0.00039411712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039497018,0.0002901855,0.0006888971,0.00026709965,0.00008409878,0.00004091767,0.00013529812,0.00018267368,0.000009983265],"category_scores_gemma":[0.00074611953,0.00028290806,0.0002588984,0.0004119421,0.00018035974,0.000014697279,0.0001596315,0.00008560996,0.0000012397949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037434645,0.00019502013,0.035801172,0.00039210793,0.0012664078,0.0000066537323,0.00046530575,0.0009553928,0.9154595,0.00011287796,0.0029733682,0.0049375356],"study_design_scores_gemma":[0.10293961,0.0073730056,0.14763395,0.0002577934,0.004918589,0.000022888735,0.0018477447,0.00036416342,0.71485394,0.0001341749,0.017726583,0.0019275466],"about_ca_topic_score_codex":0.001079883,"about_ca_topic_score_gemma":0.00064184004,"teacher_disagreement_score":0.20060557,"about_ca_system_score_codex":0.000099430414,"about_ca_system_score_gemma":0.00025073125,"threshold_uncertainty_score":0.99996233},"labels":[],"label_agreement":null},{"id":"W4388048268","doi":"10.1136/jitc-2023-sitc2023.0838","title":"838 Oncolytic virus induced tumour-infiltrating lymphocytes (TILs) for the treatment of colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Agricultural Research Institute of Ontario; University of Ottawa","funders":"","keywords":"Oncolytic virus; Tumor-infiltrating lymphocytes; Medicine; Adoptive cell transfer; Colorectal cancer; Tumor microenvironment; Cancer research; Immunotherapy; Cancer; Immune system; Immunology; T cell; Internal medicine","score_opus":0.03767717695858579,"score_gpt":0.31901405281430145,"score_spread":0.28133687585571565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961578,0.002375852,0.000005192428,0.00043439856,0.00019728865,0.00064874627,0.00009795947,0.00002890306,0.000053805958],"genre_scores_gemma":[0.9967745,0.0020968148,0.000091901755,0.00009862216,0.00027195425,0.000293961,0.00007005607,0.000042558084,0.00025963548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869597,0.00005792149,0.00028934656,0.0003508437,0.00021840492,0.00038751736],"domain_scores_gemma":[0.9991718,0.00010366269,0.00013115158,0.00026564332,0.00010384336,0.00022390258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003387125,0.00021733511,0.00023674057,0.00006187418,0.00021140094,0.00004598457,0.0001778194,0.00014928545,0.000006446467],"category_scores_gemma":[0.00018765898,0.00016058295,0.00013669097,0.00018091968,0.00023795462,0.000007284218,0.00003566592,0.000060788556,0.000004892309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050940964,0.000055572484,0.0012350851,0.000040724954,0.00019323864,0.0000049189716,0.0002843917,0.0004673331,0.9913951,0.000013140902,0.00064803095,0.0051530167],"study_design_scores_gemma":[0.0011229537,0.0025137758,0.0095772445,0.000030632484,0.000055913573,0.000011961012,0.00017619954,0.00088121544,0.9813774,0.000076736724,0.0039958977,0.00018001976],"about_ca_topic_score_codex":0.00040335875,"about_ca_topic_score_gemma":0.0008637853,"teacher_disagreement_score":0.010017687,"about_ca_system_score_codex":0.000077199074,"about_ca_system_score_gemma":0.0006560061,"threshold_uncertainty_score":0.65483826},"labels":[],"label_agreement":null},{"id":"W4388048272","doi":"10.1136/jitc-2023-sitc2023.0766","title":"766 A clinical trial to evaluate the safety, tolerability and preliminary efficacy of VG161 in combination with Nivolumab in patients with advanced pancreatic cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Tolerability; Medicine; Pharmacodynamics; Nivolumab; Oncolytic virus; Internal medicine; Pharmacokinetics; Gastroenterology; Refractory (planetary science); Pancreatic cancer; Adverse effect; Cancer; Oncology; Urology; Pharmacology; Immunotherapy; Biology","score_opus":0.025696820659456922,"score_gpt":0.33101462625382705,"score_spread":0.3053178055943701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774885,0.0002037692,0.0000024017713,0.00057476485,0.000049463775,0.0013823406,0.0000147846595,0.000008343606,0.000015301343],"genre_scores_gemma":[0.99943346,0.00016819432,0.00008084943,0.00008165961,0.00002977363,0.00010439016,0.00004976281,0.000021166641,0.000030729818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982963,0.00029628555,0.00042909477,0.00041520034,0.00031114905,0.00025196245],"domain_scores_gemma":[0.9991898,0.00009106525,0.00009636866,0.00033744576,0.00011009045,0.00017521811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012212736,0.00015613523,0.0002907446,0.000077805926,0.00005618716,0.000018425695,0.00012748354,0.000105469306,0.0000018468365],"category_scores_gemma":[0.0004801233,0.00010767499,0.000030431394,0.00029442032,0.00031530065,0.000011725136,0.00007883116,0.00016087099,8.5565154e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23006451,0.00071216485,0.73347676,0.00013768609,0.00013192989,0.000009481157,0.0005522766,0.0035786112,0.01305795,0.000010419546,0.000119387056,0.01814881],"study_design_scores_gemma":[0.03042618,0.010894026,0.9492078,0.00014350971,0.000025204341,0.0000011616369,0.00005255748,0.00013398731,0.008837946,0.00005748295,0.00007060102,0.00014957502],"about_ca_topic_score_codex":0.00012342416,"about_ca_topic_score_gemma":0.00073233305,"teacher_disagreement_score":0.215731,"about_ca_system_score_codex":0.000033099357,"about_ca_system_score_gemma":0.00032239946,"threshold_uncertainty_score":0.43908587},"labels":[],"label_agreement":null},{"id":"W4388048274","doi":"10.1136/jitc-2023-sitc2023.0277","title":"277 SynNotch-CAR T cells demonstrate potent anti-tumor efficacy in a preclinical immunocompetent mouse model for glioblastoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer research; Glioma; Immunotherapy; Chimeric antigen receptor; Tumor microenvironment; Flow cytometry; Immune system; Epidermal growth factor receptor; Antigen; Cytotoxic T cell; Brain tumor; Biology; Immunology; Medicine; Receptor; Pathology; Internal medicine; In vitro","score_opus":0.04880684535185395,"score_gpt":0.3212046304507716,"score_spread":0.27239778509891766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541616,0.0002709513,0.00006351903,0.0015340428,0.00023632134,0.0020227206,0.00007587937,0.00024827835,0.00013213416],"genre_scores_gemma":[0.99363077,0.00039304318,0.0014126417,0.0003635834,0.00018537093,0.00017036447,0.00005992677,0.00012074505,0.0036635548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964436,0.00011597748,0.0009534693,0.00082501426,0.00067851593,0.0009833813],"domain_scores_gemma":[0.9976794,0.00028788825,0.00017958146,0.0006795624,0.0001657946,0.0010077505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014620892,0.00042348797,0.0008307323,0.0004082054,0.0001555829,0.000115027884,0.00025292078,0.0002724511,0.000023374463],"category_scores_gemma":[0.00056335324,0.00039117233,0.0003395813,0.00050288613,0.00046697987,0.00015396159,0.00014036559,0.0006435439,0.00007333626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008185664,0.00050203496,0.0023409303,0.0004764065,0.00019329574,0.00035950696,0.00047322386,0.0052719284,0.9855669,0.000095068484,0.0013587796,0.0025433719],"study_design_scores_gemma":[0.011973687,0.0013386407,0.08728997,0.0009517263,0.00027072066,0.00039410274,0.0003694509,0.20470077,0.68695915,0.0008530629,0.0038406178,0.0010580772],"about_ca_topic_score_codex":0.000071935494,"about_ca_topic_score_gemma":0.00003709058,"teacher_disagreement_score":0.2986077,"about_ca_system_score_codex":0.00015590621,"about_ca_system_score_gemma":0.00073728606,"threshold_uncertainty_score":0.999854},"labels":[],"label_agreement":null},{"id":"W4388048378","doi":"10.1136/jitc-2023-sitc2023.0619","title":"619 First-in-class anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies: updated phase 1 results","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University Health Network","funders":"","keywords":"Tolerability; Medicine; Internal medicine; Oncology; Cancer; Cohort; Toxicity; Adverse effect","score_opus":0.016204629377014217,"score_gpt":0.300082005965044,"score_spread":0.28387737658802975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574405,0.00014389156,0.0000016048999,0.0013959521,0.0001967139,0.001244347,0.00013599507,0.0001790157,0.00095842395],"genre_scores_gemma":[0.99613005,0.00033635867,0.00018966554,0.0002521233,0.00008296149,0.000039928345,0.0011178919,0.00009348869,0.0017575382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963527,0.0000937621,0.0008121071,0.0008335314,0.0009106897,0.0009972404],"domain_scores_gemma":[0.9980352,0.0001029158,0.0001988528,0.0006872838,0.00021712457,0.0007586268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008369247,0.00041963905,0.00075928227,0.0006457974,0.00012603034,0.00008129671,0.0001976111,0.0002532302,0.0000612431],"category_scores_gemma":[0.00059968594,0.00036229886,0.000085424435,0.0014432089,0.00040833798,0.00032314088,0.00008997677,0.00056678674,0.000070634014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007755016,0.00198333,0.71719193,0.0007931641,0.0002823839,0.0031678067,0.0022673465,0.0018133172,0.2518743,0.00007357275,0.008843684,0.0039541447],"study_design_scores_gemma":[0.02930551,0.0011445272,0.91361445,0.0011256424,0.000049866867,0.000045500605,0.00027423294,0.00095479813,0.031533495,0.00007550046,0.02132607,0.0005503883],"about_ca_topic_score_codex":0.00023449415,"about_ca_topic_score_gemma":0.0002146794,"teacher_disagreement_score":0.2203408,"about_ca_system_score_codex":0.0001957325,"about_ca_system_score_gemma":0.00044003737,"threshold_uncertainty_score":0.9998829},"labels":[],"label_agreement":null},{"id":"W4388048382","doi":"10.1136/jitc-2023-sitc2023.0588","title":"588 Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer (pA/rEC) in the RUBY trial: post hoc analysis of the costs of grade ≥3 adverse events (AEs)","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"U.S. National Library of Medicine","keywords":"Placebo; Medicine; Post-hoc analysis; Carboplatin; Internal medicine; Oncology; Urology; Chemotherapy; Cisplatin","score_opus":0.02494451060476337,"score_gpt":0.29188659036916054,"score_spread":0.26694207976439716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931146,0.00344681,0.0000066945277,0.00079948315,0.0004693843,0.001373777,0.0007740454,0.000003564282,0.000011636342],"genre_scores_gemma":[0.98498374,0.014173929,0.00009617994,0.00017306331,0.00013358008,0.00018632672,0.00018710949,0.00002017166,0.000045907018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866384,0.00008658597,0.00051093684,0.00027361198,0.0002465026,0.00021853897],"domain_scores_gemma":[0.99858105,0.00033561068,0.0004156807,0.00048335132,0.0001097223,0.00007456036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041082813,0.00018971483,0.0004290426,0.00012352086,0.000070964845,0.000007648293,0.0002734899,0.00010823568,0.0000027516398],"category_scores_gemma":[0.00038139336,0.00010145894,0.00035370336,0.00067294773,0.00021312121,0.000006093176,0.000040573887,0.000057092213,1.4040701e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11148437,0.003885277,0.042140312,0.0007239239,0.009989996,0.000014643459,0.007749182,0.018899612,0.68381673,0.00053309783,0.004367399,0.11639545],"study_design_scores_gemma":[0.089179076,0.009553777,0.35388023,0.0003255232,0.0038825558,0.000008556648,0.002784833,0.00071943307,0.48354504,0.0002909186,0.055038363,0.0007917103],"about_ca_topic_score_codex":0.00046617442,"about_ca_topic_score_gemma":0.0011779355,"teacher_disagreement_score":0.31173992,"about_ca_system_score_codex":0.00007958784,"about_ca_system_score_gemma":0.00041025676,"threshold_uncertainty_score":0.41373757},"labels":[],"label_agreement":null},{"id":"W4388048531","doi":"10.1136/jitc-2023-sitc2023.1372","title":"1372 TriTCE Co-Stim: a novel trispecific T cell engager platform, with integrated CD28 costimulation, engineered to widen the therapeutic window for treatment of poorly infiltrated tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"CD28; Cancer research; T cell; CD3; Cytokine; In vivo; Antibody; Immunotherapy; Immunology; Chemistry; Immune system; Medicine; Biology; CD8","score_opus":0.05746762826388186,"score_gpt":0.3030686027193463,"score_spread":0.24560097445546447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99400556,0.00029563167,0.00040638313,0.0014423704,0.00009382734,0.0030935525,0.00016370494,0.0001696664,0.0003292836],"genre_scores_gemma":[0.99403715,0.000083690895,0.0006982161,0.0002035619,0.00013267972,0.0002266011,0.00038242686,0.00010114272,0.0041345004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977126,0.00006698598,0.0005958718,0.00047311903,0.00058994046,0.000561485],"domain_scores_gemma":[0.99766636,0.0006457131,0.0001701086,0.00053446373,0.00037623223,0.00060712086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000701026,0.00040629657,0.0006760263,0.00037920702,0.00020660085,0.00009508789,0.000166389,0.00017275433,0.000058661422],"category_scores_gemma":[0.00030820843,0.00025835139,0.00015395953,0.001072533,0.00029639143,0.0001294441,0.000016089058,0.00024360557,0.000020233074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028674614,0.00038268632,0.006558316,0.00023835019,0.00054507435,0.000065793974,0.0033739642,0.0039229845,0.9766834,0.0001143701,0.0019574042,0.0032902367],"study_design_scores_gemma":[0.015544639,0.004881358,0.17084172,0.00043962483,0.00046457222,0.00022413676,0.0019796507,0.0066055153,0.76211023,0.00016341118,0.03611256,0.0006325441],"about_ca_topic_score_codex":0.00021733786,"about_ca_topic_score_gemma":0.00003103505,"teacher_disagreement_score":0.2145731,"about_ca_system_score_codex":0.00020565983,"about_ca_system_score_gemma":0.0007433502,"threshold_uncertainty_score":0.9999869},"labels":[],"label_agreement":null},{"id":"W4388068153","doi":"10.1136/jitc-2023-sitc2023.0126","title":"126 Mapping neuro-oncological cellular landscape of human and mouse brain tumors using imaging mass cytometry","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Human brain; Tumor microenvironment; Pathology; Brain tumor; Flow cytometry; Cancer research; Biology; Medicine; Phenotype; Neuroscience; Immunology; Tumor cells","score_opus":0.024058872493263616,"score_gpt":0.2470022134413314,"score_spread":0.22294334094806778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388068153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983147,0.000551606,0.0004105312,0.00023725771,0.0001316366,0.00015157003,0.000022674005,0.000050941962,0.00012908006],"genre_scores_gemma":[0.99834406,0.000067114364,0.00085140404,0.00028694235,0.00016895194,0.0000039698502,0.000091790345,0.000040606083,0.00014514568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854016,0.00007841843,0.00037767267,0.00045919724,0.00018675832,0.0003577659],"domain_scores_gemma":[0.9992228,0.000033905802,0.00014421801,0.00024133368,0.000052637646,0.00030511772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041352503,0.00023684098,0.00029907227,0.00015616252,0.00018032774,0.00006617124,0.00013943767,0.00017353352,0.0000032537748],"category_scores_gemma":[0.00024014626,0.00023236831,0.00008789763,0.00021490004,0.0003178393,0.000015020381,0.00009716791,0.0001678604,0.0000014984558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013484255,0.000021272423,0.09797071,0.00010716076,0.000027101554,0.000052343097,0.00009060483,0.00009537411,0.9010151,0.000034193454,0.00046648292,0.000106177045],"study_design_scores_gemma":[0.0008911263,0.00016248097,0.054148424,0.000088920926,0.00003833827,0.000088687026,0.00037467957,0.0021813798,0.939689,0.000301224,0.0016115985,0.0004241813],"about_ca_topic_score_codex":0.000057060468,"about_ca_topic_score_gemma":0.0000068603704,"teacher_disagreement_score":0.043822285,"about_ca_system_score_codex":0.000010999006,"about_ca_system_score_gemma":0.000078887344,"threshold_uncertainty_score":0.9475705},"labels":[],"label_agreement":null},{"id":"W4388071235","doi":"10.1136/jitc-2023-sitc2023.1490","title":"1490 High-plex co-detection of RNA and protein to explore tumor-immune interactions utilizing RNAscope with imaging mass cytometry","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; RNA; Biology; Molecular biology; Computational biology; Phenotype; Biochemistry","score_opus":0.018451658947243155,"score_gpt":0.2781303994629118,"score_spread":0.25967874051566864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388071235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482214,0.00014634017,0.0039329124,0.00044255547,0.000041320618,0.00037534293,0.000019158637,0.00009682955,0.00012341602],"genre_scores_gemma":[0.9917896,0.00005550801,0.0076839286,0.00008490077,0.000071301125,0.00006195944,0.00006163844,0.000035734993,0.00015544926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990134,0.000022034279,0.00024981934,0.00036545677,0.00012957447,0.00021969015],"domain_scores_gemma":[0.99925923,0.000009889165,0.00014089778,0.00029711355,0.00009217974,0.0002006612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016272337,0.00017473545,0.00017551842,0.0001345054,0.00016148026,0.000045692977,0.000083372426,0.000057715508,8.8394137e-7],"category_scores_gemma":[0.00011024461,0.0001621076,0.00003555038,0.00028232537,0.00019103558,0.000021263844,0.00007292729,0.00012411986,0.0000028039726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034820365,0.0000124891585,0.00040430768,0.00004603395,0.000022123393,0.00000747654,0.00004885203,0.000033323737,0.99787754,0.00005915844,0.00017634468,0.0012775045],"study_design_scores_gemma":[0.00020741572,0.00012239044,0.011116346,0.00014992527,0.000018691153,0.00006782868,0.00036022623,0.000070460104,0.98210007,0.00035931214,0.0052290326,0.00019827766],"about_ca_topic_score_codex":0.00006475546,"about_ca_topic_score_gemma":0.000011708754,"teacher_disagreement_score":0.015777472,"about_ca_system_score_codex":0.000016705346,"about_ca_system_score_gemma":0.000047382222,"threshold_uncertainty_score":0.66105556},"labels":[],"label_agreement":null},{"id":"W4388072202","doi":"10.1136/jitc-2023-sitc2023.0594","title":"594 SQZ-PBMC-HPV-101: Increased overall survival in a subset of patients with recurrent, locally advanced, or metastatic HPV16<sup>+</sup>tumors treated with cell-based vaccine, SQZ-PBMC-HPV","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Peripheral blood mononuclear cell; Medicine; Antigen; CD8; T cell; Immunotherapy; Immunology; Immune system; Internal medicine; Oncology; Biology","score_opus":0.019666628283641647,"score_gpt":0.2677507664605239,"score_spread":0.24808413817688227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388072202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958803,0.00024107471,0.000028048844,0.00037649268,0.000056460478,0.0017031888,0.00033812638,0.0001644569,0.0012118405],"genre_scores_gemma":[0.9966936,0.00008548678,0.00076133985,0.0002715005,0.00006550597,0.00013011925,0.0014462555,0.00013989523,0.00040629593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99514663,0.00027541927,0.0009987582,0.0009790233,0.001529276,0.0010708973],"domain_scores_gemma":[0.99659187,0.00029918744,0.0003482084,0.0007423672,0.0005891385,0.0014292483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074666954,0.0006923409,0.0013415026,0.00064059236,0.00015021962,0.00007909833,0.0002855237,0.00019493446,0.00040618476],"category_scores_gemma":[0.00045677004,0.0004821669,0.00015738436,0.0016926663,0.00039812713,0.00031086456,0.00008651106,0.0007072225,0.000024465398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031850956,0.0021197565,0.93981785,0.0041278107,0.0005150812,0.002020761,0.0007726182,0.008289513,0.0011459652,0.0000609832,0.0038446311,0.005434086],"study_design_scores_gemma":[0.02430778,0.0036985888,0.9589711,0.0005419242,0.00037366952,0.00003603965,0.00040408675,0.0043068547,0.005866718,0.00009307818,0.0007014723,0.00069868343],"about_ca_topic_score_codex":0.0016872055,"about_ca_topic_score_gemma":0.0012605843,"teacher_disagreement_score":0.019153265,"about_ca_system_score_codex":0.00024828257,"about_ca_system_score_gemma":0.001734082,"threshold_uncertainty_score":0.999763},"labels":[],"label_agreement":null},{"id":"W4388072441","doi":"10.1136/jitc-2023-sitc2023.0866","title":"866 The effect of butyrophilin 1A1 blockade in combination with radiation treatment in colon and Lewis lung carcinoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radioresistance; Cancer research; Lung cancer; Lewis lung carcinoma; Apoptosis; Medicine; CD44; Radiation therapy; Flow cytometry; Pathology; Cell; Biology; Cancer; Internal medicine; Immunology; Metastasis","score_opus":0.008263332487901847,"score_gpt":0.24190241718371935,"score_spread":0.2336390846958175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388072441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956271,0.0015850072,4.4545428e-7,0.0019173658,0.0000592325,0.0007363587,0.0000063339567,0.00001978969,0.00004836879],"genre_scores_gemma":[0.99932134,0.0003803563,0.000012319483,0.000043070813,0.000025482515,0.00005119009,0.00003389978,0.0000134685515,0.000118899945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991619,0.00008814318,0.0002359772,0.00018897341,0.00016401675,0.00016101604],"domain_scores_gemma":[0.99956095,0.00010617427,0.00008998511,0.00014008964,0.000016158334,0.00008663426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043488084,0.00013708792,0.0002585005,0.00016497492,0.00004536464,0.00001628914,0.000030721494,0.000084538915,0.0000017970009],"category_scores_gemma":[0.00006398922,0.00008633416,0.000031748776,0.00033503084,0.00018573196,0.000060484894,0.000009543215,0.0000909994,5.86158e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011557187,0.000057461457,0.9269652,0.00025492834,0.00007733093,0.00008771526,0.0015414985,0.000069917965,0.059407752,0.000022747026,0.00010853193,0.010251205],"study_design_scores_gemma":[0.005609411,0.0012332457,0.8881684,0.00018452153,0.000068997106,0.000048621114,0.00011427247,0.00076850154,0.10341834,0.00003138663,0.0002721644,0.00008211735],"about_ca_topic_score_codex":0.001372532,"about_ca_topic_score_gemma":0.00032300394,"teacher_disagreement_score":0.044010594,"about_ca_system_score_codex":0.00013785932,"about_ca_system_score_gemma":0.00011054584,"threshold_uncertainty_score":0.3520605},"labels":[],"label_agreement":null},{"id":"W4388074720","doi":"10.1136/jitc-2023-sitc2023.1396","title":"1396 TriTCE CPI: a novel trispecifc T cell engager platform with integrated PD-1/PD-L1 checkpoint inhibition engineered for the treatment of immunosuppressed tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Cancer research; Tumor microenvironment; PD-L1; T cell; Immunotherapy; Immune checkpoint; Cytotoxicity; Cytotoxic T cell; Immune system; Chemistry; Cancer immunotherapy; In vitro; Biology; Immunology; Tumor cells; Biochemistry","score_opus":0.040494279708013003,"score_gpt":0.2694589960541106,"score_spread":0.2289647163460976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388074720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947912,0.00077489845,0.0001828175,0.0012324762,0.0001732709,0.0021924744,0.00015317387,0.00015346386,0.0003462414],"genre_scores_gemma":[0.9929757,0.00061911315,0.00085485744,0.00006701159,0.00023600523,0.0003144202,0.00032491898,0.00009750415,0.0045104795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778,0.000040879942,0.0006060056,0.0004513068,0.00057234016,0.0005494628],"domain_scores_gemma":[0.998096,0.00045454566,0.00019946403,0.0005638284,0.0002563425,0.00042981934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072355353,0.0003923426,0.000633489,0.0002808554,0.00019546435,0.0000729547,0.00010831377,0.0001934897,0.00007226085],"category_scores_gemma":[0.00025943885,0.00024564532,0.0002473367,0.0006302821,0.00038036692,0.00013977257,0.000025684316,0.00035329486,0.000010899849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00228246,0.0005107818,0.00028356066,0.00037839258,0.00038228562,0.000103214756,0.0026099568,0.00029558106,0.99045235,0.00009540874,0.0012804655,0.0013255475],"study_design_scores_gemma":[0.010679793,0.0022503086,0.019320855,0.0003685351,0.00027801626,0.00017412889,0.0015574035,0.002696514,0.93904376,0.00009742066,0.023227677,0.00030557823],"about_ca_topic_score_codex":0.00029792805,"about_ca_topic_score_gemma":0.000027678336,"teacher_disagreement_score":0.051408574,"about_ca_system_score_codex":0.00022296705,"about_ca_system_score_gemma":0.00045152064,"threshold_uncertainty_score":0.9999996},"labels":[],"label_agreement":null},{"id":"W4388076128","doi":"10.1136/jitc-2023-sitc2023.1250","title":"1250 Molecular predictors and mechanisms of immune checkpoint inhibitor-induced myocarditis: a case-control study with translational correlates","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Christie (Canada); McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"Jewish General Hospital","keywords":"Myocarditis; Immune system; Peripheral blood mononuclear cell; Medicine; Immune checkpoint; Immunology; Internal medicine; Biology; Immunotherapy; Genetics","score_opus":0.010502649626950758,"score_gpt":0.2293011904421242,"score_spread":0.21879854081517341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388076128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970646,0.0007777826,0.00012984664,0.0006057066,0.0001802912,0.0010103098,0.00006333088,0.0001092539,0.000058858594],"genre_scores_gemma":[0.9994484,0.000049164963,0.00019157784,0.00009650133,0.00005325818,0.000049375267,0.000025816033,0.000043930806,0.000041969623],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99827504,0.000074171025,0.000551328,0.00037907995,0.00044635887,0.00027399178],"domain_scores_gemma":[0.9990909,0.000061198,0.0001843908,0.00025597215,0.00009539298,0.00031215337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063300505,0.0002667991,0.0004928676,0.00018050877,0.00011887102,0.00003601734,0.000050247152,0.0001532422,0.00001046927],"category_scores_gemma":[0.0000669322,0.00021632701,0.0001229389,0.00031466343,0.0002467718,0.00012033823,0.000015037585,0.0002127135,0.0000017294932],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018203806,0.00025382556,0.046696056,0.00036437146,0.002239296,0.004238652,0.0032365688,0.00009173293,0.9388164,0.00022378546,0.00008325376,0.0019356495],"study_design_scores_gemma":[0.011159636,0.0026254929,0.7833858,0.00056215003,0.0009291029,0.0044683465,0.0028399143,0.0005129297,0.1923894,0.00068144104,0.00004031664,0.00040545777],"about_ca_topic_score_codex":0.00024240208,"about_ca_topic_score_gemma":0.00003182592,"teacher_disagreement_score":0.746427,"about_ca_system_score_codex":0.000028401773,"about_ca_system_score_gemma":0.00020969182,"threshold_uncertainty_score":0.88215595},"labels":[],"label_agreement":null},{"id":"W4388076165","doi":"10.1136/jitc-2023-sitc2023.1316","title":"1316 Enabling single-cell resolution in spatial transcriptomics for comprehensive cellular profiling with variational autoencoders and optimal transport","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Non-negative matrix factorization; Autoencoder; Pattern recognition (psychology); Artificial intelligence; Deconvolution; Matrix decomposition; Algorithm; Deep learning; Physics","score_opus":0.0248519500191286,"score_gpt":0.22200164790413168,"score_spread":0.19714969788500308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388076165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978754,0.00044558273,0.01967284,0.00021633825,0.0001978896,0.0005363845,0.0000709595,0.00006179558,0.000044236458],"genre_scores_gemma":[0.9852975,0.00014008686,0.013418881,0.000116556635,0.00017649969,0.000035522728,0.0006879273,0.000054055785,0.00007299164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983763,0.00004287799,0.00038361037,0.00057484995,0.00019993659,0.0004223918],"domain_scores_gemma":[0.99934983,0.000027302656,0.00010489534,0.0001692619,0.00010429412,0.00024443792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027625263,0.00027891624,0.00026869448,0.00012922216,0.00016979323,0.00005395081,0.00009846405,0.00026217214,7.2598937e-7],"category_scores_gemma":[0.000042752785,0.00027916933,0.00007446633,0.00015169477,0.00023028802,0.000025720094,0.000016308071,0.0001651362,6.826723e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031887976,0.00009342236,0.011602478,0.00028043022,0.000041521966,0.000021727885,0.0005671877,0.018682232,0.96808064,0.000114458344,0.000063951695,0.00013304818],"study_design_scores_gemma":[0.007270812,0.0012847516,0.035772864,0.00024810075,0.00021098416,0.00008036072,0.0014155945,0.07394977,0.8738837,0.0003673601,0.0042750547,0.0012406228],"about_ca_topic_score_codex":0.00019154139,"about_ca_topic_score_gemma":0.00016956979,"teacher_disagreement_score":0.09419694,"about_ca_system_score_codex":0.000028954471,"about_ca_system_score_gemma":0.00022222578,"threshold_uncertainty_score":0.999966},"labels":[],"label_agreement":null},{"id":"W4388077811","doi":"10.1136/jitc-2023-sitc2023.0760","title":"760 Interim PK/PD, safety and efficacy data of monotherapy dose escalation of a phase 1/2 study with MDNA11 in patients with advanced solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Adverse effect; Pharmacokinetics; Internal medicine; Dosing; Toxicity; Response Evaluation Criteria in Solid Tumors; Melanoma; Gastroenterology; Oncology; Pharmacology; Phases of clinical research; Urology; Cancer research","score_opus":0.025246474224272793,"score_gpt":0.30882989092477237,"score_spread":0.2835834167004996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388077811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839646,0.00023492645,0.000010429146,0.0001649233,0.00004082813,0.0010211003,0.00006822914,0.00003884238,0.000024273215],"genre_scores_gemma":[0.9992679,0.00014616358,0.00028202686,0.000040669074,0.000012723782,0.0000097841685,0.00018678865,0.00003081741,0.000023161876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985165,0.000050750998,0.0005256804,0.00038282378,0.00032819365,0.00019607163],"domain_scores_gemma":[0.99895674,0.000046218647,0.00027953778,0.0004913211,0.00007935438,0.00014684493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039633046,0.00020176466,0.000493026,0.00018967639,0.000041349533,0.000014589108,0.00010731852,0.000059316204,0.0000037274444],"category_scores_gemma":[0.00007594092,0.00014684268,0.000024655097,0.00041099722,0.00032122215,0.00021828858,0.000047420297,0.00012270748,3.648991e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061943978,0.0030267122,0.83080596,0.00053783704,0.00072179135,0.000081373815,0.005801695,0.0001477047,0.04135465,0.000010254194,0.0001154898,0.055452537],"study_design_scores_gemma":[0.02890602,0.004384837,0.9582225,0.00078113086,0.00009228617,0.000010249841,0.00089345523,0.00025322466,0.006108471,0.000009259245,0.00016559596,0.00017296882],"about_ca_topic_score_codex":0.00016565358,"about_ca_topic_score_gemma":0.00007568384,"teacher_disagreement_score":0.12741652,"about_ca_system_score_codex":0.000031881158,"about_ca_system_score_gemma":0.00016254204,"threshold_uncertainty_score":0.59880704},"labels":[],"label_agreement":null},{"id":"W4388081144","doi":"10.1136/jitc-2023-sitc2023.0178","title":"178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Liquid biopsy; Exome sequencing; Tumor-infiltrating lymphocytes; Biopsy; Exome; Transcriptome; Cancer research; Deep sequencing; Medicine; Cancer; Pathology; Computational biology; Immunotherapy; Biology; Mutation; Internal medicine; Gene; Gene expression; Genome; Genetics","score_opus":0.03762420379382995,"score_gpt":0.28809596548987787,"score_spread":0.2504717616960479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388081144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954601,0.0010179922,0.000082377635,0.00095753185,0.00030175,0.0013021359,0.00010435107,0.0005162306,0.00025755152],"genre_scores_gemma":[0.9926392,0.00035152698,0.0023571134,0.0006832828,0.0009103733,0.00014639372,0.0008010938,0.00016613175,0.0019449207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997118,0.00010320894,0.00062207953,0.00071683753,0.00065288105,0.0007870264],"domain_scores_gemma":[0.9979697,0.00021461479,0.00021733086,0.000477618,0.00038485345,0.00073591096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007726402,0.00038286945,0.00056805945,0.00030198664,0.00035124292,0.00019671879,0.00017599222,0.00017847307,0.00009159065],"category_scores_gemma":[0.0008956134,0.00036613137,0.00015355444,0.00097215455,0.0002461406,0.00027138524,0.000052339055,0.00029975382,0.00006104517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045841714,0.000030153564,0.005004367,0.00016052059,0.00015367637,0.00022653722,0.0008509376,0.000068513145,0.99043864,0.00003346196,0.0008749243,0.0016998465],"study_design_scores_gemma":[0.0044418867,0.0007468119,0.067955494,0.00056095707,0.000090873036,0.000533926,0.00066932774,0.0050616004,0.9037553,0.00060606527,0.0149698565,0.0006078829],"about_ca_topic_score_codex":0.0004709905,"about_ca_topic_score_gemma":0.000022060716,"teacher_disagreement_score":0.086683325,"about_ca_system_score_codex":0.00032799612,"about_ca_system_score_gemma":0.001511193,"threshold_uncertainty_score":0.99987906},"labels":[],"label_agreement":null},{"id":"W4388082927","doi":"10.1136/jitc-2023-sitc2023.1464","title":"1464 Endogenous retroviral protein particles in malignant pleural mesothelioma as potential immunotherapy targets; novel approaches for identification and prioritization","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Epitope; Immunotherapy; Computational biology; Genome; Human genome; Gene; Biology; Mesothelioma; Antigen; Cancer; Cancer research; Bioinformatics; Genetics; Medicine; Pathology","score_opus":0.029997622943478876,"score_gpt":0.23102435589482695,"score_spread":0.20102673295134807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388082927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964158,0.0012210415,0.00096489635,0.0004245802,0.00008440375,0.0007949769,0.000032584576,0.00003173212,0.000030014273],"genre_scores_gemma":[0.9974265,0.0002399534,0.0014083631,0.000055756907,0.00009470115,0.00014826105,0.00036280532,0.000035985424,0.00022765416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987361,0.00003101578,0.0004352515,0.00033246132,0.00014323778,0.00032194663],"domain_scores_gemma":[0.9994292,0.000007272506,0.00016666291,0.00022976493,0.00004908143,0.00011802148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004910929,0.00019770305,0.00018525889,0.00010188821,0.00015825617,0.00014165568,0.00011292847,0.00016167785,7.0576937e-7],"category_scores_gemma":[0.00015810187,0.0001866297,0.00006146222,0.00014462242,0.00010757324,0.000039651455,0.000059908816,0.000071626666,0.0000027264716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009396346,0.00004462095,0.0011796177,0.00011475794,0.000046425997,0.0000028210668,0.00037420046,0.0003317768,0.9951228,0.0006777489,0.00007773351,0.0019335184],"study_design_scores_gemma":[0.0021210655,0.00033739867,0.059703488,0.00005984049,0.00003228557,0.00015328985,0.0009365593,0.012024212,0.92079043,0.0021460894,0.0012559283,0.0004394055],"about_ca_topic_score_codex":0.000054918844,"about_ca_topic_score_gemma":0.000013158321,"teacher_disagreement_score":0.07433238,"about_ca_system_score_codex":0.000015441983,"about_ca_system_score_gemma":0.00009203619,"threshold_uncertainty_score":0.7610538},"labels":[],"label_agreement":null},{"id":"W4388083490","doi":"10.1136/jitc-2023-sitc2023.0783","title":"783 Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: a report from the International RRD consortium","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Stand Up To Cancer","keywords":"Ipilimumab; Medicine; Nivolumab; Internal medicine; Immunotherapy; Progression-free survival; Oncology; Melanoma; Progressive disease; Chemotherapy; Cancer research; Cancer","score_opus":0.03118325356358788,"score_gpt":0.29310738592172403,"score_spread":0.26192413235813616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388083490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97824883,0.0008363287,0.000042915137,0.01821814,0.0008136927,0.0012952561,0.00010407341,0.00039593165,0.000044831893],"genre_scores_gemma":[0.9951338,0.00025783593,0.0018057325,0.0010942048,0.00025500392,0.00035853204,0.00075294194,0.000067801244,0.00027413864],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99745524,0.000042621516,0.0008584798,0.0007877306,0.00048603106,0.00036991888],"domain_scores_gemma":[0.99777144,0.00028733475,0.00043276438,0.0010525797,0.0001847785,0.0002710854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007969531,0.00031996702,0.00048385744,0.00015076595,0.00027890707,0.00014982879,0.00019334242,0.00016607463,0.000010231137],"category_scores_gemma":[0.0007159416,0.00023098903,0.000303493,0.0002770047,0.00021248405,0.00012950259,0.00005399611,0.00016420074,0.000015406558],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035808719,0.0005442435,0.3711526,0.00008944775,0.0013293141,0.000722003,0.00062491617,0.00008597895,0.60874504,0.0013346629,0.012756311,0.0022573704],"study_design_scores_gemma":[0.004595698,0.0002206539,0.8392689,0.00015621135,0.00024954678,0.000289015,0.000278855,0.0014756657,0.13474736,0.0016686929,0.016745547,0.00030381593],"about_ca_topic_score_codex":0.0007674894,"about_ca_topic_score_gemma":0.000031151692,"teacher_disagreement_score":0.47399768,"about_ca_system_score_codex":0.00012351734,"about_ca_system_score_gemma":0.00018226834,"threshold_uncertainty_score":0.9419459},"labels":[],"label_agreement":null},{"id":"W4388084134","doi":"10.1136/jitc-2023-sitc2023.0741","title":"741 TWT-101: a first-in-clinic study of CFI-402411, a hematopoietic progenitor Kinase-1 (HPK1) inhibitor, as single agent or combined with pembrolizumab in subjects with advanced solid malignancies","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; University Health Network; Ottawa Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Adverse effect; Gastroenterology; Oncology; Toxicity; Cancer; Immunotherapy","score_opus":0.022824699747663726,"score_gpt":0.2716791618740001,"score_spread":0.24885446212633638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388084134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959788,0.0006132535,5.38552e-7,0.00062244915,0.00019179046,0.0022803121,0.000009278482,0.0001293077,0.0001742928],"genre_scores_gemma":[0.9983832,0.00015708045,0.00016117703,0.00015100956,0.000059909707,0.00021768795,0.000025053805,0.00008547368,0.0007594102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969741,0.00009552891,0.0008907755,0.0006816132,0.0007198765,0.0006381055],"domain_scores_gemma":[0.99845916,0.00012370621,0.00034917775,0.0005358507,0.0001358193,0.00039627092],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048397447,0.0004659804,0.0009473981,0.00043485104,0.000110005836,0.000056036908,0.00015278219,0.00017409168,0.000024189902],"category_scores_gemma":[0.0002201505,0.00033239354,0.00009558148,0.0012574731,0.0004273125,0.0001948259,0.00006052286,0.00029384554,0.000013130557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.104189485,0.0107798325,0.523491,0.006363291,0.0015861394,0.014315191,0.03509759,0.00040325377,0.29998076,0.00004212102,0.0018625151,0.0018888031],"study_design_scores_gemma":[0.05087716,0.030436378,0.67162013,0.0073645236,0.00040673252,0.0010608146,0.015870495,0.00008961055,0.21999495,0.00012579128,0.0010275402,0.0011258868],"about_ca_topic_score_codex":0.00056185044,"about_ca_topic_score_gemma":0.00411617,"teacher_disagreement_score":0.14812909,"about_ca_system_score_codex":0.00020215187,"about_ca_system_score_gemma":0.0008141621,"threshold_uncertainty_score":0.9999128},"labels":[],"label_agreement":null},{"id":"W4388087237","doi":"10.1136/jitc-2023-sitc2023.0839","title":"839 TALL<sup>TM</sup> (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncolytic virus; Immunotherapy; Adoptive cell transfer; Tumor microenvironment; Medicine; Cancer research; Chimeric antigen receptor; Cancer; Immune system; Tumor-infiltrating lymphocytes; Antigen; Immunology; T cell; Internal medicine","score_opus":0.046547665589573975,"score_gpt":0.31310218700715103,"score_spread":0.2665545214175771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388087237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99058896,0.0017145034,0.00006580574,0.0027238152,0.00038982293,0.0036604234,0.000071812254,0.0005539064,0.00023092327],"genre_scores_gemma":[0.98738337,0.004455814,0.001324584,0.0006842374,0.0006831393,0.00052403,0.0010646301,0.000291647,0.003588524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995191,0.00022549079,0.0012448819,0.0009830808,0.0010613549,0.0012941958],"domain_scores_gemma":[0.99634224,0.00015979096,0.00028357754,0.0012685417,0.00041046416,0.0015354092],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002358448,0.00070607424,0.001011338,0.0007150177,0.00054402184,0.00024112905,0.0004409592,0.0005169459,0.0002296829],"category_scores_gemma":[0.00040104243,0.00066346466,0.00048303793,0.0008947821,0.00037493109,0.00052153174,0.00012142436,0.0007093977,0.00013181182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019604324,0.00040226374,0.0013118627,0.0002183944,0.00038796713,0.00007412465,0.0053160414,0.00023515,0.97351545,0.000038778104,0.0015055567,0.015033972],"study_design_scores_gemma":[0.0064529506,0.0022592149,0.046384946,0.00035547902,0.000045445733,0.00013855554,0.0016623902,0.001111344,0.88130766,0.0006821412,0.058812227,0.0007876646],"about_ca_topic_score_codex":0.0006228223,"about_ca_topic_score_gemma":0.000019838917,"teacher_disagreement_score":0.09220782,"about_ca_system_score_codex":0.00037836574,"about_ca_system_score_gemma":0.00054021523,"threshold_uncertainty_score":0.99958163},"labels":[],"label_agreement":null},{"id":"W4388089028","doi":"10.1136/jitc-2023-sitc2023.0119","title":"119 Uncovering spatial biology of mouse tumor immune microenvironment using imaging mass cytometry","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada); Canadian Standards Association","funders":"","keywords":"Mass cytometry; Tumor microenvironment; Immune system; Cancer research; Context (archaeology); Pathology; Medicine; Biology; Immunology; Phenotype","score_opus":0.01232713183653427,"score_gpt":0.2271004150665001,"score_spread":0.21477328322996583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388089028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652934,0.0010282184,0.0017148153,0.00007614147,0.0003566644,0.00014619937,0.00006322472,0.000033154938,0.00005223003],"genre_scores_gemma":[0.99749815,0.00024937597,0.0016591287,0.000105913045,0.00015876353,0.000004947612,0.00014417493,0.00004812786,0.00013140654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985795,0.000052964697,0.00042346714,0.00041972977,0.00014067415,0.0003836732],"domain_scores_gemma":[0.9992466,0.00001280612,0.00017480514,0.00031935005,0.000033255874,0.00021315736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027817814,0.00024156996,0.000286581,0.00012269421,0.00010948678,0.000031722317,0.00016573792,0.00012725058,0.000004529056],"category_scores_gemma":[0.00010218366,0.0002484401,0.00011985051,0.00013690993,0.000325004,0.000011378767,0.00010723725,0.00012843747,0.000005685723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002996575,0.000026141446,0.06292603,0.00007913433,0.000054284566,0.000012809665,0.000040761588,0.00069151615,0.93581617,0.000014291461,0.00005374151,0.00025515354],"study_design_scores_gemma":[0.0005716735,0.00007956023,0.021338733,0.00004950849,0.000038731025,0.000044444998,0.00008230961,0.00072190305,0.9749759,0.00010691073,0.0017142054,0.0002761259],"about_ca_topic_score_codex":0.00046770167,"about_ca_topic_score_gemma":0.000014178165,"teacher_disagreement_score":0.041587297,"about_ca_system_score_codex":0.000030112335,"about_ca_system_score_gemma":0.00010005534,"threshold_uncertainty_score":0.9999968},"labels":[],"label_agreement":null},{"id":"W4388089593","doi":"10.1136/jitc-2023-sitc2023.0865","title":"865 Combining radiotherapy with novel TLR-based immunotherapy for improved tumor control in lung cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Sting; Cancer research; Cancer immunotherapy; Immunotherapy; Immune system; Prostate cancer; Cancer; Chemistry; Pharmacology; Medicine; Immunology; Internal medicine","score_opus":0.011441972537060655,"score_gpt":0.2562417504485607,"score_spread":0.24479977791150004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388089593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887644,0.005830548,0.0010006477,0.0023027775,0.000682172,0.0010257268,0.00017471552,0.0001832534,0.00003573874],"genre_scores_gemma":[0.9959439,0.00022314563,0.00037219527,0.0019677137,0.000041940624,0.0003247877,0.00009599206,0.00007735202,0.00095298386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983164,0.00011273937,0.00044369115,0.00043232422,0.00005305702,0.00064176775],"domain_scores_gemma":[0.99912506,0.0002244281,0.00019412024,0.0002883883,0.000084206025,0.00008377382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053809525,0.0003365546,0.0005391293,0.0002629719,0.00021506344,0.00006570384,0.00019869267,0.00021534503,0.000037208174],"category_scores_gemma":[0.00011334236,0.0002784579,0.00011045972,0.0002348505,0.00039253876,0.00014064737,0.000015428339,0.00033762457,0.0000065789595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024812003,0.000097992735,0.005612203,0.00009099609,0.00034220246,0.000010164987,0.00043069155,0.00027927122,0.98760766,0.0002844601,0.002244682,0.0005185016],"study_design_scores_gemma":[0.049399007,0.0018029877,0.13537785,0.0009941102,0.00016765489,0.00019731108,0.0005902535,0.012915188,0.7333511,0.00012842509,0.06362921,0.0014468669],"about_ca_topic_score_codex":0.00052021083,"about_ca_topic_score_gemma":0.00011047251,"teacher_disagreement_score":0.2542565,"about_ca_system_score_codex":0.00009999021,"about_ca_system_score_gemma":0.0004900707,"threshold_uncertainty_score":0.99996674},"labels":[],"label_agreement":null},{"id":"W4404052762","doi":"10.1136/jitc-2024-sitc2024.1011","title":"1011 Metabolic reprogramming alters natural killer cell responses in chronic graft-versus-host disease","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Reprogramming; Disease; Host (biology); Graft-versus-host disease; Cell; Biology; Immunology; Medicine; Ecology; Genetics; Internal medicine","score_opus":0.013706992167502747,"score_gpt":0.24671118888038512,"score_spread":0.2330041967128824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404052762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9103154,0.0740673,0.000007852928,0.0010083774,0.013591581,0.00028102,0.000005687923,0.0002299464,0.0004928554],"genre_scores_gemma":[0.9794302,0.00088896777,0.000042831383,0.00019041807,0.00012702843,0.000036828435,0.00013288409,0.000040375064,0.019110477],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819595,0.00020914999,0.0004395013,0.0005907599,0.000079386475,0.00048528082],"domain_scores_gemma":[0.9992402,0.00014244964,0.00009100707,0.00033703863,0.000036170662,0.00015312218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040316704,0.00030116906,0.00028736,0.00031611003,0.0001822481,0.00014268987,0.0001331338,0.00020116905,0.0001543033],"category_scores_gemma":[0.00028038723,0.00027148804,0.0001618561,0.00025363456,0.00032699454,0.0004275205,0.000066341294,0.0006585311,0.0004064612],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019229929,0.00014916738,0.002731956,0.00041100456,0.00039243925,0.00031393656,0.00128916,0.00006942595,0.9600558,0.0021673823,0.02549733,0.0049993964],"study_design_scores_gemma":[0.0018961861,0.00017835184,0.053710926,0.00034891814,0.00018949957,0.000121587975,0.0003767004,0.00016431903,0.14485748,0.00010010372,0.7975083,0.000547644],"about_ca_topic_score_codex":0.00028502883,"about_ca_topic_score_gemma":0.000059990485,"teacher_disagreement_score":0.8151983,"about_ca_system_score_codex":0.00016079143,"about_ca_system_score_gemma":0.0003741139,"threshold_uncertainty_score":0.9999737},"labels":[],"label_agreement":null},{"id":"W4404052940","doi":"10.1136/jitc-2024-sitc2024.0103","title":"103 A deep-learning approach to guide acquisition region selection for Imaging Mass Cytometry","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Computer science; Selection (genetic algorithm); Artificial intelligence; Deep learning; Machine learning; Chemistry","score_opus":0.01268774742898928,"score_gpt":0.24808452451177052,"score_spread":0.23539677708278123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404052940","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024204869,0.00091284805,0.97003436,0.0015003529,0.00095971784,0.00044586632,0.0000018021126,0.000750934,0.001189232],"genre_scores_gemma":[0.8793749,0.000035288438,0.11882524,0.00044265,0.0005038738,0.00013495827,0.000013596224,0.00004650173,0.0006229662],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980224,0.000074031595,0.00034250968,0.0008065835,0.000340735,0.00041378083],"domain_scores_gemma":[0.9990528,0.0000717856,0.000097117314,0.00027138676,0.00013055088,0.00037635065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071305037,0.00023591114,0.00019415801,0.0004042668,0.0003227218,0.0007462918,0.00026471925,0.00012333744,9.692936e-7],"category_scores_gemma":[0.00019170741,0.00024608392,0.00009663837,0.0008583129,0.000064388274,0.0010016112,0.00007959231,0.0002702036,0.000019020012],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018954997,0.000172396,0.01155147,0.0032052572,0.00044413382,0.00014446865,0.008532709,0.047465146,0.46371964,0.04162877,0.064830616,0.35811585],"study_design_scores_gemma":[0.00043812857,0.00022758546,0.007816968,0.00039467067,0.000077067256,0.0010193196,0.00020166313,0.8463171,0.04814537,0.00960466,0.084990084,0.00076736783],"about_ca_topic_score_codex":0.00005973266,"about_ca_topic_score_gemma":0.0000034468471,"teacher_disagreement_score":0.8551701,"about_ca_system_score_codex":0.0003533429,"about_ca_system_score_gemma":0.00016769062,"threshold_uncertainty_score":0.99999917},"labels":[],"label_agreement":null},{"id":"W4404053084","doi":"10.1136/jitc-2024-sitc2024.0716","title":"716 A randomized phase II window of opportunity clinical trial of PD-1 +/- IL-4 inhibition in early-stage ER+ HER2- breast cancer","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Stage (stratigraphy); Oncology; Window of opportunity; Window (computing); Internal medicine; Medicine; Cancer; Computer science; Biology; Real-time computing","score_opus":0.045850144807708965,"score_gpt":0.3498682161185697,"score_spread":0.3040180713108608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404053084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937434,0.0015521665,0.000009212943,0.0022159927,0.00071402773,0.0011956977,0.0002868631,0.00004456102,0.00023808186],"genre_scores_gemma":[0.99691737,0.001826043,0.00008972763,0.00026167868,0.00029551133,0.000056774483,0.000051413343,0.000030728424,0.00047072803],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973335,0.00025103215,0.0013899973,0.00037520428,0.00040048404,0.00024973406],"domain_scores_gemma":[0.99864763,0.00018876612,0.00034628581,0.00028247226,0.000104260485,0.0004305657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025556784,0.00023758462,0.0010679758,0.00022076053,0.00004759421,0.000027606056,0.00005716856,0.00026827323,0.000104035695],"category_scores_gemma":[0.0004416378,0.00018973942,0.00042347432,0.00030589927,0.0009570604,0.00018188774,0.000036771307,0.0003720216,0.0000012023085],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88354725,0.0019772418,0.0033810262,0.0015871747,0.0011037085,0.000434129,0.0016797878,0.00000929029,0.0850994,0.0003550321,0.00185769,0.018968288],"study_design_scores_gemma":[0.8894608,0.0023509972,0.046514776,0.0036545894,0.0007042165,0.00019510457,0.00020144922,0.00029098915,0.051276226,0.00049397233,0.004441597,0.00041526128],"about_ca_topic_score_codex":0.0023669212,"about_ca_topic_score_gemma":0.00011900964,"teacher_disagreement_score":0.04313375,"about_ca_system_score_codex":0.00007476315,"about_ca_system_score_gemma":0.001190333,"threshold_uncertainty_score":0.7737349},"labels":[],"label_agreement":null},{"id":"W4404053144","doi":"10.1136/jitc-2024-sitc2024.0677","title":"677 A phase 1, open-label, dose escalation study of the safety and tolerability of ANK-101 in advanced solid tumors","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Tolerability; Medicine; Pharmacology; Adverse effect","score_opus":0.04145467211093979,"score_gpt":0.37129023927340876,"score_spread":0.329835567162469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404053144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997136,0.00048633083,0.000006504141,0.0010206563,0.000042102147,0.0009144341,0.000025156005,0.000018152514,0.00035069545],"genre_scores_gemma":[0.99955094,0.000043819713,0.00019136826,0.000055843262,0.000025806134,0.000028865345,0.000009109309,0.000011074238,0.00008319411],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988004,0.00004489287,0.0005325817,0.00030188996,0.00018689096,0.00013334886],"domain_scores_gemma":[0.9992629,0.00006886635,0.00010051218,0.0002963399,0.000047388014,0.00022396761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041520983,0.00012881469,0.00034777223,0.000033355467,0.000059854454,0.000026298683,0.00010476621,0.00006617805,0.0000067318456],"category_scores_gemma":[0.00023863408,0.000094816285,0.000026150798,0.000283559,0.00028798552,0.00013425527,0.00007511187,0.00022839787,4.194701e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093624304,0.004142578,0.05233782,0.0019740092,0.00014934344,0.000054978962,0.0033339239,0.00032957172,0.9232759,0.00082934793,0.00012223015,0.012514073],"study_design_scores_gemma":[0.0123597495,0.00080181105,0.585927,0.0012921017,0.00034589693,0.00014956953,0.0011943062,0.005592775,0.388627,0.0017253391,0.0016800112,0.00030444612],"about_ca_topic_score_codex":0.00004699431,"about_ca_topic_score_gemma":0.000010529145,"teacher_disagreement_score":0.5346489,"about_ca_system_score_codex":0.000036185407,"about_ca_system_score_gemma":0.0001621868,"threshold_uncertainty_score":0.38664958},"labels":[],"label_agreement":null},{"id":"W4404064195","doi":"10.1136/jitc-2024-sitc2024.0172","title":"172 The application of single-cell resolved spatial transcriptomics to prostate adenocarcinoma reveals tumor microenvironmental signatures that correlate with distinct histological features","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Prostate cancer; Transcriptome; Prostate; Adenocarcinoma; Prostatic adenocarcinoma; Prostate adenocarcinoma; Pathology; Biology; Cancer research; Medicine; Internal medicine; Cancer; Gene; Gene expression; Genetics","score_opus":0.009365542690208811,"score_gpt":0.21832421762146423,"score_spread":0.20895867493125542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004334,0.007940873,0.0004325273,0.00056673255,0.00007880863,0.0006558547,0.00015021075,0.000018413117,0.00011323679],"genre_scores_gemma":[0.99865085,0.0000770982,0.0003586434,0.0001657132,0.00007623144,0.000074262716,0.00019134996,0.000031137333,0.0003747156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987769,0.000056696237,0.00019220276,0.00046448148,0.00023436999,0.00027534785],"domain_scores_gemma":[0.99934304,0.000018989931,0.0000747912,0.00027682405,0.00002248722,0.00026384226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013405216,0.00021564087,0.00017936484,0.000038229347,0.000106784,0.00006928122,0.00015634141,0.000090924106,0.0000025829331],"category_scores_gemma":[0.00002894605,0.00013971647,0.0000764003,0.000072041854,0.0003812898,0.000009254508,0.000056978257,0.00017881014,0.0000034218367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000510246,0.00009289375,0.019913733,0.00012266779,0.00010301183,0.00006846059,0.0002264574,0.0000788171,0.9757885,0.00003107959,0.0020886678,0.0009754993],"study_design_scores_gemma":[0.0008933214,0.0011184795,0.28644785,0.000122577,0.00015379932,0.0002347033,0.000115902076,0.000058991023,0.6946109,0.00017758153,0.015732827,0.00033307762],"about_ca_topic_score_codex":0.00037827558,"about_ca_topic_score_gemma":0.00032321573,"teacher_disagreement_score":0.28117758,"about_ca_system_score_codex":0.00005269039,"about_ca_system_score_gemma":0.00009908677,"threshold_uncertainty_score":0.56974727},"labels":[],"label_agreement":null},{"id":"W4404064202","doi":"10.1136/jitc-2024-sitc2024.0057","title":"57 It’s about time: rapid on-site fixation of whole blood samples prior to high-dimensional flow cytometric analysis","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blood flow; Fixation (population genetics); Flow (mathematics); Computer science; Biomedical engineering; Medicine; Physics; Mechanics; Cardiology","score_opus":0.01145368257426029,"score_gpt":0.22626985665778512,"score_spread":0.21481617408352482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965613,0.0013590836,0.00037344947,0.0008593845,0.00025835726,0.00018192019,0.00026934352,0.0000328903,0.00010429845],"genre_scores_gemma":[0.99446225,0.00010950477,0.0033073046,0.0005073831,0.0002204811,0.000010383148,0.0006584973,0.00003318682,0.00069099484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841803,0.000054266657,0.00039834,0.0005478257,0.00032229818,0.00025921516],"domain_scores_gemma":[0.999084,0.00004302409,0.00008707586,0.00033234528,0.0001095846,0.0003439674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032978752,0.00024296994,0.00032679673,0.00042325776,0.00009543777,0.00009232683,0.00013188834,0.00021072898,0.000028922217],"category_scores_gemma":[0.00022974519,0.0002225513,0.00020539119,0.00074379484,0.000121088095,0.000013277676,0.000046082114,0.0001253083,0.000033672957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006590115,0.000106814754,0.0023663745,0.00010514589,0.0006906366,0.000015565394,0.0001335502,0.004127445,0.98611856,0.00005401606,0.003439256,0.0027767667],"study_design_scores_gemma":[0.00069943327,0.0005792418,0.083212286,0.00018506433,0.000958063,0.000025455574,0.00001597087,0.0025234248,0.8942513,0.00011083586,0.016953116,0.00048583787],"about_ca_topic_score_codex":0.00011780059,"about_ca_topic_score_gemma":0.000038208807,"teacher_disagreement_score":0.09186726,"about_ca_system_score_codex":0.000017463177,"about_ca_system_score_gemma":0.00016743524,"threshold_uncertainty_score":0.9075379},"labels":[],"label_agreement":null},{"id":"W4404064248","doi":"10.1136/jitc-2024-sitc2024.0525","title":"525 Adenosine uptake through equilibrative nucleoside transporter-1 suppresses antitumor immunity by pyrimidine starvation","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nucleoside; Adenosine; Chemistry; Transporter; Pyrimidine; Starvation; Immunity; Biochemistry; Pharmacology; Biology; Immune system; Endocrinology; Immunology; Gene","score_opus":0.012914654672315229,"score_gpt":0.2452678759199089,"score_spread":0.23235322124759367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97639674,0.019817883,0.0011223812,0.0012581759,0.0003137753,0.00021508551,0.00017860344,0.000093642484,0.00060372264],"genre_scores_gemma":[0.99497694,0.0010481899,0.0012797503,0.00041082632,0.00037111892,0.000017010569,0.0009981166,0.00005954321,0.00083852967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984131,0.000058407957,0.0004267256,0.00052878726,0.0002262744,0.0003467038],"domain_scores_gemma":[0.9992526,0.00002502304,0.00009296599,0.0003163108,0.00007414703,0.00023892288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002150437,0.00032222626,0.0002587876,0.000049401297,0.00016494212,0.00017178776,0.00017840533,0.00021737901,0.00003952407],"category_scores_gemma":[0.0000993959,0.00029718064,0.00010781579,0.00016276959,0.00026781723,0.000076535965,0.00005866184,0.00023329166,0.00000881951],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005109259,0.000058763904,0.000843109,0.00020149721,0.0001499516,0.000059302052,0.00040310674,0.00010665971,0.9029167,0.0006782837,0.09438584,0.0001456362],"study_design_scores_gemma":[0.00043185055,0.00025180136,0.0054098377,0.00021137444,0.000119922304,0.00011139055,0.0002239278,0.00017519889,0.83269125,0.0011359917,0.15877016,0.00046727623],"about_ca_topic_score_codex":0.0001770909,"about_ca_topic_score_gemma":0.000009380151,"teacher_disagreement_score":0.07022549,"about_ca_system_score_codex":0.000016301066,"about_ca_system_score_gemma":0.00019414902,"threshold_uncertainty_score":0.999948},"labels":[],"label_agreement":null},{"id":"W4404064319","doi":"10.1136/jitc-2024-sitc2024.0617","title":"617 Combined histone deacetylase and PD-L1 inhibition is safe and efficacious for the treatment of virus-associated cancers: results of a phase II clinical trial","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Histone deacetylase; Histone deacetylase inhibitor; Medicine; Cancer research; Virology; Pharmacology; Chemistry; Histone; Biochemistry; Gene","score_opus":0.040241847453322425,"score_gpt":0.3652573165335079,"score_spread":0.32501546908018547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069947,0.006412817,0.000014819937,0.00087862957,0.0002752904,0.0010186639,0.00064886466,0.000014778044,0.000036672613],"genre_scores_gemma":[0.9956154,0.0031508731,0.00013619164,0.000057329118,0.00021298298,0.00007228985,0.00021285751,0.000029593397,0.00051248545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820155,0.00012405461,0.00070945884,0.000498785,0.00022097852,0.00024518915],"domain_scores_gemma":[0.9988608,0.00020312985,0.00021968686,0.0003060559,0.0001270884,0.00028324276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008050011,0.00022194363,0.00040211904,0.00007147287,0.00018150575,0.000035236168,0.00006746803,0.0002794859,0.0000018532498],"category_scores_gemma":[0.00073393807,0.00017131807,0.0001635284,0.000104448874,0.000845304,0.000011544612,0.0000534456,0.00012402686,4.969017e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029873254,0.0016315351,0.000043892716,0.00032760523,0.0008331282,0.000033897635,0.0022045504,0.000017328408,0.93216705,0.000067578876,0.019524992,0.013275188],"study_design_scores_gemma":[0.056874134,0.014909795,0.00042372962,0.00021468107,0.00031542426,0.000025362,0.0001110281,0.0007293269,0.88886386,0.00009830836,0.037168078,0.00026624923],"about_ca_topic_score_codex":0.00040033675,"about_ca_topic_score_gemma":0.00024931884,"teacher_disagreement_score":0.043303166,"about_ca_system_score_codex":0.00008239641,"about_ca_system_score_gemma":0.00043738235,"threshold_uncertainty_score":0.6986148},"labels":[],"label_agreement":null},{"id":"W4404064334","doi":"10.1136/jitc-2024-sitc2024.0575","title":"575 Epigenetic modulation by KDM6B in myeloid cells regulates glioblastoma immune checkpoint therapy outcomes","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Texas MD Anderson Cancer Center; Andrew Sabin Family Foundation","keywords":"Epigenetics; Glioblastoma; Cancer research; Epigenetic therapy; Immune checkpoint; Immune system; Medicine; DNA methylation; Immunotherapy; Biology; Gene; Immunology; Genetics; Gene expression","score_opus":0.008360031046056688,"score_gpt":0.24798554494770764,"score_spread":0.23962551390165096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98695546,0.0111666275,0.000039104674,0.0008562826,0.00032768515,0.00039119783,0.000038238522,0.00006002442,0.00016539071],"genre_scores_gemma":[0.9957105,0.0009892208,0.00024942344,0.000097504475,0.0001628632,0.00004780731,0.00012939818,0.00007991452,0.0025334042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767196,0.0001260695,0.00058790104,0.00072841544,0.0003734093,0.00051224825],"domain_scores_gemma":[0.9989718,0.000031474232,0.00008845125,0.00048407025,0.00006811699,0.00035605003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057122024,0.00035723796,0.00033017804,0.00019485479,0.000107738495,0.00015829325,0.00020756248,0.00034417593,0.0000169352],"category_scores_gemma":[0.00015248754,0.0003315577,0.00016224445,0.0002501922,0.00033327486,0.000025806581,0.00009710666,0.0002896183,0.00004088824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000496503,0.000060557693,0.0011637113,0.00008097688,0.00006641564,0.00003663134,0.0001860397,0.00029215906,0.9928677,0.000021289894,0.0033400918,0.0018347477],"study_design_scores_gemma":[0.00054497743,0.0002226408,0.021742363,0.00010327177,0.000009812322,0.000041368072,0.000042709748,0.00068219844,0.9556587,0.00023014161,0.020353649,0.00036821314],"about_ca_topic_score_codex":0.00023371342,"about_ca_topic_score_gemma":0.00008185089,"teacher_disagreement_score":0.037209075,"about_ca_system_score_codex":0.00007971299,"about_ca_system_score_gemma":0.00023866695,"threshold_uncertainty_score":0.99991363},"labels":[],"label_agreement":null},{"id":"W4404064412","doi":"10.1136/jitc-2024-sitc2024.0361","title":"361 Early differentiation and memory transcription programs drive long-term persistence of NY-ESO-1 specific TCR-T cells in adoptive cell therapy","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"T-cell receptor; Term (time); Persistence (discontinuity); Biology; Computer science; T cell; Immunology; Physics; Engineering; Immune system","score_opus":0.035798880816205,"score_gpt":0.2570067381479863,"score_spread":0.2212078573317813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905348,0.0074482523,0.000027498507,0.00026499096,0.00024462125,0.0009907808,0.000012910481,0.00006136577,0.00041479393],"genre_scores_gemma":[0.9948377,0.003194623,0.00021575259,0.00003220604,0.00012383757,0.000030472822,0.000057156307,0.000047183043,0.0014610969],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99809605,0.00009960517,0.00041089414,0.0005312538,0.00051062356,0.0003515978],"domain_scores_gemma":[0.99911803,0.000048234953,0.000085045,0.00026423685,0.00010142605,0.00038304247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038010487,0.00026555042,0.00039389372,0.00027260522,0.000058551974,0.00013768983,0.000090128,0.00020108068,0.00007317883],"category_scores_gemma":[0.000012336704,0.00023272594,0.0001332966,0.0002982597,0.00048407205,0.0002439378,0.000021626129,0.00042500443,0.0000069760736],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025986135,0.0002161864,0.038553733,0.00066064246,0.00008994786,0.00014686644,0.006412554,0.0000045163206,0.9325042,0.00003331924,0.000058611324,0.021059602],"study_design_scores_gemma":[0.0015110129,0.00068505574,0.5453105,0.0006648677,0.00006741556,0.000059010425,0.0005585801,0.00016117674,0.4502512,0.000109015884,0.00039717165,0.00022502753],"about_ca_topic_score_codex":0.00009978317,"about_ca_topic_score_gemma":0.000031166634,"teacher_disagreement_score":0.5067567,"about_ca_system_score_codex":0.00010703714,"about_ca_system_score_gemma":0.00016171928,"threshold_uncertainty_score":0.94902885},"labels":[],"label_agreement":null},{"id":"W4404064430","doi":"10.1136/jitc-2024-sitc2024.1314","title":"1314 Immunostimulatory nanofilaments turn cancer cells into neoantigen agnostic cancer vaccines","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Cancer; Computational biology; Cancer cell; Computer science; Cancer research; Biology; Genetics","score_opus":0.01022391758609406,"score_gpt":0.2572536201186203,"score_spread":0.24702970253252624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75606084,0.23743308,0.0000101254045,0.0008514929,0.0048763626,0.000330605,0.00007616163,0.00022895429,0.0001324087],"genre_scores_gemma":[0.97941184,0.012124658,0.00006109962,0.0006400161,0.0001755977,0.00010870047,0.00006778895,0.00009530746,0.007314999],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99759084,0.0002237394,0.0006454301,0.0006968697,0.00012908892,0.0007140347],"domain_scores_gemma":[0.998862,0.00025564068,0.00016178949,0.00047287348,0.000104381055,0.00014325944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003931081,0.0005374971,0.00055451423,0.0002564385,0.00046566222,0.00019632767,0.0003451089,0.00047316268,0.00060197565],"category_scores_gemma":[0.00014900923,0.00046172622,0.00020954992,0.0002799281,0.00050245406,0.00040399024,0.00012152757,0.0005534245,0.00048180425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018097406,0.000060316655,0.0030945002,0.0002606371,0.0008718069,0.00006255586,0.0014594694,0.000104214385,0.97238654,0.00016105166,0.012486505,0.008871419],"study_design_scores_gemma":[0.0009223057,0.00012638295,0.03727246,0.0009655297,0.00023330722,0.00012784761,0.00013347526,0.000033590895,0.75813895,0.00032989774,0.20110999,0.00060623983],"about_ca_topic_score_codex":0.002553633,"about_ca_topic_score_gemma":0.000082408726,"teacher_disagreement_score":0.22530842,"about_ca_system_score_codex":0.0001457531,"about_ca_system_score_gemma":0.00081421575,"threshold_uncertainty_score":0.99978346},"labels":[],"label_agreement":null},{"id":"W4404064451","doi":"10.1136/jitc-2024-sitc2024.1291","title":"1291 Profiling bispecific T-cell engagers: strategies for enhancing potency while minimizing cytokine release","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Profiling (computer programming); Potency; Computer science; Bispecific antibody; Cytokine; Human–computer interaction; Chemistry; Medicine; Immunology; Antibody; Operating system","score_opus":0.03727982372611302,"score_gpt":0.2903729767150358,"score_spread":0.25309315298892276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802872,0.0070718187,0.0007447023,0.0014980761,0.0006876608,0.0013985009,0.00005740968,0.00041285646,0.007841781],"genre_scores_gemma":[0.9852941,0.0005128043,0.006235303,0.00019640203,0.00094086694,0.000113202645,0.00011801734,0.00014059248,0.0064487164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99719334,0.000086053165,0.0006155145,0.0007989358,0.0005687778,0.0007373813],"domain_scores_gemma":[0.9981292,0.00029579172,0.000095930765,0.00047252205,0.00018434139,0.00082221226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011593591,0.0003927421,0.0005071518,0.00033475875,0.0002865548,0.000496954,0.0001459186,0.00025623903,0.00012864894],"category_scores_gemma":[0.00040751437,0.0003554688,0.00023972889,0.00037721213,0.00028200078,0.0004402167,0.000057449426,0.0007424626,0.000036683552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017148316,0.00007828364,0.00023667375,0.0023068902,0.00011780546,0.00038230055,0.0011908703,0.00006926855,0.9880864,0.0009553593,0.002558073,0.0038465739],"study_design_scores_gemma":[0.0017131179,0.00048825087,0.0006736858,0.0014525689,0.0002547257,0.00042698585,0.004905349,0.0027248827,0.92446244,0.0021392514,0.060159173,0.00059957564],"about_ca_topic_score_codex":0.0000950967,"about_ca_topic_score_gemma":0.000029439329,"teacher_disagreement_score":0.06362398,"about_ca_system_score_codex":0.00017195364,"about_ca_system_score_gemma":0.0012993388,"threshold_uncertainty_score":0.99988973},"labels":[],"label_agreement":null},{"id":"W4404064955","doi":"10.1136/jitc-2024-sitc2024.0418","title":"418 Dendritic cell-activation of T cells provides metabolic signals for improved <i>in vivo</i> persistence and anti-tumour performance","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"In vivo; Persistence (discontinuity); Cell biology; Cell; Chemistry; Biology; Engineering; Biochemistry; Biotechnology","score_opus":0.013582975857025576,"score_gpt":0.21882290239331617,"score_spread":0.20523992653629058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404064955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675921,0.031024817,0.00004253971,0.0002411317,0.00037906005,0.00056954613,0.00004431677,0.000043502077,0.00006293778],"genre_scores_gemma":[0.9963995,0.0020154961,0.00024505163,0.00010880337,0.000023488745,0.000067060006,0.000015712074,0.000028816217,0.0010960572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872875,0.000101527046,0.0004312312,0.00035464572,0.000044650733,0.0003391823],"domain_scores_gemma":[0.9993845,0.0002167575,0.00012184162,0.00016455019,0.00006448951,0.000047847156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004799422,0.00023199973,0.00039322732,0.00018359271,0.00014059286,0.00006160565,0.00011436749,0.0002053914,0.0000138840405],"category_scores_gemma":[0.00010497373,0.00020712748,0.000091786314,0.00014766949,0.00041197392,0.0003580602,0.000030369703,0.0002015523,0.000004564793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014357985,0.000048856793,0.00039503694,0.00059581775,0.00008395736,0.0000019684935,0.0006442854,0.000023547087,0.99615806,0.000105450825,0.00023702899,0.0015624003],"study_design_scores_gemma":[0.000772569,0.00023114386,0.005939575,0.00039528956,0.00007240666,0.000059836417,0.00028614263,0.00024986427,0.97845936,0.00008495314,0.013217644,0.00023124536],"about_ca_topic_score_codex":0.0000863139,"about_ca_topic_score_gemma":0.000003344332,"teacher_disagreement_score":0.029009322,"about_ca_system_score_codex":0.00001872292,"about_ca_system_score_gemma":0.00020388083,"threshold_uncertainty_score":0.8446413},"labels":[],"label_agreement":null},{"id":"W4404065332","doi":"10.1136/jitc-2024-sitc2024.0878","title":"878 The immunomodulatory impact of chemotherapy when combined with PD-1 blockade in resectable lung cancers","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"","keywords":"Blockade; Medicine; Chemotherapy; Lung; Oncology; Internal medicine; Cancer research; Receptor","score_opus":0.009662269831908502,"score_gpt":0.2611179576055441,"score_spread":0.25145568777363564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404065332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836194,0.01302637,0.000004514209,0.0019498111,0.00018244657,0.00055707956,0.000017873575,0.000060645736,0.0005818856],"genre_scores_gemma":[0.99804246,0.00064596056,0.00013289147,0.00028118564,0.00009671856,0.00003022683,0.000015706284,0.0000513612,0.0007034995],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985015,0.000051626044,0.0004070488,0.00034126235,0.0003382237,0.00036038388],"domain_scores_gemma":[0.99913675,0.00006421341,0.000105945626,0.0004239327,0.0000583847,0.00021078483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005405844,0.00026708044,0.00041200576,0.00016844978,0.000077973375,0.00007285511,0.00013443535,0.00013538566,0.00006598151],"category_scores_gemma":[0.00003724237,0.00016014109,0.00016881974,0.00037880166,0.0004923165,0.0001600389,0.000020410289,0.00034902064,0.0000017658949],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015193017,0.00030573722,0.23116462,0.002133165,0.004499128,0.000499393,0.013282619,0.0008453207,0.69792855,0.00031517603,0.027390933,0.0064423177],"study_design_scores_gemma":[0.006326087,0.001697069,0.9012707,0.002319674,0.00025069332,0.00046162523,0.0005472015,0.0021297275,0.076905,0.00053192343,0.0070593925,0.0005009191],"about_ca_topic_score_codex":0.004796182,"about_ca_topic_score_gemma":0.000314445,"teacher_disagreement_score":0.67010605,"about_ca_system_score_codex":0.0004408092,"about_ca_system_score_gemma":0.0014151733,"threshold_uncertainty_score":0.7250424},"labels":[],"label_agreement":null},{"id":"W4404065577","doi":"10.1136/jitc-2024-sitc2024.1435","title":"1435 Therapeutic mRNA cancer vaccine for GBM reaches complete response in a preclinical model","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; Providence Health Care","funders":"","keywords":"Cancer; Cancer vaccine; Cancer research; Messenger RNA; Medicine; Internal medicine; Biology; Immunotherapy; Gene; Genetics","score_opus":0.05780815849520819,"score_gpt":0.32106252314046096,"score_spread":0.26325436464525276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404065577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91428584,0.07926384,0.00022360234,0.0044895727,0.00083227805,0.0005687195,0.000134542,0.00014954776,0.000052058105],"genre_scores_gemma":[0.9935636,0.001504756,0.0003335375,0.00075881515,0.000058651858,0.00019148983,0.000059492377,0.00006284831,0.0034667912],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977912,0.0003849873,0.00065209216,0.000559748,0.00006696547,0.00054504786],"domain_scores_gemma":[0.9985976,0.0007951467,0.00010321717,0.00036537292,0.00005638445,0.000082283696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014682036,0.0003347023,0.00050574023,0.00022900832,0.00018720294,0.00008813691,0.00022736347,0.00041990838,0.000042110954],"category_scores_gemma":[0.00042925944,0.0002832197,0.00018414306,0.00017985894,0.0003215309,0.00021358886,0.000052064428,0.0005019231,0.000038524566],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073632365,0.00011899528,0.0013498577,0.00018849784,0.0004654817,0.000021812635,0.0016020086,0.00027893254,0.9758926,0.0012191201,0.0029245198,0.008574928],"study_design_scores_gemma":[0.009499553,0.001756069,0.18301824,0.0020913316,0.00050782086,0.0006304684,0.00045096516,0.009577707,0.37381744,0.016288273,0.40053046,0.0018316923],"about_ca_topic_score_codex":0.00015403681,"about_ca_topic_score_gemma":0.00003951193,"teacher_disagreement_score":0.60207516,"about_ca_system_score_codex":0.00008621585,"about_ca_system_score_gemma":0.0005714756,"threshold_uncertainty_score":0.999962},"labels":[],"label_agreement":null},{"id":"W4415898573","doi":"10.1136/jitc-2025-sitc2025.0164","title":"164 A 50-marker mass cytometry intracellular cytokine staining panel: unprecedented resolution enables unrivaled detection of functional diversity present among human immune cell subsets","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Immune system; Intracellular; Flow cytometry; Cytokine; Resolution (logic); Functional diversity","score_opus":0.01718002217721588,"score_gpt":0.21537268725179692,"score_spread":0.19819266507458105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823615,0.006224884,0.008878429,0.00015574151,0.0010160226,0.0006808782,0.00010203244,0.000050803537,0.0005297031],"genre_scores_gemma":[0.99644965,0.00097264483,0.00025287128,0.000051917214,0.00028633076,0.000019128232,0.00046884504,0.00006101492,0.0014376263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99591327,0.00039988226,0.0012081662,0.0010946924,0.00061903,0.0007649368],"domain_scores_gemma":[0.9975925,0.00006450654,0.0006846761,0.0007028228,0.00044074937,0.0005147326],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010471182,0.0006740889,0.0007343685,0.00042349612,0.0010447083,0.0001535713,0.00038509158,0.0009386297,0.000021765845],"category_scores_gemma":[0.00027555562,0.0007620932,0.00039729744,0.00053849583,0.001046847,0.00006911085,0.0004522853,0.00061584584,0.000002362719],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007125678,0.0003464714,0.06331575,0.00087417575,0.0005454357,0.000024024699,0.00020912285,0.0016021974,0.9317684,0.000035472032,0.00019288882,0.00037349915],"study_design_scores_gemma":[0.002507618,0.0003296137,0.15986922,0.00039291318,0.0005243238,0.000014866292,0.0005398219,0.0018475906,0.8310734,0.00021232643,0.0020978265,0.0005904958],"about_ca_topic_score_codex":0.0013023237,"about_ca_topic_score_gemma":0.00018355109,"teacher_disagreement_score":0.10069502,"about_ca_system_score_codex":0.00020435858,"about_ca_system_score_gemma":0.0003894246,"threshold_uncertainty_score":0.999483},"labels":[],"label_agreement":null},{"id":"W4415898589","doi":"10.1136/jitc-2025-sitc2025.0176","title":"176 Spatial and seromic profiling of tumor infiltrating B-cell subtypes and autoantibody production in oral cancers","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Tumor-infiltrating lymphocytes; Autoantibody; Profiling (computer programming); Gene expression profiling; Oral Cancers; Lymphocytic infiltration","score_opus":0.014191246541385222,"score_gpt":0.2703179880950271,"score_spread":0.2561267415536419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791163,0.017052956,0.000005116792,0.0012474529,0.0009679742,0.000890349,0.00002174862,0.00003351157,0.0006645679],"genre_scores_gemma":[0.99558824,0.0029875794,0.00066223997,0.0001818496,0.00024591567,0.000024808514,0.000010304763,0.000031034113,0.00026803667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731356,0.00011781769,0.00094412384,0.0007983717,0.00029448187,0.0005316557],"domain_scores_gemma":[0.99878454,0.00008516292,0.0003472102,0.0002640141,0.00014538161,0.00037366894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085813727,0.0004322296,0.001014596,0.0003051468,0.00024046951,0.00006767933,0.00007122432,0.00020030719,0.0000037331856],"category_scores_gemma":[0.00082001626,0.00042002398,0.00005616304,0.00038530247,0.00092947076,0.0002653466,0.000110664565,0.0005106262,6.813593e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032521025,0.000121460165,0.6839719,0.0063995323,0.00018605436,0.000056706813,0.0027679238,0.00011273562,0.30098766,0.00017691034,0.00028504815,0.0046088807],"study_design_scores_gemma":[0.002733635,0.0004453832,0.6097607,0.004804119,0.0003946702,0.00007715637,0.0023288985,0.0015430067,0.37690672,0.00026499978,0.00032199564,0.00041867793],"about_ca_topic_score_codex":0.00521307,"about_ca_topic_score_gemma":0.0015648789,"teacher_disagreement_score":0.075919084,"about_ca_system_score_codex":0.00017351507,"about_ca_system_score_gemma":0.0015837422,"threshold_uncertainty_score":0.9998252},"labels":[],"label_agreement":null},{"id":"W4415898595","doi":"10.1136/jitc-2025-sitc2025.1251","title":"1251 Impact of intra-tumoral mammary microbiota on macrophage biology and anti-tumor immune response in breast cancer","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Immune system; Macrophage; Breast cancer; Mammary gland; Cancer; Mammary tumor","score_opus":0.0068481748058390485,"score_gpt":0.26674911915837546,"score_spread":0.2599009443525364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92937803,0.06316981,0.000004921646,0.002962745,0.00258813,0.00075649185,0.0008930717,0.00004466853,0.00020213607],"genre_scores_gemma":[0.99106604,0.00691825,0.000094591196,0.0005853837,0.00006533686,0.000041928302,0.000078707155,0.000070787624,0.0010789834],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9942426,0.00131385,0.0017254879,0.001302283,0.0000930602,0.0013227332],"domain_scores_gemma":[0.9972568,0.00043256234,0.000775376,0.0010832587,0.00019538405,0.00025661345],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0015804116,0.0010028745,0.0017791702,0.0009155744,0.0003118298,0.000097406424,0.00065640203,0.0011678657,0.00018107657],"category_scores_gemma":[0.00038849804,0.00094981666,0.00035847322,0.0007296757,0.0035836373,0.00028238952,0.00054626865,0.0015695033,0.00001897831],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055107893,0.0003595806,0.07035436,0.0005524356,0.00091548165,0.00020841324,0.0005224892,0.00009341288,0.91720814,0.00061621534,0.0018060732,0.0018526205],"study_design_scores_gemma":[0.0038815786,0.00055191386,0.7423047,0.0017228858,0.00017716209,0.00077651965,0.00012240936,0.000022599099,0.24797969,0.00040848152,0.0013853593,0.00066674076],"about_ca_topic_score_codex":0.0029343418,"about_ca_topic_score_gemma":0.000035767353,"teacher_disagreement_score":0.6719503,"about_ca_system_score_codex":0.00055090897,"about_ca_system_score_gemma":0.0024640663,"threshold_uncertainty_score":0.99929523},"labels":[],"label_agreement":null},{"id":"W4415898627","doi":"10.1136/jitc-2025-sitc2025.1230","title":"1230 Enhancing tissue microarray design for immune profiling: tissue microarray vs whole-slide quantification of CD8 in non-small cell lung carcinoma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Queen's University","funders":"","keywords":"Immune system; Microarray; Tissue microarray; Microarray analysis techniques; CD8; Lung cancer; Cytotoxic T cell","score_opus":0.013997620393194875,"score_gpt":0.26727838706133306,"score_spread":0.2532807666681382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7901663,0.00736015,0.19789682,0.00084143877,0.00032914762,0.00307783,0.00014012092,0.000037129146,0.00015103321],"genre_scores_gemma":[0.89394337,0.0005420879,0.10325556,0.0001340502,0.00013336237,0.00019815081,0.00041722442,0.000078899546,0.0012972651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962674,0.000121448546,0.001470505,0.0012551685,0.00016578559,0.00071969745],"domain_scores_gemma":[0.9974186,0.000092704184,0.0007533092,0.0010503153,0.00038406037,0.00030101396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093482656,0.0006259781,0.00076725805,0.00025480817,0.00030631362,0.00010954974,0.00044340882,0.0007998354,0.0000012079129],"category_scores_gemma":[0.00031688286,0.0007053004,0.00018083304,0.00040548987,0.0005013361,0.000028560515,0.00016623136,0.0003565257,0.0000024984934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001702953,0.00019963951,0.00091295136,0.0014051886,0.000056696077,0.0000057712787,0.00020648415,0.00047395512,0.9943638,0.0001654143,0.00072451314,0.0013153349],"study_design_scores_gemma":[0.0010898133,0.0003129451,0.0021813072,0.0006747475,0.0001931882,0.000021431104,0.00024826525,0.0005732428,0.9794511,0.00051241624,0.014097219,0.0006443043],"about_ca_topic_score_codex":0.00019160964,"about_ca_topic_score_gemma":0.00006241329,"teacher_disagreement_score":0.10377707,"about_ca_system_score_codex":0.0001152333,"about_ca_system_score_gemma":0.00084097876,"threshold_uncertainty_score":0.9995398},"labels":[],"label_agreement":null},{"id":"W4415898651","doi":"10.1136/jitc-2025-sitc2025.1224","title":"1224 Glioblastoma: bridging mouse model insights to human tumor microenvironment using imaging mass cytometry","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Tumor microenvironment; Bridging (networking); Flow cytometry; Mass cytometry; Tumor cells","score_opus":0.01079983947566746,"score_gpt":0.23531166254559555,"score_spread":0.2245118230699281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97406226,0.0052385903,0.018272469,0.0005246788,0.00068688346,0.00065964134,0.00009192235,0.000053806747,0.00040971633],"genre_scores_gemma":[0.99030256,0.0002597536,0.005096286,0.002261759,0.00036164044,0.000020396421,0.00006052528,0.0001344908,0.001502612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956936,0.00013229556,0.001091247,0.0015638032,0.0004482624,0.0010707383],"domain_scores_gemma":[0.9974881,0.000015893702,0.0003068924,0.00091630005,0.00012411312,0.0011487291],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003898445,0.00091111346,0.00074183935,0.00048203437,0.0008304309,0.00043946135,0.0005079012,0.00038913573,0.000005028362],"category_scores_gemma":[0.00013713361,0.0010400035,0.00031444998,0.00038234185,0.00064242736,0.000053105956,0.00036570983,0.00052279385,0.000009574431],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013101389,0.00020751572,0.0063715363,0.00038894493,0.00022197772,0.00006677462,0.00027451618,0.011498307,0.97961336,0.00013613784,0.0006735887,0.00041630905],"study_design_scores_gemma":[0.0014651706,0.00016764272,0.0014166692,0.00057564426,0.00032460553,0.00006576013,0.0002112458,0.028546715,0.96093875,0.00034020498,0.0048317555,0.0011158368],"about_ca_topic_score_codex":0.0001850162,"about_ca_topic_score_gemma":0.00005495211,"teacher_disagreement_score":0.018674629,"about_ca_system_score_codex":0.00028735728,"about_ca_system_score_gemma":0.00058713206,"threshold_uncertainty_score":0.99920505},"labels":[],"label_agreement":null},{"id":"W4415898660","doi":"10.1136/jitc-2025-sitc2025.0128","title":"128 Enabling sensitive and reproducible functional profiling for immuno-oncology research on the CyTOF XT PRO mass cytometer","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Profiling (computer programming); Mass spectrometry; Tandem mass spectrometry","score_opus":0.08514801184976346,"score_gpt":0.3306256824787652,"score_spread":0.24547767062900178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817865,0.004108868,0.0008140373,0.007930679,0.0012906943,0.0018996425,0.00009793607,0.000025246258,0.0020464358],"genre_scores_gemma":[0.99206764,0.0012254453,0.0015441985,0.0011369153,0.00080275524,0.00018984912,0.00015181933,0.00006341539,0.0028179416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958663,0.00050853624,0.00073100475,0.0015887638,0.00041483168,0.0008905837],"domain_scores_gemma":[0.9973748,0.00048854086,0.00021771502,0.0008368213,0.00072778243,0.00035439513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040434534,0.00049056223,0.000523101,0.00027297737,0.0012021799,0.00032146473,0.00025144286,0.0007462115,0.000004623199],"category_scores_gemma":[0.0022087526,0.0004053578,0.0002019781,0.00038336462,0.0014205689,0.000027965056,0.0001899963,0.0007877005,0.0000037206282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011984617,0.00017291817,0.0015192968,0.0004804859,0.00046833756,0.00001879014,0.00036266245,0.00015581687,0.98844075,0.0026987744,0.0023898354,0.002093854],"study_design_scores_gemma":[0.0014909621,0.0009832393,0.0017313134,0.00037370468,0.0001654305,0.000063323336,0.0017229319,0.0006422328,0.93745553,0.0023915563,0.052533392,0.00044637875],"about_ca_topic_score_codex":0.000081786886,"about_ca_topic_score_gemma":0.000025103336,"teacher_disagreement_score":0.050985232,"about_ca_system_score_codex":0.00014208842,"about_ca_system_score_gemma":0.0014571075,"threshold_uncertainty_score":0.99983984},"labels":[],"label_agreement":null},{"id":"W4415898666","doi":"10.1136/jitc-2025-sitc2025.1196","title":"1196 TriTCE Co-stim: a differentiated T cell engager platform with conditional <i>cis</i> CD28 co-stimulation is transferable to diverse targeting strategies","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"T cell; CD28; Cell; T-cell receptor; Ubiquitin-Protein Ligases","score_opus":0.02448960916072105,"score_gpt":0.2953962097737661,"score_spread":0.27090660061304506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799175,0.0013642333,0.0019999642,0.0017965677,0.00044636521,0.0027241944,0.00068802165,0.00019774283,0.010865402],"genre_scores_gemma":[0.9831001,0.0004657071,0.00054245297,0.0015284496,0.00034423164,0.000099936704,0.0012670392,0.00013038587,0.012521707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99376106,0.00029245106,0.0013237586,0.0014388312,0.0017144734,0.0014694303],"domain_scores_gemma":[0.99600846,0.000537852,0.00028271895,0.000708244,0.00060243695,0.0018603079],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013581888,0.0010364705,0.001292229,0.0007343168,0.0011856618,0.0007968379,0.00037600432,0.0006765417,0.002248572],"category_scores_gemma":[0.00027728995,0.0009694797,0.00030119505,0.0009926505,0.0010256135,0.0009090611,0.000086397056,0.001693882,0.00012707207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059109284,0.0012636986,0.023028985,0.0036670414,0.0017723464,0.00067324744,0.009340936,0.0050074933,0.90846276,0.0013585747,0.038099818,0.0014141396],"study_design_scores_gemma":[0.020765455,0.002527903,0.07019233,0.0028708414,0.001689698,0.00013912695,0.009095258,0.0061053433,0.8383158,0.0025208995,0.043664083,0.0021132794],"about_ca_topic_score_codex":0.0004535168,"about_ca_topic_score_gemma":0.000050561775,"teacher_disagreement_score":0.070147015,"about_ca_system_score_codex":0.0004372144,"about_ca_system_score_gemma":0.0026166844,"threshold_uncertainty_score":0.99927557},"labels":[],"label_agreement":null},{"id":"W4415898701","doi":"10.1136/jitc-2025-sitc2025.0078","title":"78 Exploratory radiomics analysis in unresectable hepatocellular carcinoma treated with durvalumab alone or combined with tremelimumab or bevacizumab","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Tremelimumab; Bevacizumab; Radiomics; Hepatocellular carcinoma; Nivolumab; Exploratory analysis","score_opus":0.015160175798743708,"score_gpt":0.25031871104562703,"score_spread":0.23515853524688332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98862815,0.0044193347,0.00057994784,0.0033350727,0.00031197738,0.0018335808,0.000048195743,0.00018809408,0.00065563316],"genre_scores_gemma":[0.9898199,0.001259023,0.0019338101,0.001078833,0.00019195779,0.000108469605,0.0002996103,0.00019955647,0.005108861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921302,0.00070102036,0.002021897,0.002019808,0.0013833913,0.0017436816],"domain_scores_gemma":[0.9946727,0.0005004993,0.00077335397,0.0015589489,0.0004316972,0.0020627666],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0020028297,0.001425631,0.0032528993,0.0021463458,0.0006153787,0.00045597856,0.0005662038,0.0006763996,0.0001474966],"category_scores_gemma":[0.0015603094,0.0009807748,0.00032444796,0.005790945,0.0018043054,0.0005831122,0.00018528414,0.0019917393,0.000011947511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024370648,0.0012749052,0.93649185,0.0023751745,0.007231806,0.013623709,0.00243241,0.004127275,0.0045011514,0.00025881588,0.0015188644,0.0017933901],"study_design_scores_gemma":[0.07492948,0.00848369,0.52040786,0.008555257,0.024548858,0.0015746794,0.005911015,0.32252783,0.02410229,0.00022397084,0.005167169,0.0035679452],"about_ca_topic_score_codex":0.0031858103,"about_ca_topic_score_gemma":0.0020009717,"teacher_disagreement_score":0.41608402,"about_ca_system_score_codex":0.0008982941,"about_ca_system_score_gemma":0.0048912386,"threshold_uncertainty_score":0.9998494},"labels":[],"label_agreement":null},{"id":"W4415898738","doi":"10.1136/jitc-2025-sitc2025.0718","title":"718 Global quantitative patient chart review of multidisciplinary team (MDT) care and treatment use in early-stage non-small-cell lung cancer (NSCLC)","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montfort Hospital","funders":"AstraZeneca","keywords":"Multidisciplinary approach; Lung cancer; Chart; MEDLINE; Patient care; Lung disease","score_opus":0.019939317980088075,"score_gpt":0.30876162806235,"score_spread":0.28882231008226195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6797274,0.31467935,0.0000022710847,0.00080663787,0.00050035317,0.0028364698,0.00066408206,0.00001943263,0.00076400273],"genre_scores_gemma":[0.76657474,0.23139767,0.0006233697,0.00039531742,0.00005544756,0.00044396642,0.00009411128,0.000041045852,0.00037430116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995932,0.00020694506,0.001395591,0.0012327563,0.0004895959,0.00074314943],"domain_scores_gemma":[0.99722207,0.00019139204,0.00062528334,0.000723304,0.00035079033,0.0008871789],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002716708,0.00088099466,0.0016493397,0.00020800017,0.00021803945,0.00009631963,0.00013905847,0.0003278898,0.000020234953],"category_scores_gemma":[0.0001770215,0.0007434229,0.0003099085,0.00055661413,0.0005397594,0.00029666343,0.00021359275,0.0003050132,0.000004024144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003416357,0.0012693941,0.9476282,0.034022074,0.0010117128,0.00034080498,0.008772013,0.000086114414,0.00034276678,0.00020851751,0.0014313752,0.004545372],"study_design_scores_gemma":[0.007956848,0.0026715908,0.85437816,0.111388,0.003321019,0.000015763893,0.0035608523,0.00036188215,0.012853073,0.000023771518,0.0027452295,0.00072380586],"about_ca_topic_score_codex":0.013927258,"about_ca_topic_score_gemma":0.0029567257,"teacher_disagreement_score":0.09325005,"about_ca_system_score_codex":0.0021439241,"about_ca_system_score_gemma":0.0023720486,"threshold_uncertainty_score":0.9995017},"labels":[],"label_agreement":null},{"id":"W4415898748","doi":"10.1136/jitc-2025-sitc2025.0082","title":"82 AI-guided spatial profiling of tertiary lymphoid structures in human lung cancer by imaging mass cytometry","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Lung cancer; Human lung; Profiling (computer programming); Flow cytometry","score_opus":0.006854862872212871,"score_gpt":0.26774149573051886,"score_spread":0.260886632858306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97087353,0.024240965,0.001783726,0.00069596124,0.0011266439,0.0006142134,0.00022576487,0.000024173665,0.00041500933],"genre_scores_gemma":[0.99637306,0.0010317613,0.0007302941,0.0009496976,0.00027818096,0.00003377701,0.00026840973,0.00007227119,0.0002625413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99635255,0.00017248454,0.0012885695,0.0010543424,0.000368492,0.0007635436],"domain_scores_gemma":[0.99839824,0.000026041283,0.00039943124,0.00056236214,0.00019917476,0.00041473474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046489274,0.000658434,0.00074044097,0.0003366958,0.00025287218,0.00015900908,0.00042497227,0.00060032646,0.000014992809],"category_scores_gemma":[0.000192407,0.00070767524,0.00023243597,0.00036299255,0.0007368727,0.00004087213,0.00015260719,0.0004739352,3.0225678e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006397378,0.00007630102,0.37779987,0.0007806195,0.00017017344,0.00001666975,0.000090207584,0.00019907382,0.61841756,0.000060548155,0.0011768994,0.0011481104],"study_design_scores_gemma":[0.0021562919,0.000056158635,0.04596714,0.0007083238,0.00023623835,0.000025192337,0.0001021575,0.0028181237,0.9457727,0.0005722737,0.0009318571,0.0006535431],"about_ca_topic_score_codex":0.00332792,"about_ca_topic_score_gemma":0.00022228001,"teacher_disagreement_score":0.33183274,"about_ca_system_score_codex":0.00016142483,"about_ca_system_score_gemma":0.0010356753,"threshold_uncertainty_score":0.9995374},"labels":[],"label_agreement":null},{"id":"W4415898803","doi":"10.1136/jitc-2025-sitc2025.0400","title":"400 New ICD code-based case definition correctly identifies ICI-IA from administrative health data","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Vancouver Coastal Health; University of Manitoba; University of Calgary; McGill University; Alberta Health Services; University of Alberta","funders":"","keywords":"Health data; Data collection; Data quality; MEDLINE; Health care","score_opus":0.3509173051807121,"score_gpt":0.45081514445663345,"score_spread":0.09989783927592133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7456753,0.018658979,0.012315347,0.17513733,0.02174651,0.006465308,0.0102919405,0.00084158784,0.0088677015],"genre_scores_gemma":[0.9592494,0.0016207654,0.004510282,0.026137339,0.0010381729,0.00006611317,0.0047280923,0.000070432805,0.0025794075],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99116766,0.001562561,0.0035056525,0.0013412107,0.0009550895,0.0014678409],"domain_scores_gemma":[0.9900661,0.0019301431,0.0019550093,0.0018676049,0.0003898184,0.0037912885],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0045354045,0.0007727736,0.0013052901,0.00042272694,0.0033939641,0.00036975337,0.0006697827,0.0011380403,0.00032917096],"category_scores_gemma":[0.006136306,0.00078438537,0.00013767846,0.000672962,0.0007847574,0.0010315183,0.0003827439,0.0025224234,0.000275377],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007748744,0.00042873205,0.00824142,0.010831485,0.0004024132,0.0008446384,0.018717168,0.00009714683,0.00016839043,0.00828722,0.93179,0.019416498],"study_design_scores_gemma":[0.02764542,0.0029667926,0.1779756,0.07244567,0.002967062,0.001114966,0.072242364,0.079071395,0.0045494474,0.070552245,0.48274872,0.005720322],"about_ca_topic_score_codex":0.022698373,"about_ca_topic_score_gemma":0.012159231,"teacher_disagreement_score":0.44904128,"about_ca_system_score_codex":0.0005654664,"about_ca_system_score_gemma":0.025132027,"threshold_uncertainty_score":0.9997788},"labels":[],"label_agreement":null},{"id":"W4415898806","doi":"10.1136/jitc-2025-sitc2025.0441","title":"441 Reimagining bladder cancer immunotherapy: local non-viral gene delivery of DNA-encoded immune checkpoint inhibitors","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Saint-Laurent","funders":"","keywords":"Bladder cancer; Immune system; Gene; Immune checkpoint; Gene delivery","score_opus":0.01088837622101589,"score_gpt":0.25748898297937334,"score_spread":0.24660060675835746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92935586,0.0603856,0.00024688407,0.0027882326,0.0039953147,0.0013598166,0.00014879197,0.00014648969,0.0015730164],"genre_scores_gemma":[0.98516464,0.008645018,0.0007134852,0.0010995057,0.000742584,0.00013831152,0.000069071575,0.00020490345,0.0032224997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99400365,0.00019303113,0.0023466337,0.0012956145,0.00094404205,0.001217045],"domain_scores_gemma":[0.99648476,0.000102119295,0.0008519352,0.0011231285,0.0004959962,0.00094205735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008454777,0.0011363904,0.0018471249,0.00051582535,0.00037024697,0.00014990263,0.0004106386,0.0007339105,0.00014353215],"category_scores_gemma":[0.00014203072,0.0009891969,0.00067518326,0.0007240762,0.0020790382,0.00049615983,0.0002489706,0.0011338589,0.000020590298],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001779795,0.00082616584,0.0257994,0.0017663778,0.005397732,0.00037456013,0.0037667067,0.00039072792,0.9206461,0.00011872856,0.003003109,0.036130626],"study_design_scores_gemma":[0.008575318,0.00063313544,0.12995005,0.0038855032,0.0019507855,0.000112114925,0.0010161584,0.00073054765,0.8474251,0.00068431103,0.0041687135,0.00086824293],"about_ca_topic_score_codex":0.010012793,"about_ca_topic_score_gemma":0.00012130326,"teacher_disagreement_score":0.10415064,"about_ca_system_score_codex":0.00064043136,"about_ca_system_score_gemma":0.0049415207,"threshold_uncertainty_score":0.99925584},"labels":[],"label_agreement":null},{"id":"W4415898841","doi":"10.1136/jitc-2025-sitc2025.0384","title":"384 Features of neoantigen-reactive T cells with <i>ex vivo</i> expansion capacity","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"T cell; T lymphocyte; Work (physics); Population","score_opus":0.008710869836876198,"score_gpt":0.20621346275863206,"score_spread":0.19750259292175587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712675,0.017099537,0.00005619727,0.0012022565,0.002906106,0.0008489802,0.00020147538,0.000102768936,0.0063151335],"genre_scores_gemma":[0.9814296,0.0022459493,0.00037241066,0.00059583265,0.00008570177,0.000022189068,0.0000639941,0.000064655294,0.015119695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954322,0.000631525,0.0012077488,0.0013163647,0.00020183511,0.0012103287],"domain_scores_gemma":[0.9969975,0.00031755434,0.0008804859,0.0010872477,0.000405686,0.0003115581],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00064511976,0.00102157,0.0015608219,0.00044412175,0.0006656169,0.000092407536,0.00059517036,0.0016304515,0.00016629421],"category_scores_gemma":[0.00020035772,0.00087029475,0.00032631433,0.0005708,0.0045294054,0.00035799525,0.00030730778,0.0015432279,0.00009116595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008760494,0.00058098446,0.0022120557,0.00057274435,0.0014783386,0.00007238421,0.0019717813,0.000042803524,0.9778726,0.0020355098,0.011221414,0.0010633],"study_design_scores_gemma":[0.0030810419,0.000781923,0.013944087,0.0010688272,0.000759599,0.00037225304,0.0011426163,0.000004623814,0.9417667,0.0010345749,0.035247322,0.0007964286],"about_ca_topic_score_codex":0.0017214702,"about_ca_topic_score_gemma":0.00021861405,"teacher_disagreement_score":0.03610593,"about_ca_system_score_codex":0.00011360589,"about_ca_system_score_gemma":0.0011378436,"threshold_uncertainty_score":0.9996656},"labels":[],"label_agreement":null},{"id":"W4415898865","doi":"10.1136/jitc-2025-sitc2025.0320","title":"320 Integrated efficacy and safety analysis of letetresgene autoleucel, a T-cell receptor T-cell therapy, across clinical trials of patients with synovial sarcoma and myxoid/round cell liposarcoma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Clinical trial; Soft tissue sarcoma; Synovial sarcoma; Liposarcoma; Sarcoma; Receptor","score_opus":0.043261942524745856,"score_gpt":0.3526277013207987,"score_spread":0.3093657587960528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757227,0.018359037,0.000059380334,0.00040182174,0.00056674395,0.0029771354,0.0013652322,0.0000523378,0.0004956187],"genre_scores_gemma":[0.98405814,0.011662312,0.00081691594,0.00020395567,0.00018392058,0.000028798611,0.00054373953,0.00012744243,0.0023747983],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.98742527,0.0028122189,0.0050639743,0.0018942828,0.0015501023,0.0012541672],"domain_scores_gemma":[0.9894531,0.0036798862,0.0023896308,0.0015068159,0.0011283653,0.0018422224],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.009336512,0.0012042648,0.005119988,0.0011019962,0.00041137432,0.00028807187,0.0005344919,0.0011041712,0.00034351915],"category_scores_gemma":[0.0021838353,0.000963808,0.0008480129,0.00268932,0.0041630827,0.00029336743,0.00040954686,0.0015220008,0.000003841447],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030498484,0.008257327,0.4102369,0.0026938596,0.011027036,0.00006389936,0.0033823065,0.00008841859,0.48485848,0.000031759173,0.0011305858,0.047730945],"study_design_scores_gemma":[0.05950972,0.009370269,0.6304628,0.0015268609,0.008596866,0.0000104382525,0.0017050919,0.0012206468,0.27055848,0.000049219514,0.015635626,0.0013539951],"about_ca_topic_score_codex":0.0010191945,"about_ca_topic_score_gemma":0.00013834979,"teacher_disagreement_score":0.2202259,"about_ca_system_score_codex":0.00020502145,"about_ca_system_score_gemma":0.0020993468,"threshold_uncertainty_score":0.9992812},"labels":[],"label_agreement":null},{"id":"W4415898942","doi":"10.1136/jitc-2025-sitc2025.0283","title":"283 Functional profiling of CAR T cells using high-dimensional CyTOF: integrating cytokine, transcription factor and immune checkpoint marker signatures","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Transcription factor; Profiling (computer programming); Immune system; Immune checkpoint; Transcription (linguistics); Gene expression profiling","score_opus":0.023002610327908395,"score_gpt":0.26604151805324533,"score_spread":0.24303890772533693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849887,0.010400533,0.00035537317,0.00065765216,0.0016847099,0.0013313207,0.00020905418,0.00005762559,0.00031505947],"genre_scores_gemma":[0.9928414,0.00048894563,0.004104604,0.00018537372,0.00041578308,0.000021798858,0.00013706279,0.00009261254,0.0017123964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99482137,0.00035287085,0.0016763043,0.0010876536,0.0012027138,0.0008590622],"domain_scores_gemma":[0.99717915,0.0003118093,0.00051674485,0.0005546439,0.0006402379,0.00079741766],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014743786,0.0007816111,0.0012454208,0.0006499299,0.00045976473,0.00017983324,0.00018095422,0.00075936056,0.00042154276],"category_scores_gemma":[0.0006355616,0.00072808104,0.0003699505,0.0006142326,0.0013007489,0.00038995675,0.00015770677,0.0015378918,0.0000032442742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00113785,0.00019955816,0.0037854423,0.0019383437,0.0007870046,0.00006646165,0.00057728513,0.0008220927,0.9879309,0.0006118576,0.00010265324,0.002040554],"study_design_scores_gemma":[0.0030119454,0.00030365336,0.09544119,0.0026502542,0.0005416315,0.000105546584,0.00063348975,0.010151053,0.885762,0.0005467396,0.00034364636,0.0005088883],"about_ca_topic_score_codex":0.0009672146,"about_ca_topic_score_gemma":0.000029833762,"teacher_disagreement_score":0.10216894,"about_ca_system_score_codex":0.00037779514,"about_ca_system_score_gemma":0.001748066,"threshold_uncertainty_score":0.999517},"labels":[],"label_agreement":null},{"id":"W4415898972","doi":"10.1136/jitc-2025-sitc2025.0406","title":"406 Imaging mass cytometry detects true dynamic range of low-abundance T cell exhaustion biomarkers in human cancers","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; T cell; Flow cytometry; Dynamic range; Range (aeronautics); Cell","score_opus":0.005140404900735351,"score_gpt":0.23085852397252465,"score_spread":0.2257181190717893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810937,0.014613679,0.0011961024,0.00024947547,0.0010754634,0.0005620333,0.00008748699,0.000024057328,0.0010980226],"genre_scores_gemma":[0.9968502,0.0016149591,0.0006366404,0.00022850317,0.00009197862,0.000024633911,0.00009624106,0.00006670209,0.00039014444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99663746,0.00016863647,0.001079508,0.0010431319,0.00032042217,0.0007508342],"domain_scores_gemma":[0.998314,0.000035141114,0.0004373939,0.000633086,0.00015697323,0.00042335887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006290239,0.00061242725,0.0006836571,0.00048336256,0.00023790859,0.00011725949,0.00038946245,0.00057728746,0.000007044163],"category_scores_gemma":[0.00017227858,0.0007154737,0.00025406768,0.0005503131,0.0009565442,0.000041629864,0.00009694377,0.00043364227,0.0000014469618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002243561,0.0001299018,0.07258474,0.0017568048,0.00017474443,0.000041759602,0.00018130711,0.000563722,0.92231464,0.000020645488,0.00014187752,0.001865512],"study_design_scores_gemma":[0.0035512163,0.0001843196,0.06608499,0.001481328,0.0002175229,0.000017734157,0.00038156184,0.003269401,0.9228796,0.00036801424,0.000746846,0.0008174644],"about_ca_topic_score_codex":0.0010287273,"about_ca_topic_score_gemma":0.0006604433,"teacher_disagreement_score":0.015756518,"about_ca_system_score_codex":0.00032502649,"about_ca_system_score_gemma":0.0009335339,"threshold_uncertainty_score":0.99952966},"labels":[],"label_agreement":null},{"id":"W4415898975","doi":"10.1136/jitc-2025-sitc2025.0407","title":"407 Relationships between lymphocyte counts and clinical outcomes in patients with recurrent glioblastoma treated with pembrolizumab","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Pembrolizumab; Lymphocyte; Glioblastoma; Immunotherapy; Immune system","score_opus":0.018150357305015703,"score_gpt":0.2713920643638617,"score_spread":0.253241707058846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956251,0.0014984459,0.0000016074888,0.0007528117,0.00023526952,0.0010357848,0.0000892788,0.000045743745,0.0007159636],"genre_scores_gemma":[0.99864656,0.00047075847,0.00015420107,0.00010439861,0.00006287179,0.00003620339,0.00009854799,0.000044676977,0.0003817741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708927,0.00021888231,0.00092743465,0.00077696325,0.00049430766,0.0004931405],"domain_scores_gemma":[0.997877,0.00035446548,0.00031605925,0.0004577107,0.00018177005,0.0008129771],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043340583,0.0005363323,0.0010064677,0.00036256696,0.00022480395,0.000115765324,0.00009351363,0.00039048394,0.000013273428],"category_scores_gemma":[0.00041584787,0.0003508064,0.000097285054,0.00047200316,0.0006316803,0.00018104103,0.000061032235,0.0005200428,0.00002728074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010257843,0.0007286484,0.99145555,0.00016162216,0.00084297947,0.00014975006,0.000101445614,0.0000051081947,0.0000010373536,0.00014442278,0.00041742387,0.004966241],"study_design_scores_gemma":[0.016322792,0.001965179,0.97631675,0.0019287015,0.0014490329,0.000016132875,0.000073682735,0.000043092263,0.00013035927,0.00009451311,0.0013027586,0.0003569882],"about_ca_topic_score_codex":0.00015440097,"about_ca_topic_score_gemma":0.00021222331,"teacher_disagreement_score":0.015297007,"about_ca_system_score_codex":0.00030940524,"about_ca_system_score_gemma":0.00065334945,"threshold_uncertainty_score":0.9998944},"labels":[],"label_agreement":null},{"id":"W4415899041","doi":"10.1136/jitc-2025-sitc2025.0853","title":"853 Design of a next generation tumor targeted masked IL-12Fc for enhanced tolerability and localized anti-tumor activity","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Tolerability; Tumor cells; Clinical trial; Context (archaeology); Solid tumor","score_opus":0.054974113793201766,"score_gpt":0.30744779321598054,"score_spread":0.25247367942277876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97976625,0.005153195,0.008092454,0.0027731475,0.0006788615,0.0030842852,0.00026239158,0.000051188996,0.00013821058],"genre_scores_gemma":[0.99134827,0.0009761986,0.005245337,0.00060622697,0.00036620913,0.00015860546,0.00009019693,0.000053147167,0.0011558221],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952306,0.0005316079,0.0013280277,0.0012203241,0.0007276137,0.0009617961],"domain_scores_gemma":[0.99646485,0.00062987267,0.00054013607,0.0006234983,0.00063719397,0.0011044554],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019004896,0.0007114135,0.0016739697,0.00032063358,0.00053149805,0.0001962126,0.00023370606,0.0003533062,0.000052683296],"category_scores_gemma":[0.0024521279,0.0006437671,0.00029185286,0.00050942984,0.0016927626,0.00042512274,0.00018483287,0.00059813686,0.0000051005586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026003937,0.0005209588,0.0045459066,0.0040426543,0.00050726166,0.000055179506,0.00044137592,0.00024047644,0.98013216,0.00060787634,0.0015917168,0.0047140527],"study_design_scores_gemma":[0.0042850296,0.0010574495,0.064657755,0.0010295488,0.0005273832,0.00006702732,0.00019473136,0.046004675,0.87679344,0.0015112449,0.0032763195,0.0005953761],"about_ca_topic_score_codex":0.0006112713,"about_ca_topic_score_gemma":0.000039892802,"teacher_disagreement_score":0.10333869,"about_ca_system_score_codex":0.00015161851,"about_ca_system_score_gemma":0.001934912,"threshold_uncertainty_score":0.99960136},"labels":[],"label_agreement":null},{"id":"W4415899043","doi":"10.1136/jitc-2025-sitc2025.0982","title":"982 Targeting glycans for cancer immunotherapy","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"","score_opus":0.012602089408156391,"score_gpt":0.29857917280003904,"score_spread":0.28597708339188266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9211275,0.060324334,0.0019190916,0.009959817,0.0018227895,0.0022103798,0.00028453048,0.000080920945,0.0022706403],"genre_scores_gemma":[0.97598994,0.008648385,0.0019113035,0.0015673366,0.0006016913,0.0003294926,0.00021341961,0.00010937808,0.010629084],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969375,0.00013430482,0.00075304287,0.0009686298,0.0003344541,0.0008720613],"domain_scores_gemma":[0.99813294,0.000056712834,0.0002462284,0.00057104987,0.00043112913,0.00056192814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080580666,0.0005087898,0.00048023247,0.00018385063,0.00050511793,0.00029140865,0.00036864216,0.0006347348,0.000039670245],"category_scores_gemma":[0.0008959701,0.000523864,0.0002811671,0.00030081143,0.0005742369,0.000024901809,0.00015930638,0.00035347085,0.000005248746],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006248387,0.00016398497,0.0064692707,0.0009094752,0.0007584387,0.000010932974,0.00029674228,0.00036554143,0.91865116,0.0015685045,0.039309703,0.03087143],"study_design_scores_gemma":[0.001794998,0.00018829657,0.0033066953,0.00023766051,0.000067617744,0.000008356459,0.000197041,0.0006231918,0.34839424,0.0007537066,0.6439723,0.0004558942],"about_ca_topic_score_codex":0.00044139335,"about_ca_topic_score_gemma":0.00018218056,"teacher_disagreement_score":0.6046626,"about_ca_system_score_codex":0.000099324585,"about_ca_system_score_gemma":0.00168344,"threshold_uncertainty_score":0.9997213},"labels":[],"label_agreement":null},{"id":"W4415899076","doi":"10.1136/jitc-2025-sitc2025.0854","title":"854 Amplification &amp; redirection of endogenous IL-15 activity with a bispecific antibody","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Acuitas Therapeutics (Canada)","funders":"","keywords":"Bispecific antibody; Endogeny; Antibody; Antibody response; Cell culture","score_opus":0.02288873498355517,"score_gpt":0.25139613198913935,"score_spread":0.22850739700558417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769964,0.005362649,0.0015282208,0.00086804584,0.0070623606,0.0008005134,0.000045865112,0.00013467977,0.007201259],"genre_scores_gemma":[0.98134184,0.0020889544,0.00016211299,0.00012624187,0.000097816155,0.00003140831,0.00027905396,0.000042915945,0.01582968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969733,0.00044634208,0.0009522082,0.0008906365,0.00016037078,0.0005771713],"domain_scores_gemma":[0.9975422,0.00016299084,0.00087818113,0.0008068258,0.00044759686,0.0001621929],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006704178,0.00056006166,0.0008062711,0.00054957345,0.00063574384,0.00011365317,0.00021533611,0.0007712046,0.00023260203],"category_scores_gemma":[0.00039306964,0.0005325286,0.00020473023,0.0006457023,0.0011704738,0.0004916386,0.00008286319,0.00086373254,0.00012175983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013598087,0.0005029228,0.005636191,0.00042059625,0.0007409364,0.000006574923,0.0006675663,0.000044599725,0.9798957,0.0008554839,0.006023611,0.0038459685],"study_design_scores_gemma":[0.0016682171,0.0004788488,0.08497671,0.00071512134,0.00048917695,0.00047954085,0.0005517089,0.000026039172,0.7315617,0.00016918429,0.17839803,0.00048570326],"about_ca_topic_score_codex":0.00097267417,"about_ca_topic_score_gemma":0.00011783275,"teacher_disagreement_score":0.24833402,"about_ca_system_score_codex":0.00019848788,"about_ca_system_score_gemma":0.0006549137,"threshold_uncertainty_score":0.99971265},"labels":[],"label_agreement":null},{"id":"W4415899080","doi":"10.1136/jitc-2025-sitc2025.0016","title":"16 Automated tertiary lymphoid structure detection and prognostic value in colorectal liver metastases","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Polytechnique Montréal","funders":"","keywords":"Value (mathematics); Colorectal cancer; Lymphatic system; Metastasis","score_opus":0.014902788863567617,"score_gpt":0.22608262810304677,"score_spread":0.21117983923947917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666479,0.029468652,0.000015870766,0.0006140002,0.0007221968,0.0019276445,0.0001247983,0.0002696369,0.0002092768],"genre_scores_gemma":[0.99733186,0.0012994761,0.00037810492,0.00035037962,0.0001510873,0.00008713636,0.00016002884,0.00006506783,0.00017687032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962218,0.00046814603,0.0009632039,0.0010777402,0.00044751057,0.00082164345],"domain_scores_gemma":[0.99807495,0.0002738006,0.00026548383,0.000355771,0.00013475577,0.0008952618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057524926,0.00079588697,0.0009652291,0.0006484976,0.00035012953,0.00025545564,0.00013320072,0.00068613933,0.00003978602],"category_scores_gemma":[0.00090663374,0.0007347797,0.00017896129,0.00075540453,0.00074309844,0.0003913613,0.0001491439,0.000539404,0.000010702646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032050646,0.00029007834,0.91701674,0.001875717,0.0007448786,0.0012455077,0.00072086154,0.0000214325,0.06850158,0.00014129998,0.0003727976,0.008748574],"study_design_scores_gemma":[0.0036799782,0.00047998846,0.7257705,0.0016772973,0.0025053595,0.0008356101,0.00025036852,0.030241081,0.23290253,0.00052828295,0.0005442177,0.0005848436],"about_ca_topic_score_codex":0.0016605362,"about_ca_topic_score_gemma":0.00041660183,"teacher_disagreement_score":0.19124632,"about_ca_system_score_codex":0.00044567083,"about_ca_system_score_gemma":0.0009062374,"threshold_uncertainty_score":0.99951035},"labels":[],"label_agreement":null},{"id":"W4415899119","doi":"10.1136/jitc-2025-sitc2025.0248","title":"248 Exploitation of endogenous TCR signaling using an oncolytic virus for modulation of CAR T phenotype and function against solid tumors","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Oncolytic virus; Function (biology); Phenotype; Endogeny; Virus; T-cell receptor; Signal transduction","score_opus":0.0456889959017081,"score_gpt":0.3014719377498376,"score_spread":0.2557829418481295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931057,0.0037391847,0.0018132081,0.00004456471,0.00023303874,0.0009086881,0.00007549648,0.000010756787,0.00006936301],"genre_scores_gemma":[0.9978148,0.0004058473,0.0012060534,0.000101453494,0.00016181488,0.000027287935,0.000194247,0.000053607233,0.00003489875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754554,0.00020809977,0.0008850728,0.000646554,0.0003064466,0.00040830605],"domain_scores_gemma":[0.9982247,0.000056879144,0.00054267375,0.00041858712,0.00043866906,0.00031851997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092157087,0.00034607426,0.0005310986,0.00021517939,0.0002577105,0.00005893696,0.00014343642,0.000366086,0.0000026427704],"category_scores_gemma":[0.00038119208,0.0003961563,0.00013295557,0.0002483451,0.00048019396,0.000051421623,0.00008085093,0.0001554655,2.456534e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017021096,0.00016041387,0.0009687059,0.0007684969,0.00026986655,0.000002428581,0.00049395015,0.027677871,0.9612003,0.000053835913,0.000011138683,0.0066908887],"study_design_scores_gemma":[0.0014779677,0.002655933,0.0015713902,0.0003139937,0.00026119195,0.000008304815,0.0004941067,0.021502959,0.9701131,0.0011702152,0.00010859727,0.00032221613],"about_ca_topic_score_codex":0.000166952,"about_ca_topic_score_gemma":0.00011955852,"teacher_disagreement_score":0.008912831,"about_ca_system_score_codex":0.000087350534,"about_ca_system_score_gemma":0.0009534749,"threshold_uncertainty_score":0.999849},"labels":[],"label_agreement":null},{"id":"W4415899151","doi":"10.1136/jitc-2025-sitc2025.0744","title":"744 Mapping immune cell responses in whole blood and solid tumor tissue biopsies of renal cancer with CyTOF and imaging mass cytometry","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Immune system; Cancer; Whole blood; Whole body imaging; Solid tumor; Kidney cancer; Cell","score_opus":0.007189278954605434,"score_gpt":0.23233414959018844,"score_spread":0.225144870635583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9457403,0.052328832,0.00022529985,0.00081023306,0.00019193941,0.00035097398,0.00013243666,0.0000128126585,0.0002071839],"genre_scores_gemma":[0.99427176,0.003372977,0.0012029351,0.00020795899,0.000088726265,0.000019961271,0.000031767868,0.000046898043,0.00075704406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974904,0.0001404221,0.000783218,0.0008203338,0.00021963665,0.000545972],"domain_scores_gemma":[0.9987684,0.000056725086,0.00032403917,0.0003790879,0.00013873621,0.00033300524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049966195,0.00050561095,0.0006961459,0.00036467807,0.00020265377,0.00016254661,0.00018198289,0.00026839797,0.0000030013368],"category_scores_gemma":[0.00015053528,0.00049321953,0.00006886517,0.00037373125,0.0012139552,0.000039768747,0.00014252042,0.0003415967,2.848959e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040484726,0.00010961405,0.11085708,0.0011038716,0.0001726469,0.00010000938,0.00039548118,0.00008086188,0.885901,0.000013672072,0.000044855504,0.00081607327],"study_design_scores_gemma":[0.0026455391,0.00024860664,0.074847974,0.0014961268,0.00025603775,0.00011917306,0.00069614855,0.00024164635,0.9163124,0.00009869524,0.0025214653,0.000516166],"about_ca_topic_score_codex":0.00063936337,"about_ca_topic_score_gemma":0.00014153021,"teacher_disagreement_score":0.048955854,"about_ca_system_score_codex":0.000029580007,"about_ca_system_score_gemma":0.0006425713,"threshold_uncertainty_score":0.9997519},"labels":[],"label_agreement":null},{"id":"W4415899250","doi":"10.1136/jitc-2025-sitc2025.1219","title":"1219 High-plex spatial profiling of tumor metabolic reprogramming and cell signaling dynamics in breast cancer using imaging mass cytometry","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Breast cancer; Reprogramming; Mass cytometry; Flow cytometry; Cell; Dynamics (music); Human breast","score_opus":0.0077330287408000934,"score_gpt":0.23356212491651593,"score_spread":0.22582909617571584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97535324,0.018212171,0.004424608,0.00030830922,0.00080845295,0.0005512213,0.00023813458,0.000021608976,0.0000822401],"genre_scores_gemma":[0.987319,0.0011945305,0.010781039,0.00019895061,0.00026974332,0.000018558534,0.000092619906,0.000081812,0.000043736563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962735,0.00018086072,0.0012241965,0.0011835218,0.0003291191,0.0008087563],"domain_scores_gemma":[0.9982428,0.000043049604,0.00054934976,0.0004902277,0.0002389674,0.00043561007],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008058576,0.0006481507,0.0009061402,0.0004250746,0.0002539301,0.00021774831,0.0002717515,0.00039942027,0.0000043239716],"category_scores_gemma":[0.0001404344,0.00072287687,0.00018802044,0.00056231976,0.00072087656,0.00005159592,0.00018611901,0.0005217969,2.3961118e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014324498,0.000109330605,0.31167838,0.0009899184,0.00012756424,0.000036194095,0.00008814511,0.0010114387,0.6822704,0.00015368332,0.000003526748,0.0033881527],"study_design_scores_gemma":[0.0021796497,0.00005836021,0.032720007,0.0011736754,0.0005302048,0.00009319336,0.00080142607,0.042743698,0.9183426,0.00037955385,0.0001468451,0.0008307752],"about_ca_topic_score_codex":0.0058579617,"about_ca_topic_score_gemma":0.0003244993,"teacher_disagreement_score":0.27895838,"about_ca_system_score_codex":0.000163806,"about_ca_system_score_gemma":0.00097041856,"threshold_uncertainty_score":0.9995222},"labels":[],"label_agreement":null},{"id":"W4415899263","doi":"10.1136/jitc-2025-sitc2025.0189","title":"189 Baseline NKT cells as a potential predictive biomarker for treatment with an anchored IL-12 drug conjugate in patients with solid tumors","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biomarker; Conjugate; Baseline (sea); Drug; Clinical trial","score_opus":0.005950676006228926,"score_gpt":0.21808261094360482,"score_spread":0.2121319349373759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923396,0.00082538795,0.0003408992,0.0004867055,0.002793957,0.002429042,0.00026949213,0.00008187801,0.0004330173],"genre_scores_gemma":[0.9875027,0.0002080662,0.00020206945,0.00048269256,0.00007415129,0.00019121594,0.0011027175,0.00007237414,0.01016399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99630755,0.00047472454,0.0010184734,0.0011784835,0.00015157228,0.00086917134],"domain_scores_gemma":[0.9980605,0.000111983296,0.0005492483,0.0005665447,0.00040188522,0.00030981592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048318133,0.0008213189,0.00097233837,0.000479058,0.00053547625,0.00015870231,0.00019176386,0.0004972997,0.00012632138],"category_scores_gemma":[0.000087378445,0.0006529349,0.00017139399,0.000284677,0.0009370194,0.00062467897,0.000057756057,0.00039358242,0.000032700143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21038587,0.016036713,0.15315703,0.0017170906,0.013605924,0.0004125233,0.012962599,0.0036476096,0.5372782,0.00058973883,0.033485815,0.016720902],"study_design_scores_gemma":[0.04867151,0.021099808,0.31791615,0.0024448442,0.0022424362,0.0001599049,0.004192407,0.0028210902,0.55925995,0.00024636212,0.038917765,0.0020278012],"about_ca_topic_score_codex":0.0009249792,"about_ca_topic_score_gemma":0.00031059477,"teacher_disagreement_score":0.16475913,"about_ca_system_score_codex":0.0003468773,"about_ca_system_score_gemma":0.00095020066,"threshold_uncertainty_score":0.9995922},"labels":[],"label_agreement":null},{"id":"W4415899279","doi":"10.1136/jitc-2025-sitc2025.1036","title":"1036 KAN-004, a metabolically complete live biotherapeutic product for the treatment of immune-related colitis","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Product (mathematics); Colitis; Ulcerative colitis; Inflammatory bowel disease; Inflammation","score_opus":0.012490885317736301,"score_gpt":0.24919964792937513,"score_spread":0.23670876261163884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415899279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9294002,0.062216394,0.000076893186,0.0029509086,0.0011129536,0.0032038994,0.0006696767,0.000031092117,0.00033800758],"genre_scores_gemma":[0.9907452,0.0050777365,0.00036680835,0.00043389678,0.00026099783,0.0002868107,0.00020821411,0.000071543196,0.0025488045],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99651873,0.00025341864,0.0012856273,0.0009590898,0.00026848892,0.00071463396],"domain_scores_gemma":[0.99723077,0.00011602377,0.0005817111,0.0012092219,0.0004093461,0.00045295098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054740347,0.0006750918,0.00075934356,0.00011968981,0.00047647604,0.00013159963,0.00041772606,0.00041932418,0.000021928105],"category_scores_gemma":[0.00038302108,0.000538043,0.0006795985,0.00022045695,0.0015551196,0.000017438098,0.00009647609,0.00016279341,0.000008806318],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051580914,0.0027932124,0.016836612,0.00333534,0.016964843,0.00017149458,0.0034842524,0.0010741513,0.90088135,0.012343602,0.0039037634,0.03305327],"study_design_scores_gemma":[0.0061604003,0.0010957937,0.45788756,0.00041988236,0.0034454814,0.00006292839,0.00035302853,0.00091522385,0.23116288,0.0017546098,0.29575127,0.0009909143],"about_ca_topic_score_codex":0.00018690177,"about_ca_topic_score_gemma":0.000115083065,"teacher_disagreement_score":0.6697185,"about_ca_system_score_codex":0.00009427287,"about_ca_system_score_gemma":0.0014719687,"threshold_uncertainty_score":0.9997071},"labels":[],"label_agreement":null},{"id":"W4415900069","doi":"10.1136/jitc-2025-sitc2025.0064","title":"64 A novel application of selective exo-enzymatic glycan labeling to co-quantify cell-surface glycans and protein-based biomarkers of the tumour immune microenvironment","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Glycan; Immune system; Tumor microenvironment; Cell","score_opus":0.007676710676286933,"score_gpt":0.2483286297433944,"score_spread":0.24065191906710745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98978555,0.002719565,0.0025805135,0.0018670133,0.00007458136,0.00256042,0.00014970485,0.000007981565,0.00025466603],"genre_scores_gemma":[0.99558777,0.00010756189,0.0035564303,0.00015507729,0.000020845271,0.0000801851,0.000045683617,0.00003654488,0.00040990778],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972822,0.00019098984,0.00088582013,0.0007299642,0.00045499986,0.00045600766],"domain_scores_gemma":[0.9981505,0.00004490488,0.0005238422,0.0006946932,0.00022557136,0.00036043892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075616664,0.00040116103,0.00048609753,0.00014245049,0.00027605565,0.000065003056,0.00036016485,0.00033184804,0.0000036922665],"category_scores_gemma":[0.0003660584,0.00036218387,0.00015716619,0.000500601,0.0008224197,0.0000139653785,0.00022265298,0.00028495057,0.0000020420523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030217122,0.00025306715,0.0053564315,0.001200274,0.00019214986,0.0000010912623,0.00020104561,0.0014073468,0.9904704,0.000092544455,0.00011631314,0.0004071736],"study_design_scores_gemma":[0.001588061,0.0002887416,0.034661718,0.00056905294,0.00011151779,0.0000072630705,0.00029331498,0.00226534,0.95764375,0.000056890774,0.0022126713,0.000301666],"about_ca_topic_score_codex":0.00062248314,"about_ca_topic_score_gemma":0.00007219383,"teacher_disagreement_score":0.03282663,"about_ca_system_score_codex":0.00009263156,"about_ca_system_score_gemma":0.0009051015,"threshold_uncertainty_score":0.999883},"labels":[],"label_agreement":null},{"id":"W4415900112","doi":"10.1136/jitc-2025-sitc2025.0167","title":"167 Assessment of pathologic complete response following neoadjuvant therapy in patients with resectable lung cancer is equivalent across scoring systems","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Complete response; Neoadjuvant therapy; Lung cancer; Lung; Cancer; Scoring system","score_opus":0.02213456210844184,"score_gpt":0.3351564247441748,"score_spread":0.31302186263573295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96159184,0.031919703,0.000016222291,0.0012955717,0.0017830599,0.0028434088,0.00032564337,0.000041364066,0.00018321577],"genre_scores_gemma":[0.9947755,0.0035485262,0.00021261859,0.0004407147,0.00009252159,0.00042649763,0.000045042572,0.0000729118,0.0003856737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99447554,0.00049773336,0.0014658995,0.0012338542,0.0011462646,0.0011807256],"domain_scores_gemma":[0.9970725,0.00031366813,0.0006904519,0.00095500704,0.00034379604,0.00062454806],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001967701,0.00077264453,0.0016573727,0.00033619328,0.00037624134,0.00022491331,0.00023897726,0.00034138167,0.000022494298],"category_scores_gemma":[0.00019143276,0.00060579216,0.00026772064,0.00075730216,0.00040946327,0.00033019937,0.0001996891,0.0005814684,0.0000012935146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021210385,0.0009834642,0.9854094,0.0020181185,0.0014417162,0.00049287215,0.0022048135,0.0015608143,0.0023947668,0.00009407004,0.0005238838,0.0007550779],"study_design_scores_gemma":[0.014661267,0.0017916675,0.95692444,0.018582132,0.0006213643,0.000010546769,0.0008019568,0.0011479987,0.004281137,0.00003266469,0.0006161953,0.0005286553],"about_ca_topic_score_codex":0.003217112,"about_ca_topic_score_gemma":0.00016285978,"teacher_disagreement_score":0.033183683,"about_ca_system_score_codex":0.0018485697,"about_ca_system_score_gemma":0.0019959414,"threshold_uncertainty_score":0.99963933},"labels":[],"label_agreement":null},{"id":"W4415900166","doi":"10.1136/jitc-2025-sitc2025.1037","title":"1037 Non-infectious sarcoid-like inflammatory granulomatous conditions (NSIGC) associated with Immune checkpoint inhibitors (ICIs) for cancer: updated results from the international ICARUS consortium","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"ICARUS; Immune system; Inflammation; Immunotherapy; Inflammatory response","score_opus":0.01564778829486315,"score_gpt":0.27336484578651404,"score_spread":0.2577170574916509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96588475,0.0036821214,0.000027239186,0.018694755,0.003151618,0.003396583,0.0037224467,0.00020275648,0.0012377392],"genre_scores_gemma":[0.9891494,0.0016700729,0.000059908634,0.0018466087,0.0008576202,0.00067086227,0.002741879,0.0001246256,0.002879015],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99297875,0.00033332882,0.0025236863,0.0014714034,0.0014218435,0.0012709688],"domain_scores_gemma":[0.99371076,0.0014804015,0.0012655164,0.001122922,0.0013995878,0.0010208173],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0023723394,0.00095847563,0.0013625392,0.00046633222,0.0013406955,0.00065027334,0.00070676964,0.00082006736,0.00011265149],"category_scores_gemma":[0.0039076987,0.0007443471,0.0005777244,0.00097163685,0.0024232958,0.0004298882,0.00033054865,0.0014658066,0.000024591807],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007983274,0.0030040909,0.28630015,0.00104689,0.020237206,0.00078009185,0.004747292,0.0012928289,0.45924196,0.00090466934,0.20836504,0.006096498],"study_design_scores_gemma":[0.02110704,0.00060779025,0.7170377,0.005580469,0.0028245826,0.0001119539,0.0014824006,0.0032875268,0.2103931,0.0010993901,0.035124626,0.0013434158],"about_ca_topic_score_codex":0.0060939207,"about_ca_topic_score_gemma":0.0034258002,"teacher_disagreement_score":0.43073753,"about_ca_system_score_codex":0.0008494311,"about_ca_system_score_gemma":0.0034952783,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W4415900229","doi":"10.1136/jitc-2025-sitc2025.1235","title":"1235 Abemaciclib differentially reshapes the immunopeptidome of breast cancer subtypes","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Breast cancer; Cancer; Human breast; Clinical trial","score_opus":0.009399993672740354,"score_gpt":0.2676627313144038,"score_spread":0.25826273764166346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8751539,0.106463365,0.000141937,0.012709528,0.0021622907,0.0015539995,0.00046108972,0.000113881135,0.0012400178],"genre_scores_gemma":[0.9862212,0.006515345,0.00020880732,0.0012823861,0.0007413664,0.00014718107,0.00002554336,0.000095868214,0.004762326],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99572235,0.00024028686,0.0013931274,0.0009059727,0.000803404,0.00093483616],"domain_scores_gemma":[0.9967228,0.00025471626,0.0007572979,0.0011306475,0.00051644584,0.0006180622],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00067972054,0.0008064484,0.0012996182,0.0002900256,0.0005001961,0.00016152515,0.00060401316,0.0004221396,0.00024848417],"category_scores_gemma":[0.00022375281,0.0005909158,0.00035401725,0.0007256997,0.002934543,0.0003757402,0.00029340445,0.0008676081,0.000017071743],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057429937,0.0011098281,0.16174278,0.0100425985,0.008796205,0.00018397604,0.005215791,0.00060124765,0.6160951,0.013414974,0.0032229843,0.17383151],"study_design_scores_gemma":[0.004458613,0.00020922557,0.8711308,0.006347006,0.0020133755,0.00031250538,0.0013074562,0.00013723118,0.07412088,0.0055682776,0.033575706,0.00081892096],"about_ca_topic_score_codex":0.0010501994,"about_ca_topic_score_gemma":0.00017749766,"teacher_disagreement_score":0.709388,"about_ca_system_score_codex":0.00024409313,"about_ca_system_score_gemma":0.0018425204,"threshold_uncertainty_score":0.9997789},"labels":[],"label_agreement":null},{"id":"W4415900237","doi":"10.1136/jitc-2025-sitc2025.0614","title":"614 Treatment with diacylglycerol kinase (DGK) alpha specific inhibitor BAY2862789 exhibits combination potential with DGK zeta inhibition in biomarker assays during FIH monotherapy trial","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Diacylglycerol kinase; Biomarker; Alpha (finance); Kinase; In vivo","score_opus":0.008923470580566912,"score_gpt":0.22727474598230546,"score_spread":0.21835127540173854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881834,0.0075871916,0.0002514947,0.0006388048,0.00067681965,0.002268817,0.00011722408,0.000066591696,0.00020968975],"genre_scores_gemma":[0.9962636,0.0012045077,0.00037738532,0.00013574201,0.0005197387,0.00025816282,0.000625455,0.00012978129,0.00048561033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952062,0.00040403998,0.0011630235,0.0016734868,0.0006510208,0.0009022721],"domain_scores_gemma":[0.99753994,0.000052608233,0.0005784646,0.0008608655,0.00024944564,0.00071869],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045848076,0.001049794,0.0008370873,0.00048149898,0.00047452783,0.00044757366,0.0002015835,0.0007109735,0.000022877339],"category_scores_gemma":[0.00010097198,0.000939253,0.00025259203,0.00054159254,0.0007777858,0.000101838945,0.00011466862,0.0003411745,0.0000075163302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055793133,0.003490274,0.011599138,0.0006187972,0.0012026263,0.000957536,0.0005312092,0.0015772743,0.91807806,0.000100883866,0.0008097393,0.0052413144],"study_design_scores_gemma":[0.08314112,0.00319896,0.048389513,0.0015132666,0.00042689807,0.0001208524,0.00023065673,0.00028962753,0.8573689,0.00015759564,0.0038839835,0.0012786349],"about_ca_topic_score_codex":0.0001789647,"about_ca_topic_score_gemma":0.00020581565,"teacher_disagreement_score":0.060709182,"about_ca_system_score_codex":0.00038402938,"about_ca_system_score_gemma":0.0012250378,"threshold_uncertainty_score":0.9993058},"labels":[],"label_agreement":null},{"id":"W4415900261","doi":"10.1136/jitc-2025-sitc2025.0658","title":"658 KAN-001, a defined live biotherapeutic product (LBP) for NSCLC, enhances ICI response in preclinical models and demonstrates manufacturing consistency and strain-resolved viability","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"University of Texas MD Anderson Cancer Center","keywords":"Consistency (knowledge bases); Product (mathematics); New product development; Selection (genetic algorithm); Manufacturing process","score_opus":0.025380657972440542,"score_gpt":0.2998519849065107,"score_spread":0.27447132693407017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96769106,0.028108023,0.00019368617,0.001476956,0.00041367934,0.0016631145,0.0002689966,0.00003213955,0.00015234006],"genre_scores_gemma":[0.99472946,0.0030444167,0.0009493049,0.00058096816,0.00014369811,0.00017143978,0.00006996662,0.000044987002,0.00026574175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958309,0.0005008694,0.0011102374,0.0016350782,0.00020370333,0.0007192474],"domain_scores_gemma":[0.9978106,0.00043066932,0.00033888908,0.0006184876,0.00016501106,0.00063631637],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013272058,0.0006674197,0.0007583295,0.00017478608,0.0004664433,0.00029659882,0.00019761932,0.0006276556,0.000007175938],"category_scores_gemma":[0.0013293525,0.0006427793,0.00019599944,0.00013089359,0.0016328943,0.00006309112,0.00021797721,0.00036813942,8.4079505e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008576329,0.0010654471,0.018737864,0.0030261802,0.00086550676,0.000039538296,0.0007980356,0.0006567592,0.9503831,0.0006018454,0.00058451603,0.014664865],"study_design_scores_gemma":[0.008490039,0.002886014,0.1644265,0.002156241,0.00080276857,0.00015646649,0.00093476224,0.0038162556,0.7773416,0.032633357,0.0042833574,0.0020726526],"about_ca_topic_score_codex":0.00020947272,"about_ca_topic_score_gemma":0.0002638666,"teacher_disagreement_score":0.17304154,"about_ca_system_score_codex":0.000050836436,"about_ca_system_score_gemma":0.00095531915,"threshold_uncertainty_score":0.9996024},"labels":[],"label_agreement":null},{"id":"W4415900298","doi":"10.1136/jitc-2025-sitc2025.0097","title":"97 Statistical and systematic uncertainties affect biomarker reliability: a case study in multiplex immunofluorescence","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Reliability and Agreement in Measurement","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiplex; Biomarker; Immunofluorescence; Affect (linguistics)","score_opus":0.06942844363114892,"score_gpt":0.3442540651931056,"score_spread":0.27482562156195667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843964,0.0070784097,0.00034291326,0.0011919491,0.001311748,0.005415051,0.000054602704,0.000053289798,0.00015562924],"genre_scores_gemma":[0.9977437,0.0002944605,0.00089880486,0.00019706845,0.00003320166,0.00023160393,0.00000439511,0.000027490736,0.00056926394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9874678,0.003505121,0.0036111902,0.0022147158,0.0021935566,0.0010075689],"domain_scores_gemma":[0.9914002,0.0046511437,0.00067539385,0.001818284,0.0005577257,0.000897242],"candidate_categories":["metaresearch","metaepi_narrow","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.020333517,0.0008706836,0.001916002,0.00077891845,0.0007958395,0.0016059288,0.0007206884,0.00041940168,0.00004091349],"category_scores_gemma":[0.027733281,0.00070481247,0.00019588161,0.001467513,0.0023320506,0.00070298545,0.0006225563,0.00078635116,0.0000352731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006240028,0.0037592382,0.9116843,0.037582494,0.00082368695,0.008122471,0.018464219,0.0007429695,0.0031827865,0.0012830896,0.0017409552,0.011989803],"study_design_scores_gemma":[0.006469405,0.0012937787,0.82402754,0.02068035,0.0012351953,0.001231843,0.09796921,0.029127391,0.000804911,0.015032262,0.00030537863,0.0018227344],"about_ca_topic_score_codex":0.005592987,"about_ca_topic_score_gemma":0.0016685603,"teacher_disagreement_score":0.087656744,"about_ca_system_score_codex":0.00039093182,"about_ca_system_score_gemma":0.00096360093,"threshold_uncertainty_score":0.9995403},"labels":[],"label_agreement":null},{"id":"W4415900317","doi":"10.1136/jitc-2025-sitc2025.0597","title":"597 A phase 1 trial of the oncolytic virus SVV-001 in combination with nivolumab and ipilimumab in patients with high grade neuroendocrine neoplasms","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seneca Polytechnic","funders":"","keywords":"Nivolumab; Ipilimumab; Oncolytic virus; Immunotherapy; Virus; Melanoma","score_opus":0.008464327826013815,"score_gpt":0.2554905428203701,"score_spread":0.24702621499435629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588513,0.00073522143,0.0000022549348,0.0009272247,0.00023602808,0.002063388,0.00008872313,0.000007665726,0.000054331853],"genre_scores_gemma":[0.9988189,0.00044992415,0.000043194086,0.00019801372,0.000040429342,0.000071283546,0.000120711244,0.00004700122,0.00021056287],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996896,0.00041811157,0.00073886226,0.00079744204,0.0005637337,0.00058581645],"domain_scores_gemma":[0.99843353,0.00005890293,0.00033707608,0.00068051065,0.00019734743,0.00029266145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041035443,0.00045950513,0.00058731396,0.00028271216,0.00015121518,0.00009202866,0.00031877865,0.0001933307,0.000003763662],"category_scores_gemma":[0.00026876244,0.00035547698,0.00006176302,0.0007570206,0.0009928226,0.00003708632,0.00018516925,0.00050875155,5.545275e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5348328,0.01972879,0.19951683,0.0017023885,0.00096317154,0.0002692362,0.000779142,0.0016103527,0.22000943,0.00041600788,0.0010698563,0.019102005],"study_design_scores_gemma":[0.38295743,0.030480396,0.1449196,0.0008938377,0.00023127759,0.000033438217,0.00011629029,0.00042407334,0.4374861,0.00043179138,0.0012761015,0.00074964593],"about_ca_topic_score_codex":0.00064538774,"about_ca_topic_score_gemma":0.0031673454,"teacher_disagreement_score":0.21747668,"about_ca_system_score_codex":0.00011689552,"about_ca_system_score_gemma":0.0012372484,"threshold_uncertainty_score":0.99988973},"labels":[],"label_agreement":null},{"id":"W4415900318","doi":"10.1136/jitc-2025-sitc2025.0957","title":"957 Modulation of the tumor immune microenvironment by low dose antibody-based radiopharmaceutical therapy (RPT) and direct visualization of RPT analog microdistribution by imaging mass cytometry","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Immune system; Visualization; Tumor microenvironment; Flow cytometry; Immune modulation","score_opus":0.0081256481701865,"score_gpt":0.2888037388252827,"score_spread":0.2806780906550962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96175474,0.030728767,0.0028231489,0.0028000402,0.0001809393,0.0010227818,0.0005647248,0.000030274334,0.000094569],"genre_scores_gemma":[0.9956487,0.002823492,0.00015650225,0.00048460253,0.000060635266,0.000027530547,0.00063070655,0.000036516703,0.00013135566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99692875,0.00022805283,0.0011954096,0.00069492956,0.0004943154,0.00045851403],"domain_scores_gemma":[0.99805796,0.00016307605,0.0006251903,0.0005509859,0.00013188853,0.00047090132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007116766,0.00047870667,0.0007275071,0.00012405196,0.00030652297,0.00006714096,0.00022567553,0.00023180015,0.000025290254],"category_scores_gemma":[0.0002636169,0.00042091619,0.00020708585,0.0007130255,0.0017480738,0.00015701109,0.00006804913,0.00041495875,0.0000010316433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026182746,0.00051472575,0.041817833,0.0011717845,0.00020510663,0.000004384487,0.000052508243,0.00015941352,0.9537718,0.000072935116,0.000976009,0.0009916665],"study_design_scores_gemma":[0.0030829513,0.00005225276,0.11771281,0.00078484265,0.00046747227,0.000016567103,0.000051895317,0.015170576,0.8596288,0.00009028874,0.0026613367,0.00028022466],"about_ca_topic_score_codex":0.000049939084,"about_ca_topic_score_gemma":1.5541897e-7,"teacher_disagreement_score":0.094143026,"about_ca_system_score_codex":0.00020300025,"about_ca_system_score_gemma":0.00030979316,"threshold_uncertainty_score":0.9998243},"labels":[],"label_agreement":null},{"id":"W4415900319","doi":"10.1136/jitc-2025-sitc2025.0173","title":"173 Androgen receptor stratifies immune-cold triple negative breast cancer: meta-analysis of chemotherapy response to guide precision immunotherapy","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemotherapy; Immunotherapy; Complete response; Androgen receptor; Androgen suppression; Androgen","score_opus":0.0224521765230527,"score_gpt":0.30189445328839937,"score_spread":0.27944227676534666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8897115,0.08199908,0.00012984798,0.020916862,0.0012925391,0.0032083758,0.002272386,0.00009960443,0.00036980226],"genre_scores_gemma":[0.9528079,0.017832085,0.002198858,0.004562654,0.00020329193,0.00044049995,0.00009709243,0.00016428786,0.021693304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9921082,0.00096259994,0.0031690975,0.0015554392,0.0012140272,0.0009906017],"domain_scores_gemma":[0.9944227,0.0006746363,0.0013328908,0.0018291473,0.0008776944,0.00086297415],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041217487,0.0012092049,0.0042198347,0.0016843831,0.0004916879,0.0002962208,0.0006974333,0.0007290941,0.0015496738],"category_scores_gemma":[0.00062653876,0.001030735,0.0028309233,0.0042160098,0.0011977768,0.00043103244,0.00013201639,0.00058432645,0.000011107863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036356144,0.00050704484,0.002151074,0.00032825608,0.25825715,0.000024507648,0.0041914796,0.00034165772,0.6793912,0.00011572262,0.010614124,0.0077216434],"study_design_scores_gemma":[0.008507378,0.0010290495,0.15519033,0.0008328472,0.10591944,0.000035600813,0.0017027038,0.0002509331,0.6723296,0.00014571626,0.052849676,0.0012067129],"about_ca_topic_score_codex":0.0066109877,"about_ca_topic_score_gemma":0.00043921938,"teacher_disagreement_score":0.15303926,"about_ca_system_score_codex":0.0006895177,"about_ca_system_score_gemma":0.0030953381,"threshold_uncertainty_score":0.999388},"labels":[],"label_agreement":null},{"id":"W4415900334","doi":"10.1136/jitc-2025-sitc2025.1231","title":"1231 A scalable, proteome-wide protein profiling platform with absolute quantification of 1000 proteins","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Profiling (computer programming); Quantitative proteomics; Peptide mapping; Quantitative analysis (chemistry); Proteomics","score_opus":0.013973822773747941,"score_gpt":0.250930916148302,"score_spread":0.23695709337455403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.951658,0.0011315378,0.029060358,0.0024821386,0.00007494209,0.0076935794,0.00021148074,0.00035163638,0.0073362994],"genre_scores_gemma":[0.86235815,0.00020115041,0.12847711,0.000089716086,0.00009191382,0.0027064967,0.00013230613,0.00011471495,0.0058284383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99542326,0.000049893868,0.0016723155,0.001343353,0.00064408744,0.00086710317],"domain_scores_gemma":[0.9958672,0.00008080994,0.0013558626,0.0015013276,0.00058809284,0.0006067228],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007603542,0.00081382337,0.00092178583,0.00028352777,0.0006117944,0.00024686425,0.00060525944,0.0007364132,0.00002613427],"category_scores_gemma":[0.00042824846,0.0007817603,0.00018866426,0.0009035513,0.0012538019,0.0005989523,0.00022193184,0.0010095352,0.000010480654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003416206,0.00040862907,0.0031612285,0.005443777,0.00028271935,0.000015049598,0.00021239757,0.00047304333,0.9636925,0.024117006,0.00022602138,0.0016260487],"study_design_scores_gemma":[0.0010399042,0.0001728683,0.0016945114,0.0043494483,0.00022447552,0.000032003118,0.00023195481,0.0011847344,0.9705449,0.014139151,0.0056019714,0.00078411144],"about_ca_topic_score_codex":0.00028929926,"about_ca_topic_score_gemma":0.000037708298,"teacher_disagreement_score":0.099416755,"about_ca_system_score_codex":0.00025413407,"about_ca_system_score_gemma":0.0016596764,"threshold_uncertainty_score":0.9994633},"labels":[],"label_agreement":null},{"id":"W4415900344","doi":"10.1136/jitc-2025-sitc2025.0588","title":"588 Selective inhibition of Diacylglycerol kinase zeta exhibits increased T cell activation and anti-tumor immunity, demonstrating pharmacodynamic proof of mechanism in the FIH trial of BAY2965501","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Aldose Reductase and Taurine","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Diacylglycerol kinase; Pharmacodynamics; Mechanism (biology); T cell; Kinase; Protein kinase C; Mechanism of action; Cell","score_opus":0.007561693293307385,"score_gpt":0.23947799589209692,"score_spread":0.23191630259878954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962576,0.0013339577,0.00012991193,0.00020725877,0.00012033175,0.0014520645,0.0001100436,0.0000049724663,0.00038387242],"genre_scores_gemma":[0.99887794,0.0005201912,0.00019661976,0.00008719281,0.00008074687,0.00003883533,0.00016169735,0.000024219678,0.000012554749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971984,0.00053391024,0.0011140555,0.0005036597,0.00032375622,0.00032620717],"domain_scores_gemma":[0.9981212,0.00012459705,0.0009633679,0.00038959406,0.00025306773,0.00014818605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011252364,0.00039020734,0.0006476674,0.00024127001,0.00014495148,0.000034217726,0.00018324239,0.00031640916,0.000002292827],"category_scores_gemma":[0.0004876969,0.00035394964,0.0001521058,0.0004603762,0.000585794,0.00005131141,0.00015778396,0.00038481207,8.956598e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002108694,0.0007468999,0.001104567,0.0012019937,0.00018073816,0.000010565583,0.00039929204,0.00007501076,0.9930816,0.0002931626,0.000034880417,0.0007625679],"study_design_scores_gemma":[0.012890675,0.0007238512,0.0048495485,0.000705692,0.0003052335,0.000025751915,0.0006829608,0.0005544651,0.97776735,0.0012128645,0.000018975477,0.0002626433],"about_ca_topic_score_codex":0.0004608354,"about_ca_topic_score_gemma":0.000042890068,"teacher_disagreement_score":0.015314289,"about_ca_system_score_codex":0.000033547196,"about_ca_system_score_gemma":0.0008839752,"threshold_uncertainty_score":0.9998912},"labels":[],"label_agreement":null},{"id":"W4415900424","doi":"10.1136/jitc-2025-sitc2025.0116","title":"116 Application of a comprehensive multi-omic immune profiling strategy achieves superior checkpoint immunotherapy response prediction in lung cancer","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Lung cancer; Profiling (computer programming); Immunotherapy; Cancer immunotherapy; Nivolumab; Immune checkpoint","score_opus":0.0161937421815287,"score_gpt":0.2976826542388666,"score_spread":0.2814889120573379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415900424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9093173,0.08464494,0.00029194565,0.001865239,0.00086143427,0.0026841688,0.0002134048,0.00007083809,0.0000507024],"genre_scores_gemma":[0.98856586,0.009025426,0.000603322,0.0003500083,0.00012844203,0.0003642743,0.00009569046,0.00007871732,0.00078828103],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99516827,0.00047146797,0.0022108385,0.00096922356,0.00047245788,0.0007077478],"domain_scores_gemma":[0.9975822,0.00019644634,0.0007571669,0.0008091407,0.00034251442,0.0003125305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001515575,0.0006982875,0.0012273642,0.0006551904,0.00025933312,0.00010692659,0.00028425618,0.0006370758,0.000041622578],"category_scores_gemma":[0.00018064756,0.00069625874,0.00034003047,0.00092222064,0.0011320454,0.0003530447,0.00006648367,0.00076950557,0.0000034716236],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015184963,0.0004294671,0.068684995,0.0019447607,0.0009248098,0.000020503816,0.0015663303,0.0006119946,0.90292376,0.000071669056,0.00008779747,0.007548915],"study_design_scores_gemma":[0.008323277,0.00034945196,0.6248491,0.0029561121,0.0002862469,0.000033744953,0.0018210427,0.009936326,0.34997475,0.000041734038,0.0010414391,0.00038679637],"about_ca_topic_score_codex":0.0044949064,"about_ca_topic_score_gemma":0.00019839464,"teacher_disagreement_score":0.5561641,"about_ca_system_score_codex":0.0007813847,"about_ca_system_score_gemma":0.002615499,"threshold_uncertainty_score":0.99954885},"labels":[],"label_agreement":null},{"id":"W4416074353","doi":"10.1136/jitc-2025-sitc2025.0107","title":"107 Multi-omic assessment of blood and tissue of renal cell carcinoma patients provides a comprehensive characterization of the systemic and local immune response","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Renal cell carcinoma; Immune system; Kidney cancer; Kidney; Cell","score_opus":0.011548335764911235,"score_gpt":0.2403977365315683,"score_spread":0.22884940076665705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416074353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98933315,0.0076814555,0.000051779836,0.00023868299,0.00027186747,0.00220485,0.00017964077,0.0000094927855,0.000029055387],"genre_scores_gemma":[0.99882865,0.00041475595,0.00027987533,0.00004207699,0.00002224203,0.00003019111,0.000055073077,0.000036877955,0.00029024438],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963079,0.0006262178,0.0015686698,0.0006044442,0.0005489,0.00034385253],"domain_scores_gemma":[0.99688125,0.00024723247,0.0013080529,0.0006514849,0.00056332746,0.00034867265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055863353,0.00049509504,0.0012062453,0.00027591892,0.00014168532,0.000032907225,0.00016384704,0.00030321037,0.0000028182892],"category_scores_gemma":[0.00022133368,0.00038617707,0.00013823099,0.00029872058,0.0015440072,0.00014029416,0.00026251137,0.00030164843,2.8349325e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074976694,0.000512839,0.21317354,0.006258819,0.00031157394,0.00003148227,0.0010822626,0.000026683225,0.777327,0.000032483687,0.000006060932,0.00048748162],"study_design_scores_gemma":[0.0036579708,0.00082936254,0.5344507,0.002358481,0.0011546003,0.000063774874,0.00031020126,0.0003906657,0.45662498,0.0000075952303,0.000017681112,0.00013398104],"about_ca_topic_score_codex":0.00041483654,"about_ca_topic_score_gemma":0.0000061743754,"teacher_disagreement_score":0.32127717,"about_ca_system_score_codex":0.00013602745,"about_ca_system_score_gemma":0.001115871,"threshold_uncertainty_score":0.99985904},"labels":[],"label_agreement":null},{"id":"W4416074415","doi":"10.1136/jitc-2025-sitc2025.0106","title":"106 Spatial multi-omic characterization of tumor microenvironment heterogeneity in hepatocellular carcinoma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Tumor microenvironment; Hepatocellular carcinoma; Tumor heterogeneity; Tumor cells; Cancer","score_opus":0.028865828059463857,"score_gpt":0.2299068720586562,"score_spread":0.20104104399919234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416074415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98920846,0.00608604,0.00022018889,0.0010492733,0.0008338826,0.0022895732,0.00018779744,0.000042406733,0.00008235273],"genre_scores_gemma":[0.996855,0.0009888512,0.00042334685,0.00043110436,0.00016020116,0.00010998863,0.0004586837,0.0000859032,0.0004868988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950463,0.0003868198,0.0018619397,0.0012256277,0.0005553133,0.0009239549],"domain_scores_gemma":[0.9974268,0.00006543836,0.0006712344,0.00086475996,0.00011425901,0.00085748057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007882684,0.000884812,0.0014558783,0.0006388631,0.00020047587,0.00009450199,0.00026900164,0.000526481,0.000055935907],"category_scores_gemma":[0.00021047129,0.00092802296,0.00039835117,0.0004993436,0.0007815913,0.00025647017,0.0002236905,0.00055526674,0.000034589764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018914945,0.00065818906,0.6362301,0.0012904142,0.0002180531,0.00047264987,0.00039804052,0.0000036925555,0.35950038,0.00002830942,0.000026311604,0.0009847156],"study_design_scores_gemma":[0.0032041268,0.0002198786,0.5613929,0.0009236464,0.00066961045,0.000047583842,0.00006247029,0.008320116,0.4240521,0.000022309736,0.00071643706,0.00036884897],"about_ca_topic_score_codex":0.0019380429,"about_ca_topic_score_gemma":0.00015852883,"teacher_disagreement_score":0.074837215,"about_ca_system_score_codex":0.00047387034,"about_ca_system_score_gemma":0.00086781103,"threshold_uncertainty_score":0.99931705},"labels":[],"label_agreement":null},{"id":"W4416075617","doi":"10.1136/jitc-2025-sitc2025.1069","title":"1069 Real-world experience with durvalumab amongst older patients","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Durvalumab; Disease; MEDLINE; Population; Incidence (geometry)","score_opus":0.00956199840565414,"score_gpt":0.25784839890166195,"score_spread":0.2482864004960078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416075617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794339,0.0035856734,0.000016520296,0.0021909985,0.0018918967,0.0013908084,0.000047296482,0.00012888353,0.011314046],"genre_scores_gemma":[0.97992295,0.0020253104,0.00025357783,0.0021233012,0.00025100025,0.00010003103,0.00007555417,0.00008431731,0.015163927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954536,0.00015056774,0.0011931021,0.0012372768,0.00093235855,0.0010331165],"domain_scores_gemma":[0.996887,0.000100312245,0.0004967331,0.0010458286,0.00040148917,0.001068584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005242626,0.0008313536,0.00096758903,0.00045403835,0.00057871436,0.00030127895,0.0003405366,0.00038681243,0.00017220204],"category_scores_gemma":[0.00025894874,0.00070358923,0.00023248843,0.0011787583,0.0021240413,0.00048365502,0.0001296696,0.0006109456,0.000025604559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031697294,0.00083089207,0.9504196,0.0014009974,0.0012731715,0.0002232817,0.005013603,0.0000126453915,0.0067288983,0.0006130553,0.017514652,0.012799483],"study_design_scores_gemma":[0.008021093,0.0005642254,0.9298219,0.0040618684,0.00056452944,0.000032708173,0.0010981559,0.00006123859,0.023072338,0.00011448765,0.031803574,0.0007838787],"about_ca_topic_score_codex":0.0030976757,"about_ca_topic_score_gemma":0.00078798615,"teacher_disagreement_score":0.02059769,"about_ca_system_score_codex":0.00045072616,"about_ca_system_score_gemma":0.0014532057,"threshold_uncertainty_score":0.9995415},"labels":[],"label_agreement":null},{"id":"W4416075644","doi":"10.1136/jitc-2025-sitc2025.1091","title":"1091 Decoding clinical and molecular determinants of tertiary lymphoid structure heterogeneity in pancreatic cancer by integrating multimodal spatial transcriptomics, proteomics, and histopathology imaging","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Histopathology; Pancreatic cancer; Disease; Cancer; Pancreas; Molecular imaging","score_opus":0.008576981915853005,"score_gpt":0.26860253141103707,"score_spread":0.2600255494951841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416075644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741013,0.022549996,0.0011822804,0.0003491401,0.00076217536,0.0007448632,0.00028058433,0.000013345037,0.000016289603],"genre_scores_gemma":[0.9918302,0.0039013342,0.0034110632,0.0005833417,0.00010112264,0.00002806334,0.00006366973,0.00006145663,0.000019718322],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99591875,0.00039903764,0.0015927606,0.0012683393,0.0001804614,0.0006406749],"domain_scores_gemma":[0.99849164,0.000057497495,0.00045811912,0.00041456928,0.00011943806,0.00045872774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068090105,0.0006724104,0.0010986798,0.00018026099,0.00019409947,0.0001126696,0.0002541991,0.0007484752,0.0000021735461],"category_scores_gemma":[0.00044986277,0.00070527254,0.00018139271,0.00012131289,0.0017083883,0.000044173787,0.00016912745,0.0005377189,9.0290094e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015580533,0.000069375536,0.5000107,0.00044641105,0.00006185075,0.00003153569,0.00017950419,0.000014173875,0.48953775,0.000008871409,0.000017852915,0.009466144],"study_design_scores_gemma":[0.0036636852,0.00017432039,0.23965666,0.0010178825,0.00035622768,0.00017935816,0.00015449774,0.011336279,0.742256,0.00028184205,0.00020641104,0.0007168232],"about_ca_topic_score_codex":0.0030012352,"about_ca_topic_score_gemma":0.0022999996,"teacher_disagreement_score":0.26035404,"about_ca_system_score_codex":0.000081992956,"about_ca_system_score_gemma":0.0005983876,"threshold_uncertainty_score":0.99953985},"labels":[],"label_agreement":null},{"id":"W4416076158","doi":"10.1136/jitc-2025-sitc2025.1150","title":"1150 MaaT034, a new co-cultured microbiome ecosystem therapy candidate, potentiates anti-PD1 mediated antitumoral activity in germ-free mice","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Microbiome; Ecosystem; Bacteria; Immune system","score_opus":0.00941429106082356,"score_gpt":0.2657198795771739,"score_spread":0.2563055885163503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416076158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97484946,0.018985013,0.000015143292,0.00220676,0.0007708538,0.0012354687,0.0012496245,0.000035951565,0.00065174577],"genre_scores_gemma":[0.98594123,0.00980645,0.00015260902,0.0003443552,0.00022601058,0.000040968793,0.0008089122,0.000069208,0.0026102632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99569124,0.00034184047,0.00081296347,0.0014410029,0.0004454357,0.0012675327],"domain_scores_gemma":[0.99721503,0.0000330085,0.0003882355,0.0010311467,0.00017981128,0.0011527585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005102115,0.00085804047,0.00095187814,0.0003783828,0.0003296715,0.00045899203,0.0006880284,0.0007565072,0.00003008695],"category_scores_gemma":[0.0003112335,0.00081517914,0.00030309806,0.0006555114,0.000504776,0.00007879867,0.0003243518,0.0005175219,0.000032258573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006730249,0.0004841856,0.04409342,0.00043157936,0.0010073418,0.00034063702,0.00017071624,0.000020122134,0.9307761,0.000023441018,0.0206505,0.0013289319],"study_design_scores_gemma":[0.008956063,0.0003725441,0.11880873,0.0006057874,0.00012984534,0.00015053013,0.000092973074,0.000066280736,0.8185942,0.00020426206,0.05116223,0.000856528],"about_ca_topic_score_codex":0.0067751594,"about_ca_topic_score_gemma":0.0064617493,"teacher_disagreement_score":0.11218188,"about_ca_system_score_codex":0.00027198892,"about_ca_system_score_gemma":0.0027240373,"threshold_uncertainty_score":0.9998388},"labels":[],"label_agreement":null},{"id":"W4416076177","doi":"10.1136/jitc-2025-sitc2025.1161","title":"1161 Novel cyclophilin inhibitors could serve as an NK cell-stimulating immunotherapy for triple negative breast cancer","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; International Seafood Sustainability Foundation","keywords":"Immunotherapy; Triple-negative breast cancer; Cyclophilin A; Cancer immunotherapy; Breast cancer","score_opus":0.012852219179175036,"score_gpt":0.2814946952335048,"score_spread":0.2686424760543297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416076177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98293793,0.008787659,0.0005349788,0.0017167728,0.0020558143,0.0017416902,0.0017958105,0.00006827492,0.000361062],"genre_scores_gemma":[0.99215424,0.0007326076,0.0019682178,0.0019446738,0.0010670482,0.00025515325,0.00038894982,0.00016004869,0.0013290448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955746,0.00018084874,0.001193498,0.0016211495,0.00044286376,0.0009870508],"domain_scores_gemma":[0.99660236,0.00012609315,0.00064130384,0.0009778276,0.0006032299,0.0010491776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007837068,0.0009424519,0.00077225524,0.00016177038,0.0007334579,0.00035341168,0.0005525397,0.0009918323,0.000026419782],"category_scores_gemma":[0.00067149615,0.0010264752,0.00044464914,0.00038764233,0.00081842626,0.00006790352,0.00020862726,0.0004969942,0.0000040629707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001229673,0.000634894,0.0059934524,0.0009190405,0.0006550028,0.00001740805,0.00067689107,0.005070794,0.97945595,0.00023713986,0.0024469327,0.0026628382],"study_design_scores_gemma":[0.0073222546,0.00060080964,0.007601165,0.0010629487,0.00048754393,0.000052717452,0.00063977315,0.0024212874,0.970534,0.002603083,0.0053065564,0.0013678157],"about_ca_topic_score_codex":0.00088361715,"about_ca_topic_score_gemma":0.00009860504,"teacher_disagreement_score":0.009216319,"about_ca_system_score_codex":0.00018833001,"about_ca_system_score_gemma":0.0027492165,"threshold_uncertainty_score":0.9992186},"labels":[],"label_agreement":null},{"id":"W4416076231","doi":"10.1136/jitc-2025-sitc2025.1166","title":"1166 Avidity engineered multifunctional antibodies that strongly activate and expand anti-tumor immunity in situ, turning cold patient tumor tissue hot and exerting durable tumor control in mice","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immunity; Antibody; Avidity; Immune system; Humoral immunity; Tumor cells; Immunotherapy","score_opus":0.010206595566446732,"score_gpt":0.24623540699914992,"score_spread":0.23602881143270318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416076231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855649,0.012554428,0.00002754932,0.00029819278,0.0002568808,0.001011109,0.00018097213,0.000017339338,0.00008863326],"genre_scores_gemma":[0.9982248,0.0010225986,0.00019390645,0.0001716806,0.000068156995,0.00009203748,0.00009793614,0.000040242532,0.00008865018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968247,0.00027139016,0.00071488635,0.0009666327,0.00033412236,0.0008883153],"domain_scores_gemma":[0.9985271,0.0001360084,0.00031157737,0.00033597482,0.0001233188,0.0005660342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005576694,0.0006069468,0.0007587945,0.00028562784,0.00038682125,0.00035259145,0.0001550967,0.00020841914,0.0000046329033],"category_scores_gemma":[0.0006243873,0.0006207048,0.000082699604,0.00023326324,0.0005931513,0.00012567596,0.0002633379,0.0006657101,0.0000010379478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006305342,0.00028406625,0.18847774,0.0005244521,0.00023059618,0.00027913094,0.000321135,0.00037503336,0.808183,0.000014776586,0.00010553947,0.0005739711],"study_design_scores_gemma":[0.0049109296,0.00033492313,0.39308634,0.0007976837,0.000080731465,0.00012010319,0.0007850717,0.0005795185,0.5978803,0.00003824547,0.00092965795,0.00045650077],"about_ca_topic_score_codex":0.003139899,"about_ca_topic_score_gemma":0.0014719433,"teacher_disagreement_score":0.21030273,"about_ca_system_score_codex":0.00016945286,"about_ca_system_score_gemma":0.00064803584,"threshold_uncertainty_score":0.99962443},"labels":[],"label_agreement":null},{"id":"W4416088080","doi":"10.1136/jitc-2025-sitc2025.0599","title":"599 The MATRiX trial: a multicenter, randomized, phase II study of ATR inhibition (via tuvusertib) with or without avelumab in patients with advanced anti-PD-(L)1-refractory merkel cell carcinoma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; EMD Serono","keywords":"Avelumab; Merkel cell carcinoma; Merkel cell; Phase (matter); Carcinoma; Matrix (chemical analysis)","score_opus":0.008445985497383852,"score_gpt":0.25578565912241846,"score_spread":0.24733967362503462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416088080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895447,0.0027114013,0.0000909936,0.00015391818,0.0003975426,0.0069429944,0.00007080926,0.000023751089,0.00006391357],"genre_scores_gemma":[0.99844766,0.0002306495,0.0003058451,0.00012019921,0.00008836195,0.0002941786,0.00009550431,0.00009297585,0.0003246117],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99491626,0.0008212024,0.0016405913,0.0012247227,0.0006735336,0.00072367484],"domain_scores_gemma":[0.99698305,0.00017111792,0.0010039046,0.00097115623,0.0005204179,0.00035033753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011261374,0.0009083009,0.0017610939,0.00027166816,0.00049943017,0.00009144561,0.0003389264,0.000365462,0.0000039080714],"category_scores_gemma":[0.0006708242,0.0005756602,0.00020780615,0.0005087985,0.0012878758,0.000059501308,0.0003077934,0.0005217223,0.0000010854653],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8134071,0.01469401,0.09199566,0.0012115758,0.0016175642,0.00010319172,0.007952673,0.00092790416,0.066538855,0.0000053819103,0.00013029343,0.0014157571],"study_design_scores_gemma":[0.83467096,0.01616473,0.019311665,0.00092384464,0.001470272,0.000007919419,0.0033616903,0.00033806043,0.12253624,0.000009960785,0.00031106445,0.00089357037],"about_ca_topic_score_codex":0.00047115478,"about_ca_topic_score_gemma":0.0006278888,"teacher_disagreement_score":0.072684,"about_ca_system_score_codex":0.00009737405,"about_ca_system_score_gemma":0.00093315047,"threshold_uncertainty_score":0.9996695},"labels":[],"label_agreement":null},{"id":"W4416088167","doi":"10.1136/jitc-2025-sitc2025.0427","title":"427 Mapping the expression of therapeutically targetable molecules in the tumor microenvironment of malignant pleural mesothelioma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Queen's University","funders":"","keywords":"Tumor microenvironment; Mesothelioma; Tumor cells; In vitro; Immunohistochemistry","score_opus":0.016306256658325368,"score_gpt":0.2343329296337351,"score_spread":0.21802667297540973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416088167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742367,0.020339752,0.00004062602,0.0038024585,0.00015439512,0.0007613446,0.000084873165,0.000006919617,0.000572933],"genre_scores_gemma":[0.99656403,0.0010831988,0.00042798714,0.0015124682,0.000053555137,0.000036716003,0.000028621242,0.000021184725,0.0002722561],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973449,0.00027667225,0.0009292844,0.00040798838,0.0006434429,0.00039767288],"domain_scores_gemma":[0.9986927,0.00020435179,0.00034892219,0.0005313781,0.000025882415,0.00019675803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006835685,0.00034224967,0.0005056531,0.00014005213,0.00017255913,0.000035231114,0.0003381518,0.00011325089,0.000064389904],"category_scores_gemma":[0.00014401552,0.00019820315,0.00019402117,0.0002722814,0.0012791244,0.00010844668,0.00015059544,0.00026598983,0.000005449155],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035861542,0.0007730496,0.23199047,0.0011426659,0.00020428647,0.000064081665,0.001601345,0.0005350689,0.760789,0.0011710487,0.000694694,0.0006757291],"study_design_scores_gemma":[0.00081461377,0.00012829411,0.7443635,0.001345982,0.00026261032,0.000028124261,0.0019968655,0.00021684723,0.24733828,0.0011865563,0.0021665625,0.0001517731],"about_ca_topic_score_codex":0.00016965324,"about_ca_topic_score_gemma":0.0000064568712,"teacher_disagreement_score":0.5134507,"about_ca_system_score_codex":0.00007010732,"about_ca_system_score_gemma":0.00022247991,"threshold_uncertainty_score":0.808249},"labels":[],"label_agreement":null},{"id":"W4416088438","doi":"10.1136/jitc-2025-sitc2025.0057","title":"57 High-throughput quantitative characterization of cytotoxic antibody-drug conjugates using spheroid models reveals important considerations in potential molecular mechanisms of ADC resistance","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Cytotoxic T cell; Conjugate; Spheroid; Cytotoxicity; Cell culture","score_opus":0.026555963767107112,"score_gpt":0.3195329329115008,"score_spread":0.2929769691443937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416088438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97252333,0.006446322,0.01584884,0.001747591,0.00062376825,0.0020577125,0.00060327665,0.00003427691,0.000114911134],"genre_scores_gemma":[0.981608,0.0019948077,0.015447692,0.00029780602,0.000057473753,0.000039286184,0.00018699322,0.00008842589,0.00027953202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9932873,0.00066061964,0.002945718,0.0010922414,0.0011721537,0.000841935],"domain_scores_gemma":[0.99591017,0.00024065428,0.0013939064,0.00087775773,0.0010146014,0.00056292675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020852326,0.0006395962,0.0017035151,0.0006269256,0.00023742979,0.00012451355,0.0002576544,0.00048179948,0.000067718036],"category_scores_gemma":[0.0015751751,0.00070379226,0.00022455589,0.0010193071,0.001448248,0.00063409,0.0001843916,0.00069902994,0.0000020985456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002270034,0.0003126725,0.0021335026,0.0031711648,0.0003654949,0.00038510782,0.001063565,0.0028351196,0.9037129,0.08571519,0.00006257102,0.000015685891],"study_design_scores_gemma":[0.0023062886,0.00023237511,0.012671281,0.008315126,0.0004634503,0.00004391206,0.0008982397,0.011571251,0.8678126,0.09518549,0.000013276317,0.00048676904],"about_ca_topic_score_codex":0.0017543515,"about_ca_topic_score_gemma":0.00023095113,"teacher_disagreement_score":0.035900373,"about_ca_system_score_codex":0.00033838398,"about_ca_system_score_gemma":0.0036444587,"threshold_uncertainty_score":0.99954134},"labels":[],"label_agreement":null}]}